Efforts towards the synthesis of a tripodal library for the discovery of serine-protease mimics by Farcy, Nadia
   
La fin de ces quatre années est un moment idéal pour quelques remerciements: 
 
Tout d’abord, je désirerai remercier mon promoteur, Prof. Dr. P. De Clercq de m'avoir donnée la 
possibilité d’accomplir mon doctorat dans son laboratoire et l’opportunité de participer à tous ces 
congrès (et stages) en Europe, qui ont donné une autre dimension à ce travail. Merci encore pour tous 
vos conseils, pour les discussions (en français) toujours très enrichissantes, pour le barbecue 
traditionnel et sans oublier tous vos efforts pour améliorer mon sens de l'orientation, ce qui était 
assez courageux je dois l’avouer. 
I want to thank the European network CombiCat for the financial support. More specially, I would like 
also to present my gratitude to Prof. Dr. R.W. Hoffman, Prof. Dr. A. Berkessel and Prof. Dr. A. Davis 
to have welcomed me in their laboratory during the different trainings I have followed. I want also to 
thank all people involved in the network for the nice moments we spent all together. 
Verder, zou ik ook graag, Prof. Dr. J. Van Der Eycken bedanken voor zijn interesse in CombiChem en 
voor zijn inspanningen tijdens de lessen van bio-organische en asymmetrische synthese tijdens mijn 
doctoraatsopleiding. Prof. Dr. D. De Keukeleire ben ik erkentelijk voor de tips bij de fotochemische 
afsplitsing. Prof. Dr. José Martins wil ik ook bedanken voor zijn hulp in de analyse van de 
tweedimensionele NMR spectra. Ik wil ook Georges, Franky en Wim niet vergeten voor de 
fantastische welkom telkens als ik een NMR buisje bracht. 
Ik wil ook het ATP-personeel bedanken voor de goede sfeer en hun behulpzaamheid: Jan voor de  
‘last-minute’ bestellingen, Dirk en Hector voor de vriendelijke bezoekjes in het labo, Veerle om toch 
het magazijn buiten de openingsuren te openen. Tom en Freddy wil ik ook bedanken voor alle 
papierwerk. Ook, wil ik een woord van dank richten aan Noël Hosten voor zijn nuttige tips in de 
synthese van de scaffold. 
Een heel speciaal woord van dank richt ik aan Gerd voor de 'massa's' electrosprays die ik altijd op tijd 
gekregen heb. Nog bedankt! 
Uiteraard wil ik ook mijn collega’s en vrienden van het labo bedanken die van deze vier jaren een 
speciale tijd gemaakt hebben. Eerst en vooral wil ik Annemieke bedanken voor haar steun gedurende 
deze vier jaren zonder vergeten de leerlijke discussies en leuke momenten die wij samen 
doorgebracht hebben (feestjes, TMR-meetings…). Ook bedankt voor het nalezen van dit doctoraat. 
Vanessa, bedankt om naar mijn klagen te luisteren over mijn mislukte reacties en om altijd behulpzaam 
te zijn. Wim, heb jij verdiend dat ik u bedank? ja toch wel, om mijn chemische vragen te 
beantwoorden en voor de leuke en natte fietstochten. Verder wil ik zeker niet vergeten Pol, Jo (dank 
u voor uw lessen in dialect), Vincent, Mieke, An (mijn opvolger: blijven geloven in combichem en 
bedankt voor de reacties op vaste fase dat jij voor mij gedaan hebt), Samuel en Johan. Ik wil jullie 
allemal bedanken voor de leuke sfeer in het labo. Verder dank ik de 'oude' (niet kwaad zijn!) 
generaties. Ik bedoel: dank u aan, Mario, Sofie, Christel, Jean (veel success in Bristol), Sandra, Hilde 
Jr voor de leuke samenwerking, Gunther voor zijn optimisme, Hilde Sr voor haar fantastische stem op 
onze trouw, Sven voor de leuke Nederlandse lessen en voor de 'lekkere' vrijdagmiddagen. Een 
bijzondere bedanking ook aan alle meisjes die deelgenomen hebben aan mijn vrijgezellenavond. Ik zal 
het nooit vergeten.  
Finally, I would like to thank also the Chinese delegation, Lui Li, Ling Jie, Wang and Zhao. 
Tenslotte wil ik mijn familie in België bedanken voor hun steun in belangrijke momenten en om mij (een 
française) zo goed aanvaard te hebben. Nog bedankt voor de inspanningen in Frans als ik hier 
toekwam. 
Je voudrais également remercier de tout coeur mes parents, pour m'avoir toujours soutenue pendant 
mes études et dans mes décisions tout au long de ce parcours. J'ai toujours pu compter sur vous deux. 
Et pour finir, un remerciement très spécial est réservé à mon mari, Bart, qui a dû supporter le stress 
de ces 'six' derniers mois, et qui est devenu l'homme de maison, le cuisinier et le jardinier. Tous tes 
conseils étaient précieux et ton soutien irremplaçable. Ta présence à mes côtés était un véritable 
réconfort. Je pense manquer de mots pour te remercier alors tout simplement merci.  
   
 
List of abbreviations 
Ac Acetyl       
AcIm Acetylimidazole      
AcOH Acetic acid      
AIBN 2,2'-Azobisisobutyronitrile     
Ala Alanine       
Asp Aspartic acid      
Bn Benzyl       
Boc tert-Butoxycarbonyl      
CAN Cerium Ammonium Nitrate     
DCC Dicyclohexylcarbodiimide     
DDQ Dichlorodicyanoquinone     
DEAD Diethylazodicarboxylate     
DIC Diisopropylcarbodiimide     
DIPEA Diisopropylethylamine     
DMAP 4-Dimethylaminopyridine     
DMF N, N'-Dimethylformamide      
DMPM 3,4-Dimethoxyphenylmethyl     
DMPU N,N'-Dimethylpropyleneureum     
DMSO Dimethylsulfoxide      
EDC N-Ethyl-N'-(3-aminopropyl)-carbodiimide hydrochloride   
ES-MS Electrospray-Mass spectrometry    
Fmoc 9-Fluorenylmethoxycarbonyl     
Gly Glycine       
HBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
HF/Pyr. Hydrogen fluoride/pyridine     
His Histidine       
HOAt 1-Hydroxy-7-azabenzotriazole     
HOBt 1-Hydroxybenzotriazole     
Hz Hertz       
IR Infrared       
Leu Leucine       
m.p. Melting point      
M.W. Molecular Weight      
MeOH Methanol       
MHz MegaHertz      
NMM N-methylmorpholine      
NMR Nuclear Magnetic Resonance     
Phe Phenylalanine      
Pip. Piperidine       
PPTS Pyridinium p-toluenesulfonate    
PTSA p-Toluene sulfonic acid     
ROESY Rotational Overhauser Effect Spectroscopy      
r.t. Room temperature      
Ser Serine   
TASF Tris-(dimethylamino)sulfur trimethylsilyldifluoride     
TBAF Tetrabutylammonium fluoride     
TBDPS tert-Butyldiphenylsilyl       
TFA Trifluoroacetic acid      
   
THF Tetrahydrofuran      
THP Tetrahydropyranyl      
TNBS 2,4,6-Trinitrobenzenesulfonic acid     
UV/VIS Ultraviolet/Visible      
Val Valine       
        
 
 
 
 
 
 
 
 
 
   
Table of contents 
 
1 Introduction .................................................................................................................1 
1.1 Preface...................................................................................................................................................................1 
1.2 Combinatorial Chemistry.............................................................................................................................2 
1.2.1 Solid Phase Peptide Chemistry ......................................................................................................2 
1.2.1.1 Choice of solid support .......................................................................................................................3 
1.2.1.2 Protection schemes ..........................................................................................................................4 
1.2.1.3 Coupling methods in SPPS .............................................................................................................5 
1.2.2 Synthetic strategies towards combinatorial libraries...................................................7 
1.2.2.1 Parallel synthesis..............................................................................................................................7 
1.2.2.2 'Split and mix' synthesis...............................................................................................................8 
1.3 Serine protease: a-chymotrypsin.........................................................................................................9 
1.3.1 Introduction..............................................................................................................................................9 
1.3.2 Artificial enzymes ..............................................................................................................................12 
1.3.2.1 Mimics involving imprinted polymers ......................................................................................12 
1.3.2.2 Mimics of a-chymotrypsin involving peptides.....................................................................14 
1.4 Scope and goal of this PhD work........................................................................................................16 
2 Development of a test substrate for hydrolytic activity.............20 
2.1 Introduction....................................................................................................................................................20 
2.2 Synthesis of I.16..........................................................................................................................................25 
2.3 Applications: a novel colorimetric assay for visual detection of solid-phase bound 
amines ...............................................................................................................................................................................30 
2.3.1 Introduction...........................................................................................................................................30 
2.3.2 A new colorimetric test…...............................................................................................................31 
2.4 Conclusion..........................................................................................................................................................34 
3 The tripodal scaffold.......................................................................................35 
3.1 A new tripodal scaffold............................................................................................................................35 
3.2 Synthesis of the tripodal scaffold III.6.....................................................................................38 
3.3 Study of the selective deprotection of the THP, DMPM and TBDPS protecting 
groups................................................................................................................................................................................41 
3.4 Conclusion..........................................................................................................................................................49 
4 The incorporation of a cleavable linker ..................................................50 
4.1 Introduction....................................................................................................................................................50 
4.2 The Rink Linker: an acid labile linker...............................................................................................51 
   
4.3 The Kenner linker: a safety-catch linker......................................................................................53 
4.4 Photolabile linkers........................................................................................................................................55 
4.5 Study of the selective deprotection of the THP, DMPM and TBDPS protecting 
groups................................................................................................................................................................................61 
4.6 Conclusion..........................................................................................................................................................67 
5 Efforts towards the synthesis of a tripodal library.......................69 
5.1 Introduction....................................................................................................................................................69 
5.2 Choice of the suitable side-chain protecting groups.............................................................71 
5.3 Synthesis of a dipodal library using the ‘IRORI’ technique..............................................73 
5.3.1 Introduction of the ‘IRORI-technique’.................................................................................73 
5.3.2 Synthesis of a dipodal library using the ‘IRORI’ technique.....................................75 
5.4 Transformation of IV.24 into an amine-functionalised tripodal scaffold..............78 
5.5 Synthesis of one member of the tripodal library...................................................................82 
5.6 Conclusion..........................................................................................................................................................89 
6 General conclusion and perspectives........................................................90 
7 Experimental part ..............................................................................................96 
7.1 Products, methods, chromatography, and spectroscopy.....................................................96 
7.2 Experimental data of part 2.................................................................................................................97 
7.3 Experimental data of part 3..............................................................................................................107 
7.4 Experimental data of part 4..............................................................................................................125 
7.5 Experimental part of part 5...............................................................................................................152 
8 References...........................................................................................................179 
9 Appendix................................................................................................................184 
10 Samenvatting ......................................................................................................186 
11 Curriculum Vitae.................................................................................................191 
 
 
 
Part 1: Introduction  1 
1 Introduction 
 
1.1 Preface 
In the world of biochemistry, enzymes are molecules of primary significance. They are among 
the most remarkable biomolecules known because of their extraordinary specificity and catalytic 
power. They can catalyse biological reactions that would normally occur slowly or not at all under 
physiologically acceptable conditions. 
One of the great intellectual challenges presented to science today is a proper understanding of 
how enzymes work. What an enzyme does, is bind, and thus stabilise, selectively the transition 
state for a particular reaction. However, our current level of understanding fails the more 
severe, practical test, that of designing and developing artificial enzyme systems with catalytic 
efficiencies which rival those of natural enzymes.1 
The most remarkable property of proteases is the ease with which they are capable of cleaving 
amide bonds while a typical chemical procedure for hydrolysing aliphatic amides requires 8 N 
hydrochloric acid at reflux for 10 hours. The development of a catalyst for such a reaction 
remains one of the major challenges in organic chemistry.2 
Until now the discovery of man-made compounds with useful catalytic properties has been 
tremendously slow. A strategy for the development of such a new catalyst usually starts off 
with the design of a specific molecule that is subsequently synthesised, purified, characterised 
and tested on its activity. The activity is optimised by modification of the initial molecule. In 
this way, the development of a new catalyst requires years of research. To render this time-and 
cost intensive process more efficient, combinatorial methods have been introduced to the field 
of catalysis since a few years.3  
In a short period of time, combinatorial chemistry allows for the synthesis of large libraries of 
molecules increasing the chance of finding one or several members possessing catalytic activity. 
In this work, we describe a combinatorial approach towards the development of a new man-made 
catalyst for the hydrolysis of amide bonds, based on the well-known serine-protease a-
chymotrypsin. In this chapter, the different aspects of combinatorial chemistry will be 
discussed. Subsequently, an introduction concerning the serine-protease, a-chymotrypsin will be 
presented.   
                                                                 
1 Kirby, A.J. Angew. Chem. Int. Ed. Engl. 1994, 33, 551. 
2 (a) Kirby, A.J. Angew. Chem. Int. Ed. Engl. 1996, 35, 707; (b) Motherwell, W.B.; Bingham, M.J.; Six, Y. 
Tetrahedron 2001, 57, 4663. 
3 Bein, T. Angew. Chem. Int. Ed. Engl. 1999, 38, 323. 
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1.2 Combinatorial Chemistry  
For over a hundred years, the main task of the synthetic chemist has been the straightforward 
synthesis of one synthetic product. In contrast to classical chemistry, combinatorial chemistry 
allows for the rapid synthesis of large numbers of compounds. Since the early 1990’s, 
combinatorial chemistry has attracted the attention of companies as a means of reducing the 
time and cost associated with the drug discovery process. The possibility to synthesise hundreds 
to thousands times more compounds than conventional organic synthesis increases substantially 
the chance of finding a new target molecule. The wide applications of combinatorial chemistry in 
the drug discovery process have been well documented.4 The same way of thinking can also be 
applied in the search for new models mimicking the efficiency of enzymes. Synthesising a large 
amount of compounds increases substantially the chance of finding a catalyst compared to the 
design of one specific molecule. 
The characteristic of combinatorial chemistry is that many different compounds are synthesised 
simultaneously under identical reaction conditions in a systematic manner to form a 
‘combinatorial library’. The library is then screened for the catalytic property in question and 
the active compound is identified. The total number of all synthesised compounds within a 
combinatorial library depends on two main factors: the number of building blocks involved in each 
step (y) and the number of reaction steps (z). When the number of building blocks are identical 
in each step, the amount of possible synthesised compounds (N) is given by the equation: N = yz. 
 
1.2.1 Solid Phase Peptide Chemistry 
Almost four decades ago, Merrifield introduced the concept of solid phase 
synthesis in the area of peptide chemistry.5 The revolutionary principle 
behind is that if the peptide is bound to an insoluble polymer, unreacted 
reagents at the end of each synthetic step can be removed by a simple 
washing procedure, substantially decreasing the time required for synthesis 
and purification (figure 1.1). At the end of the synthesis, the peptide is 
cleaved from the solid support and purified. 
 
                                                                 
4 (a) Gallop, M.A.; Barrett, R.W.; Dower, W.J.; Fodor, S.P.A.; Gordon, E.M. J. Med. Chem. 1994, 37, 1233; (b) 
Gordon, E.M.; Barrett, R.W.; Dower, W.J.; Fodor, S.P.A.; Gallop, M.A. J. Med. Chem. 1994, 37, 1385; (c) 
Terret, N.K.; Gardner, M.; Gordon, D.W.; Kobylecki, R.J.; Steele, J. Tetrahedron 1995, 51, 8135. 
5 Merrifield, R.B. J. Am. Chem. Soc. 1963, 85, 2149. 
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Figure 1.1: Solid phase peptide chemistry  
 
This is only valid, however, if each individual synthetic step occurs with quantitative yields. In 
peptide chemistry, high yields can be achieved by using excess of reagents to push the reaction 
to completion. However, in order to attain such a high performance in yield, all aspects of the 
chemistry, from the solid support itself to the protecting groups and coupling reagents used, 
must be rigorously optimised.  
 
1.2.1.1 Choice of solid support 
For a solid support to be useful for SPPS (solid phase peptide synthesis), it must consist of 
physically robust particles that remain chemically inert to all reagents and solvent used during 
the synthesis. It needs functional groups allowing for the attachment of the first amino acid to 
the solid phase. The polystyrene-based resins cross linked with 1% or 2% divinylbenzene are the 
most frequently polymer supports used in SPPS. Two famous examples are the Merrifield5 resin 
and the Wang6 resin. One important feature is the swelling of the polymer in the reaction 
solvent allowing penetration of the reagents through the particles, ensuring accessibility of the 
reactive sites to the reagents.7 
 
CH2Cl
CH2OWang resin
Merrifield resin
CH2OH
PS
PS
 
 
Figure 1.2 
 
 
                                                                 
6 Wang, S.S. J. Am. Chem. Soc. 1973, 95, 1328. 
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1.2.1.2 Protection schemes 
In the synthesis of a dipeptide, merely mixing two free amino acids is not sufficient. This would 
lead to the formation of a mixture of di-, tri, and polypeptides in all possible combinations. 
Therefore, the choice of a suitable protection scheme is of great importance.  
Although many protecting groups exist, the research and development efforts in SPPS have led 
to two major protection schemes that are used today. These are the so-called Boc/Bzl (tert-
butoxycarbonyl/benzyl) approach developed by Merrifield8 and the Fmoc/tert-Bu (9-
fluorenylmethoxycarbonyl/tert-butyl) approach introduced later by Carpino9 (figure 1.3).  
 In the Boc/Bzl strategy, the Boc group is used as Na-protection in combination with 
benzyl-based side-chain protecting groups. The peptides are usually synthesised on Merrifield 
resin and are then cleaved from the polymer using hydrogen fluoride.  
 In the Fmoc/tert-Bu strategy, using a tert-butyl-based side-chain protection is obviously 
incompatible with the Boc group but fully compatible with the base labile protecting Fmoc group. 
In that case, Wang resin is used due to its higher acid lability compared to Merrifield resin. 
Peptides are cleaved from the solid support with trifluoroacetic acid (TFA). The superiority of 
the Fmoc/tert-Bu strategy over Boc/Bzl has already been proven. The synthesis of the same 
sixteen amino acids containing peptide with both methods led to a better yield and purity when 
the Fmoc strategy was applied.10 In this work, the Fmoc/tert-Bu approach will be used. 
                                                                                                                                                                                                          
7 Santini, R.; Griffith, M.C.; Qi, M. Tetrahedron Lett. 1998, 39, 8951. 
8 Merrifield, R.B. Science 1986, 232, 341. 
9 (a) Carpino, L.A.; Han, G.Y. J. Am. Chem. Soc. 1970, 92, 5748; (b) Carpino, L.A.; Han, G.Y. J. Org. Chem. 
1972, 37, 3404. 
10 Novabiochem catalog, 2000, I: Introduction and background, I1-I16 
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Figure 1.3: protecting group strategies 
 
1.2.1.3 Coupling methods in SPPS 
Carbodiimides continue to be the most widely used coupling reagents in SPPS (figure 1.4). 
Dicyclohexylcarbodiimide11 (DCC) was the first one introduced into peptide chemistry almost 50 
years ago and is actually replaced by diisopropylcarbodiimide12 (DIC) which forms a more soluble 
urea by-product. The introduction of additives like 1-hydroxybenzotriazole (HOBt)13 or 1-
hydroxy-7-azabenzotriazole (HOAt)14 into the reaction speeds up coupling processes and 
decreases dramatically the problem of racemisation and dehydration. Active research into the 
development of new carbodiimides for peptide couplings continues.15 
                                                                 
11 Sheehan, J.C.; Hess, G.P. J. Am. Chem. Soc. 1955, 77, 1067. 
12 Sarantaskis, D.; Teichman, J.; Lien, E.L.; Fenichel, R. Biochem. Biophys. Res. Commun. 1976, 73, 336. 
13 König, W.; Geiger, R. Chem. Ber. 1970, 103, 2034. 
14 Carpino, L.A. J. Am. Chem. Soc. 1993, 115, 4397. 
15 Gibson, F.S.; Park, M.S.; Rapoport, H. J. Org. Chem. 1994, 59, 7503. 
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Next to carbodiimides, many new coupling reagents have been developed. Acylphosphonium salts 
(figure 1.5) became widely used in SPPS since their appearance in 1969.16 However, the originally 
introduced 1H-benzotriazol-1-yloxy-tris(dimethylamino) phosphonium hexafluorophosphate (BOP) 
reagent developed by Castro17 has been replaced by 1H-benzotriazol-1-yloxy-
tris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP), which forms a less toxic reaction-
product.  
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Figure 1.5 
 
 
 
                                                                 
16 Gawne, G.; Kenner, G.; Sheppard, R.C. J. Am. Chem. Soc. 1969, 91, 5669. 
17 Castro, B.; Dormoy, J.R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 1219.  
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Furthermore, besides these reagents uronium salts have gained importance as coupling 
reagents.18 More recently, a new generation of phosphonium and uronium coupling reagents based 
on HOAt has been developed such as the aza analogue of 2-(1H-9-azabenzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU) known as 2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HATU). These coupling reagents appeared to be 
useful for the coupling of sterically hindered amino acids.19,20 
 
1.2.2 Synthetic strategies towards combinatorial libraries 
 
1.2.2.1 Parallel synthesis 
The simplest approach in combinatorial chemistry is parallel synthesis. Molecules are 
simultaneously synthesised in a parallel way in distinct reaction vessels (figure 1.6). Parallel 
synthesis offers the advantage that each compound in each separate vessel is known at any time. 
This method is comparable with solution phase synthesis.  
 
E
A B C D AE BE CE DE
coupling
2) coupling
F
AEF BEF CEF
1) washing
DEF
 
Figure 1.6: parallel synthesis on solid support 
 
However, the easy purification in the case of solid phase chemistry explains why parallel 
synthesis on solid support is widely used. Several methods involving parallel synthesis on solid 
phase have already been described; the so-called ‘Tea-Bag’ method developed in 1984 by 
Houghten21, the multipin-technique on polypropylene ‘pins’ in a 96-well plate introduced by 
                                                                 
18 (a) Dourtouglou, V.; Ziegler, J.-C.; Gross, B. Tetrahedron Lett. 1978, 1279; (b) Dourtouglou, V.; Gross, B.; 
Lambropoulou, V.; Ziodrou, C. Synthesis 1984, 572.  
19 Albericio, F.; Bofill, J.M.; El-Faham, A.; Kates, S.A. J. Org. Chem. 1998, 63, 9678. 
20 (a) Coste, J.; Dufour, M.N.; Pantaloni, A.; Castro, B. Tetrahedron Lett. 1990, 31, 669; (b) Frérot, E.; 
Coste, J.; Pantaloni, A.; Dufour, M.-N.; Jouin, P. Tetrahedron 1991, 47, 259. 
21 Houghten, R.A. Proc. Natl. Acad. Sci. USA 1985, 82, 5131. 
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Geysen22 in 1984 and the spatially addressable parallel synthesis on silica wafer pioneered by 
Fodor in 1991.23 
 
1.2.2.2 'Split and mix' synthesis 
The synthesis of large libraries as a mixture of compounds using the ‘split and mix’ protocol was 
reported for the first time by Furka24a in 1988. But it is also referred to as ‘divide, couple and 
recombine’ by Houghten24b or ‘the split synthesis’ by Lam.24c A schematic illustration of the split 
and combine method is given in figure 1.7.  
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IFB
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Figure 1.7 : The 'split and mix' method 
                                                                 
22 Geysen, H.M.; Meloen, R.H.; Barteling, S.J. Proc. Natl. Acad. Sci. USA 1984, 81, 3998. 
23 Fodor, S.P.A.; Rava, R.P.; Huang, X.C.; Pease, A.C.; Holmes, C.P.; Adams, C.L. Nature (London) 1993, 364, 
555.   
24 (a) Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. Int. J. Peptide Protein Res. 1991, 37, 487; (b) 
Houghten, R.A.; Pinilla, C.; Blondelle, S.E.; Appel, J.R.; Dooley, C.T.; Cuervo, J.H. Nature (London) 1991, 354, 
84; (c) Lam, K.S.; Salmon, S.E.; Hersh, E.M.; Hruby, V.J.; Kazmierski, W.M.; Knapp, R.J. Nature (London) 
1991, 354, 82. 
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The procedure is simple and involves the division of the resin in a number (y) of equal batches. A 
single different monomer is then coupled in each vessel and after the coupling, all batches are 
mixed together thoroughly. The mixed resin is divided again into y batches and another series of 
coupling reactions are carried out. Repeating this protocol for z cycles can in principle produce a 
collection of yz compounds. The coupling of a few building blocks can lead to the synthesis of 
large libraries in a short time. Furthermore, on each bead of the library, one compound is 
synthesised. The ‘split and mix’ method is also referred to as the ‘one bead /one compound’ 
concept.  
 
1.3 Serine protease: a-chymotrypsin 
 
1.3.1 Introduction 
The term serine protease derives from a class of enzymes containing a serine residue in the 
active site. The most studied example of this group is a-chymotrypsin. The mechanism of a-
chymotrypsin is probably understood in more details than any other enzyme. Its function is to 
catalyse the hydrolysis of peptide bonds of protein foods in the mammalian gut. It is secreted in 
the pancreas under an inactive form called chymotrypsinogen, a single protein chain of 245 amino 
acids, which is activated by trypsin in the small intestine by cleavage at two specific regions. The 
three-dimensional structure was elucidated by Blow in 1967.25 
In addition to the serine-195 residue, the active site contains two other amino acids implied in 
the hydrolysis of amide bonds, histidine-57 and aspartate-102. They form the so-called 
‘catalytic triad’. a-Chymotrypsin is known to have specificity for amino acids with an aromatic 
side-chain like phenylalanine, tyrosine and tryptophan due to the presence of a hydrophobic 
pocket in the binding site. Proteins are cleaved on the carboxyl side of these aromatic amino 
acids.  
For the hydrolytic activity of a-chymotrypsin, a ‘charge relay’ mechanism, which is presented in 
scheme 1.1, was first proposed in 1969 by Blow.26 Two stages can be distinguished in the 
mechanism: the acylation step during which the acyl-enzyme is formed and the deacylation step 
during which the acyl-enzyme is hydrolysed. 
                                                                 
25 (a) Mattews, B.W.; Sigler, P.B.; Henderson, R.; Blow, D.M. Nature (London) 1967, 214, 652; (b) Blow, D.M. 
Acc. Chem. Res. 1976, 9, 145.  
26 Blow, D.M.; Birktoft, J.J.; Hartley, B.S. Nature (London) 1969, 221, 337. 
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The hydroxyl function of the amino acid serine-195 is not nucleophilic enough to attack the 
carbonyl function of the scissile bond but as a result of general base catalysis by the imidazole 
ring of the amino acid histidine-57, the nucleophilicity of the serine hydroxyl function is 
enhanced making a nucleophilic attack possible. The role of the carboxylate residue of 
aspartate-102 consists in polarising the imidazole moiety. This allows for a concerted proton 
transfer mechanism.  
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Scheme 1.1: ‘charge relay’ mechanism 
 
In a first step, a tetrahedral intermediate T1 is formed, stabilised by hydrogen bond formation 
with the amide hydrogen of serine-195 and glycine-193 present on the backbone of the enzyme. 
The tetrahedral intermediate then decomposes via general acid catalysis to form the acyl-
enzyme with liberation of the amine. 
During the deacylation step, via essentially the same mechanism, the acyl-enzyme is hydrolysed 
by water. First, a molecule of water is deprotonated by the imidazole ring of the histidine-57 
with the help of aspartate-102 and attacks the acyl-enzyme. A second tetrahedral intermediate 
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T2 is formed, which subsequently decomposes with release of the carboxylic acid and 
regeneration of the catalytic system.  
The role of aspartate-10227 in the mechanism of a-chymotrypsin is still under discussion.28 An 
alternative mechanism has been proposed by Zimmerman and involves a single proton transfer 
from serine-195 to histidine-57, while the carboxylate of aspartate-102 serves to stabilize the 
charge of the imidazolium ion. This is the so- called ‘charge stabilisation’ mechanism.  
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Scheme 1.2: ‘charge stabilisation’ mechanism 
 
In 1994, a mechanism has been proposed in which a low-barrier hydrogen bound (LBHB) would be 
formed between histidine-57 and aspartate-102 (scheme 1.3).29 However, this mechanism is still 
under discussion.30 
 
                                                                 
27 (a) Sprang, S.; Standing, T.; Fletterick, R.J.; Stroud, R.M.; Finer-Moore, J.; Xuong, N.-H.; Hamlin, R.; 
Rutter, W.J.; Craik, C.S. Science 1987, 23, 905; (b) Craik, C.S.; Roczniak, S.; Largman, C.; Rutter, W.J. 
Science 1987, 23, 909. 
28 Zimmerman, S.C.; Korthalsn, J.S.; Cramer, K.D.Tetrahedron 1991, 47, 2649. 
29 (a) Frey, P.A.; Whitt, S.A.; Tobin, J.B. Science 1994, 264, 1927; (b) Cleland, W.W.; Kreevoy, M.M. Science 
1994, 267, 1887.  
30 Warshel, A.; Cleland, W.W.; Kreevoy, M.M.; Frey, P.A.; Whitt, S.A.; Tobin, J.B. Science 1995, 269, 103. 
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Scheme 1.3: ‘low barrier hydrogen bound’ mechanism 
 
1.3.2 Artificial enzymes  
The efficiency of the serine proteases has inspired scientists to the design of artificial 
enzymes. Past efforts to synthesise chymotrypsin models can be classified in three main classes: 
(1) Molecules designed with suitable functionalities which are expected to be involved in the 
catalysis of the chosen reaction,31 (2) imprinted polymers and (3) pepzymes.  
 
1.3.2.1 Mimics involving imprinted polymers 
The first successful application of molecular imprinting to the design of a stereoselective 
catalyst with esterase activity was reported almost one decade ago.32 Molecular imprinting is a 
method for obtaining specific microcavities in cross-linked polymers. The cross-link 
polymerisation is forced to take place around a transition state analogue of a chosen reaction. 
The transition state analogue is subsequently removed leaving behind an imprinted and defined 
shape bearing functional groups in specific positions, which are accessible for interactions. An 
example of molecular imprinting is given in scheme 1.4. Shea developed the network polymer I.1 
by photo-initiated free radical polymerisation of the monomers I.2 and I.3 in the presence of 
the D-enantiomer of the alkaline ester hydrolysis transition state analogue I.4. The D-
phosphonic ester I.4 is removed in the next stage to provide the polymer I.5 containing a 
stereoselective binding site and the catalytic elements responsible for hydrolytic activity.  
 
                                                                 
31 For details concerning this approach see: Annemieke Madder, PhD-thesis ‘Stapsgewijze ontwikkeling van 
niet-enzymatische hydrolasen’ 1997. 
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Scheme 1.4 
 
The rate of hydrolysis of both enantiomers D- and L-tert-butoxycarbonyl-phenylalanine p-
nitophenyl ester I.6 in presence of polymer I.5 was measured and compared to reference 
compound I.7. A 10-fold acceleration was observed and as expected, polymer I.5 proved to 
hydrolyse the complementary substrate D-tert-butoxycarbonyl-phenylalanine p-nitrophenyl 
ester faster than the L-enantiomer.  
Other applications of imprinted polymers in the field of a-chymotrypsin mimics, or more 
generally in the area of esterase mimics have been recently published.33 
 
 
                                                                                                                                                                                                          
32 Sellergren, B.; Shea, K.J. Tetrahedron, Asymmetry 1994, 5, 1403. 
33 (a) Wulff, G.; Gross, T.; Schönfeld, R. Angew. Chem. Int. Ed. Engl. 1997, 36, 1962; (b) Lele, B.S.; Kulkarni, 
M.G.; Mashelkar, R.A. Reactive and functional polymers 1999, 39, 37; (c) Sellergren, B.; Karmalkar, R.N.; 
Shea, K.J. J. Org. Chem. 2000, 65, 4009; (d) Wulff, G. Chemical Reviews  2002, 102, 1. 
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1.3.2.2 Mimics of a-chymotrypsin involving peptides 
In 1990, Hahn and Klis designed a 73-residue peptide with enzyme-like activity.34 With the help 
of computer modelling, a bundle of four short parallel amphipathic helical peptides containing the 
catalytic triad (serine, histidine and aspartate) in a spatial arrangement similar to that of the 
enzyme, was designed (figure 1.8). An ‘oxyanion hole’ and a binding site were also included. This 
assembly caused an acceleration with a factor of 105 compared to spontaneous hydrolysis in the 
cleavage of ester substrates (acetyltyrosine ethyl ester, benzyloxycarbonyltyrosine p-
nitrophenyl ester and benzoyltyrosine ethylester). The activity of the peptide was inhibited by 
a-chymotrypsin inhibitors like diisopropyl fluorophosphate. 
 
chains linked
together
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Glu Ser
His
hydrophylic 
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hydrophobic
'pocket'
 
 
Figure 1.8 
 
However, in two later reports, the earlier remarkable results in the hydrolysis of less labile 
esters and amides by the synthetic peptide were proven to be incorrect.34b, c 
 
Efforts were further invested in the design and synthesis of cyclic peptides as mimics of a-
chymotrypsin (figure 1.9). Atassi and Manshouri prepared cyclic peptides to mimic the active site 
of trypsin and a-chymotrypsin respectively.35a Peptide I.8 was generated to mimic the 
conformation and disposition of the residues present in the active site. The components of the 
catalytic triad were scaffolded onto cyclic 23 and 29 residue-peptides, separated by glycine 
spacers. Construct I.8 was claimed to cause the hydrolysis of several a-chymotrypsin 
substrates with enzyme-like efficiency and selectivity. The activity was further inhibited by 
                                                                 
34 (a) Hahn, K.W.; Klis, W.A.; Stewart, J.M. Science 1990, 248, 1544; (b) Corey, M.J.; Hallakova, E.; Pugh, K.; 
Stewart, J.M. Appl. Biochem. Biotechnol. 1994, 47, 199; (c) Corey, M.J.; Corey, E. Proc. Natl. Acad. Sci. 
USA 1996, 93, 11428. 
35 (a) Atassi, M.Z.; Manshouri, T. Proc. Natl. Acad. Sci. USA 1993, 90, 8282; (b) Matthews, B.W.; Craik, 
C.S.; Neurath, H. Proc. Natl. Acad. Sci. USA 1994, 91, 4103; (c) Corey, D.R.; Phillips, M.A. Proc. Natl. Acad. 
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diisopropyl fluorophosphate (DIFP) and 1-p-tosylamino-2-phenylethyl chloromethyl ketone 
(TPCK), two a-chymotrypsin inhibitors. However, independent laboratories could not confirm the 
unprecedented results of Atassi and Manshouri and have been unable to detect any catalytic 
activity.35b-d 
Two recent examples of cyclic a-chymotrypsin mimics include the computationally designed cyclic 
eight-residue peptide I.9 and the cyclic branched hexapeptide I.10, containing the amino acid 
residues of the catalytic triad. Compound I.9 was found to hydrolyse p-nitrophenylacetate nine 
times faster compared to free histidine.36 Hexapeptide I.10 hydrolyzed p-nitrophenyl ester 
substrates and to a small extent a p-nitroanilide substrate.37 Despite this modest activity, I.10 
represents the first example of an artificial enzyme capable of hydrolysing such an anilide 
substrate. 
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Figure 1.9 
 
The work of Fukushima involves a ß -sheet polypeptide, poly(Asp-Leu-His-Leu-Ser-Leu) as an 
artificial hydrolytic enzyme-model for the hydrolysis of both enantiomers of N-
benzyloxycarbonyl phenylalanine p-nitrophenyl ester.38 The enantioselectivity and the hydrolytic 
rate obtained with the ß -sheet polypeptide appeared to be superior to the activity of the 
hexamer (Asp-Leu-His-Leu-Ser-Leu) used as reference. The influence of different parameters 
                                                                                                                                                                                                          
Sci. USA 1994, 91, 4106; (d) Wells, J.A.; Fairbrother, W.J.; Otlewski, J.; Laskowski, M.; Burnier, J. Proc. 
Natl. Acad. Sci. USA 1994, 91, 4110.  
36 Walse, B.; Ullner, M.; Lindbladh, C.; Bülow, L.; Drakenberg, T.; Teleman, O. Journal of Computer-Aided 
Molecular Design 1996, 10, 11. 
37 Stavrakoudis, A.; Demetropoulos I.N.; Sakarellos, C.; Sakarellos-Daaitsiotis, M.; Tsikaris, V. Lett. Pept. 
Sci. 1997, 4, 481. 
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on the enantioselectivity and on the hydrolysis rate (pH, temperature and ethanol content) was 
studied. 
Recently, a dipeptide model serine-histidine was reported to have multiple cleavage activities 
towards DNA, protein (Bovin Serum Albumin) and p-nitrophenylacetate over a wide range of pH 
and temperature.39 The inverse dipeptide sequence His-Ser was shown to be inactive. 
 
1.4 Scope and goal of this PhD work 
The development of enzyme models was introduced in our laboratory about ten years ago. In the 
search to mimic the serine protease a-chymotrypsin, a first tentative was the design of a 
specific molecule I.11 (figure 1.10).40 
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A few years ago, combinatorial chemistry was introduced into this program as a method to speed 
up the search for new serine protease mimics. The traditional way of carefully designing a 
targeted molecule was replaced by the synthesis of large libraries increasing substantially the 
chance of finding a catalyst with potential hydrolytic activity. Moreover, the application of 
combinatorial chemistry for the development of hydrolase models of a-chymotrypsin has not 
been described in the literature so far. In an effort to explore this new field, a long-term 
program was set-up in our laboratory and started with the synthesis of a library I.12 (figure 
1.11) of 729 members on a rigid dipodal scaffold I.13 using the ‘split and mix’ method.41 The 
library was designed to contain the amino acids serine and histidine at different positions in the 
two independent strands to mimic the active site of the serine protease.  
                                                                                                                                                                                                          
38 Fukushima, Y. Bull. Chem. Soc. Jpn. 1996, 69, 2269. 
39 Li, Y.; Zhao, Y.; Hatfield, S.; Wan, R.; Zhu, Q.; Li, X.; McMills, M.; Ma, Y.; Li, J.; Brown, K.L.; He, C.; Liu, F.; 
Chen, X. Bioorg. Med. Chem. 2000,8, 2675. 
40 Madder, A.; De Clercq, P. J. J. Org. Chem. 1997, 63, 2548. 
41 De Muynck, H.; Madder, A.; Farcy, N.; De Clercq, P.; Pérez-Payán, M.N.; Öhberg, L.M.; Davis, A.P. Angew. 
Chem. Int. Ed. Engl. 2000, 39, 145. 
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Figure 1.11 
 
However, in the former library, the third amino 
acid of the catalytic triad, aspartate was 
omitted. As the role of aspartate-102 appears 
to be also important in the mechanism of a-
chymotrypsin27,28 the necessity to develop a 
tripodal library in which three instead of two 
parallel peptide strands are incorporated 
(figure 1.12) was fowarded as our next goal.  
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Figure 1.12 
The design and the synthesis of a tripodal scaffold such as I.14 as well as the synthesis of a 
library I.15 is the subject of this thesis.  
 
Since the scaffold I.14 will be used on solid support, a cleavavble linker has to be introduced as 
represented in compound I.15 (scheme 1.5). However, the choice of a suitable cleavable linker 
remains a challenge since it has to be stable to the chemistry which is performed during the 
synthesis and has to allow cleavage at the end of the synthesis without causing any damage to 
the compound. The critical selective deprotection of the three protected alcohol functions 
present in the scaffold I.14 should be optimised on solid support to allow for the independent 
generation of three peptide strands.  
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Before testing the introduction of the catalytic triad in the scaffold, a judicious choice of 
suitable side-chain protecting groups for the amino acids serine, histidine and aspartate should 
be examined. It has to be noted that the orthogonality of the side-chain protecting groups has 
to be compatible with the protecting groups present in the new tripodal scaffold I.14 and with 
the cleavable linker.  
Afterwards, the tripodal library I.15 will be synthesised on solid support using the ‘split and 
mix’ protocol. As outlined in scheme 1.5, many members of the library will contain the three 
amino acids serine, histidine and aspartate at different positions of the peptide chains.  
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Scheme 1.5 
 
In the next step, the tripodal library I.15 will be tested for hydrolytic activity. For the 
screening of the library towards hydrolytic activity, a new type of test substrates I.16 will be 
developed (figure 1.13). These screening substrates consist in the red-coloured dye Disperse 
Red 1 and contain an ester or amide bond. Upon exposure of the library to the dye I.16, the 
catalysts will react with the substrate and the colour will be transferred to the bead. This 
technique enables an easy visual detection of the polymer-bound active catalyst during the 
screening of the library.  
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Figure 1.13 
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2 Development of a test substrate for hydrolytic activity 
 
 
2.1 Introduction  
This work aims at the use of combinatorial techniques in the development of a new artificial 
enzyme, based on the mechanism of action of a-chymotrypsin, a well known member of the family 
of serine-proteases. Therefore, via the 'split and mix' protocol, a tripodal library (figure 2.1) 
will be constructed using one of the amino acids serine, histidine and aspartate as building block 
in each of the three branches. This leads to a mixture of several hundreds of compounds. 
Subsequently, this library will be screened for hydrolytic activity towards a chosen substrate. In 
this step, the use of a suitable substrate allowing for an easy detection of the solid-phase bound 
catalyst will be critical. Ideally, the test substrate is chosen in such a way that the catalytic 
activity is indicated by the appearance of a coloured bead.  
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Figure 2.1 
 
Several examples concerning the development of visual detection methods for the discovery of 
catalysts have already been described in the literature. A first example is the IR-thermographic 
technique. This method is based on the measurement of modest temperature changes due to 
either exothermic or endothermic processes. The most catalytically active compounds are 
identified by the infrared camera as ‘hot’ or ‘cold’ spots respectively.42 Until now, this method 
has been applied for the screening of parallel libraries but it has not yet been implemented for 
the screening of libraries as compound mixtures.  
                                                                 
42 (a) Taylor, S.J.; Morken, J.P. Science 1998, 280, 267; (b) Reetz, M.T.; Becker, M.H.; Küling, K.M.; 
Holzwarth, A. Angew. Chem. Int. Ed. Engl. 1998, 37, 2647; (c) Reetz, M.T.; Becker, M.H.; Liebl, M.; 
Fürstner, A. Angew. Chem. Int. Ed. Engl. 2000, 39, 1236. 
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The use of dyes is another technique for visual detection. In two recent publications, Berkessel 
used dyes to detect polymer bound phosphodiesterase activity.43 This method is presented in 
scheme 2.1. When the 3-hydroxylindolyl derivative II.1 is hydrolysed by a solid-phase bound 
catalyst II.2, the resulting derivative II.3 spontaneously oxidizes in the presence of air to 
afford the turquoise and insoluble dye II.4, which precipitates on the bead. In this way, the 
most active catalysts are easily detected.  
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Scheme 2.1 
 
Solid-phase bound catalyst detection can also occur by fluorescence. Miller has developed a 
polymeric gel containing the molecular sensor II.5 that fluoresces in presence of a catalyst.44 
The aminomethylanthracene II.5 is a suitable sensor to detect the acetic acid in the acylation 
reaction of alcohol II.6 in presence of the solid-phase bound catalyst (scheme 2.2). The 
advantage of using a gel is the slow diffusion of product out of the bead affording a fluorescent 
zone only around the active catalyst. Interestingly, the sensor-functionalised gel is reversibly 
fluorescent. The presence of acetic acid induces the gel II.5 to fluoresce due to the formation 
of II.8; washing with base results again in the gel II.5 that is nonfluorescent. In the same area, 
Davis has recently published the use of a gel for the screening of combinatorial libraries in 
aqueous media.45  
 
                                                                 
43 (a) Berkessel, A.; Hérault, D.A. Angew. Chem. Int. Ed. Engl. 1999, 38, 102; (b) Berkessel, A.; Riedl, R. J. 
Comb. Chem. 2000, 2, 215; (c) Danek, S.C.; Queffelec, J.; Morken, J.P. J. Chem. Soc., Chem. Commun. 2002, 
528. 
44 Harris, R.F.; Nation, A.J.; Copeland, G.T.; Miller, S.J. J. Am. Chem. Soc. 2000, 122, 11270.  
45 Müller, M.; Mathers, T.W.; Davis, A.P. Angew. Chem. Int. Ed. Engl. 2001, 40, 3813. 
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Scheme 2.2 
 
For the screening of our combinatorial library, we chose to develop a new test-substrate 
answering to the following conditions:  
1) the substrate should contain an ester or amide function;  
2) the test substrate should allow for visual detection of the solid-phase bound catalyst; 
3) the possibility of quantitative measurement for hydrolytic activity has to be taken into 
consideration;  
4) the hydrolysis should occur according to a mechanism related to the enzymatic process 
observed with serine-proteases, meaning that the acylation step leads to the formation 
of an acyl-enzyme that is subsequently hydrolysed in the presence of water. 
 
The new test substrates we designed have the general structure I.16 as presented in scheme 
2.3. All derivatives are composed of the same chromogenic unit covalently bound to an ester or 
amide function with different sensitivity towards hydrolysis: the activated p-nitrophenyl ester 
I.16a, the p-nitroanilide I.16b and the unactivated amide I.16c. The chromogenic unit is a 
derivative of the commercially available dye Disperse Red 1. The choice of Disperse Red 1 is 
based on the fact that the azo unit is reasonably chemically stable (at least under non-oxidizing 
conditions) and possesses a lmax larger than 450 nm (lmax = 503 nm).46  
                                                                 
46 Green, F.A. The Sigma-Aldrich Handbook of Stains, Dyes and Indicators Aldrich Chemical Company, 
1990, 290. 
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Scheme 2.3 
 
In contrast to the literature examples, our new substrates were designed to allow for a 
qualitative (visual) and quantitative (UV/VIS spectroscopy) measurement of both the acylation 
and deacylation step of the enzymatic process. As shown in figure 2.2, when the solid-phase 
bound catalyst present in the library is exposed to the substrate in an organic solvent in the 
absence of water, the dye will be transferred to the catalyst resulting in a coloured bead. 
Moreover, the release of the UV detectable group (X) into the solution will allow for a 
quantitative measurement of hydrolysis using UV/VIS spectroscopy. Subsequently, when water 
is added, the acyl-enzyme will be hydrolysed leading to the release of the acid-dye (l = 480 nm) 
into the solution and the catalyst will be regenerated.  
However, the fact that the screening takes place in an organic solvent is of great importance. If 
the screening occurred in water, similar to an enzymatic process, the solid-phase bound catalyst 
would hydrolyse the substrate and the catalyst would be regenerated. It is clear that the 
detection of the catalyst is impossible. 
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Figure 2.2 
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The principle of quantitative measurement of the degree of hydrolysis by UV/VIS spectroscopy 
is explained in more details in table 2.1. In the case of p-nitrophenyl ester I.16a, the hydrolysis 
of the p-nitrophenyl ester can be monitored at 405 nm (pH > 7) by measuring the amount of p-
nitrophenolate present in the solution. Concerning the hydrolysis of the p-nitroanilide derivative 
I.16b, the release of p-nitroaniline is detectable and measurable at 400 nm. Finally, compound 
I.16c is a particularly interesting substrate. The hydrolysis of the amide bound results in the 
formation of the amine II.10 detectable at 315 nm leading to an overlap in absorption with the 
amide I.16c at 293 nm. However, upon treatment of II.10 with a hot aqueous solution of 6% 
potassium hydroxide, a ‘Smiles’ rearrangement will take place leading to II.11, which is easily 
detectable at 400 nm.47 
 
Table 2.1: Quantitative monitoring via  UV/VIS spectroscopy  
After hydrolysis Substrate lmax (nm) 
Leaving Group (X) lmax (X) (nm) 
I.16a 276 nm, 480 nm p-nitrophenolate 405 nm 
I.16b 304  nm, 470 nm p-nitroaniline 400 nm 
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47 (a) Knipe, A.C. Tetrahedron Lett. 1975, 3563. (b) Caldwell, W.T.; Schweiker, G.C. J. Am. Chem. Soc. 1952, 
74, 5187. 
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2.2 Synthesis of I.16 
The synthesis of compounds I.16 was the subject of the first part of this work. p-Nitrophenyl 
ester I.16a, p-nitroanilide I.16b and the amide I.16c were prepared starting from the 
commercially available Disperse Red 1 as outlined in retrosynthetic scheme 2.4.  
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Scheme 2.4 
 
In a first attempt to synthesise carboxylic acid II.12, Disperse Red 1 was deprotonated with an 
excess of base followed by the addition of chloro or bromoacetic acid in a classical Williamson  
ether synthesis. However, only starting material or a complex mixture was obtained (table 2.2).  
 
Table 2.2: Alkylation of Disperse Red 1 with chloro or bromoacetic acid 
 XCH2COOH (eq.) base (eq.) solvent temp., time result 
1 Cl (5.2 eq.) NaH (6.2 eq.) THF reflux, 12 h no reaction 
2 Br (5.2 eq.) NaH (6.2 eq.) THF reflux, 15 h no reaction 
3 Br (2 eq.) KOH (4 eq.) DMSO 23 °C, 15 h no reaction 
4 Br (2 eq.) KOH (4 eq.) DMSO 55 °C, 15 h complex mixture 
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Alternatively, carboxylic acid II.12 can be prepared in a two step-sequence via alkylation of 
Disperse Red 1 with bromomethyl acetate followed by the hydrolysis of ester II.13 (scheme 
2.5). 
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Scheme 2.5 
 
Different conditions were tested and gave poor results (table 2.3). The use of silver oxide48 as 
reagent gave no reaction or a complex mixture even when a catalytic amount of 
tetrabutylammonium iodide was added. When Disperse Red 1 was deprotonated with sodium 
hydride in tetrahydrofuran under reflux conditions, followed by addition of bromomethyl 
acetate, a complex mixture was obtained. Changing the solvent or the temperature did not lead 
to any improvement. Finally, the addition of a catalytic amount of tetrabutylammonium iodide led 
to the formation of methyl ester II.13 in 34% yield, next to 15% of the transesterification by-
product II.14.49 
Finally, treatment of Disperse Red 1 with ethyl diazoacetate (scheme 2.5) in presence of a 
rhodium catalyst afforded ethyl ester II.15 in a satisfactory yield of 57%.50 Subsequently, 
esters II.13 and II.15 were transformed into the carboxylic acid II.12 with potassium 
hydroxide in methanol in almost quantitative yield.  
 
 
 
                                                                 
48 Bouzide, A.; Sauvé, G. Tetrahedron Lett. 1997, 38, 5945. 
49 (a) Cznernecki, S.; Georgoulis, C.; Provelenghiou, C. Tetrahedron Lett. 1976, 3535; (b) Kanay, K.; 
Sakamoto, I.; Ogawa, S.; Suami, T. Bull. Chem. Soc. Jpn. 1987, 60, 1529. 
50 Paulissen, R.; Reimlinger, H.; Hayez, E.; Hubert, A.J.; Teyssié, Ph. Tetrahedron Lett. 1973, 24, 2233. 
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Table 2.3: Alkylation of Disperse Red 1 with bromomethyl acetate  
 Base (eq.) 
Reagent (eq.) 
Solvent Temp. time Results (% II.13) 
1 Ag2O (1.5 eq.) CH2Cl2 r.t., 16 h  
then reflux 
no reaction 
complex mixture 
2 Ag2O (1.5 eq.) 
Bu4NI (0.01 eq.) 
CH2Cl2 r.t. trace of II.13 
3 NaH (2 eq.) THF Reflux, 15 h complex mixture 
4 NaH (1 eq.) DMF r.t., 36 h complex mixture 
5 NaH (1.6 eq.) 
Bu4NI (0.01 eq.) 
DMF r.t., 15 h complex mixture 
6 NaH (1.6 eq.) 
Bu4NI (0.01 eq.) 
THF r.t., 15 h II.13 (34%) 
II.14 (15%) 
 
During the esterification of II.12 with p-nitrophenol, some difficulties were encountered (table 
2.4). One of the standard conditions to esterify a carboxylic acid is the use of 
dicyclohexylcarbodiimide in presence of a catalytic amount of 4-dimethylaminopyridine.51 When 
this method was applied to the synthesis of p-nitrophenyl ester I.16a, a low yield of 35% was 
obtained. Next to the ester I.16a, 32% of a side-product was present and was identified as the 
O-acylurea II.16. 
 
DR1-O
II.12
O
OH
DR1-O
I.16a
O
O
NO2
table 2.4
p-nitrophenol
 
 
Table 2.4: Conditions for the synthesis of p-nitrophenyl ester I.16a 
 Reagent (1.1 eq.) Cat. (0.01 eq.) Solvent Temp., time Result  (% I.16a) 
1 DCC  DMAP CH2Cl2 r.t., 18 h 35% I.16a 
32% II.16 
2 DCC  4-pyrrolidinopyridine CH2Cl2 r.t., 24 h 42% 
3 POCl3  Pyridine -15 °C, 4 h 93% 
                                                                 
51 Neises, B.; Andries, T.; Steglich, W. J. Chem. Soc., Chem. Commun. 1982, 1132. 
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The mechanism of the formation of II.16 is presented in scheme 2.6 and involves the O ® N 
acyl transfer via a four-membered transition state. This side-reaction has been reported to be 
solvent independent52 and can be avoided by decreasing the reaction temperature to 0 °C.  
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Scheme 2.6 
 
The use 4-pyrrolidinopyridine as catalyst gave no significant improvement in yield.53 In our case, 
using phosphorus oxychloride54 turned out to be the best method for the activation of the 
carboxylic acid II.12. The p-nitrophenyl ester I.16a -also called NF31 (see appendix)55- was 
successfully obtained in 93% yield. 
 
Concerning the synthesis of p-nitroanilide I.16b, three different methods were tested (table 
2.5). After activation of the carboxylic acid with isobutylchloroformate,56 the anilide I.16b 
could be prepared with a poor yield of 18%. The use of carbodiimides as coupling reagent 
resulted in a significant improvement and afforded the anilide in 41% yield. However, the use of 
phosphorus oxychloride as activating reagent was also the most successful method and provided 
pure I.16b as the sole product in 57% yield after column chromatography.  
 
 
                                                                 
52 Hirschmann, R.; Nutt, R.F.; Veber, D.F.; Vitali, R.A.; Varga, S.L.; Jacob, T.A.; Holly, F.W.; Denkewalter, 
R.G. J. Am. Chem. Soc. 1969, 91, 507.  
53 Hassner, A.; Alexanian, V. Tetrahedron Lett. 1978, 46, 4475. 
54 Rijkers, D.T.S.; Hemker, H.C.; Nefkens, G.H.L.; Tesser, G.I. Recl. Trav. Chim. Pays-Bas 1991, 110, 347. 
55 Since 2001, NF31 is commercially available from ‘BACHEM’,  catalog 2002, p 1282, 50 mg cost 150 Euro 
56 Nedev, H.; Naharisoa, H.; Haertlé, T. Tetrahedron Lett. 1993, 34, 4201. 
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Table 2.5: Synthesis of p-nitroanilide I.16b 
 Reagent  
(1.1 eq.) 
Cat. (0.01 eq.) Solvent Temp., time Result (% I.16b) 
1 isoBuOCOCl      - CH2Cl2 / DMF 
9       /    1 
r.t., 24 h 18%  
2 DCC  4-pyrrolidinopyridine CH2Cl2 r.t., 24 h 41% 
3 POCl3     - pyridine -15 °C, 3 h 57% 
 
Finally, phosphorus oxychloride was also the reagent of choice to synthesise the amide I.16c 
(scheme 2.7). p-Nitrophenoxyethanamine II.10, prepared from 2-aminoethanol and p-
nitrochlorobenzene as described in the literature57 reacted with the carboxylic acid II.12 in 
presence of phosphorus oxychloride to afford the amide I.16c in 66% yield. 
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Scheme 2.7 
 
 
 
 
 
 
 
                                                                 
57 Knipe, A.C.; Sridhar, N. Synthesis 1976, 606. 
 
Part 2: Development of a new test substrate for hydrolytic activity  30 
2.3 Applications: a novel colorimetric assay for visual detection of solid-phase 
bound amines 
2.3.1 Introduction 
Even if the enthusiasm at that time was limited, the introduction of solid phase chemistry by 
Merrifield in 1963 in the field of peptide synthesis was a great invention. Today, the monitoring 
of reactions on solid support still remains somewhat tricky. As a matter of fact, the use of 
traditional direct analytical methods (NMR, ES-MS, TLC) is very limited and until now, only a few 
techniques are available for monitoring reactions on solid support. In particular, concerning solid-
phase peptide synthesis, colorimetric methods are widely used to evaluate the effectiveness of 
a coupling step. Since no intermediate purification is performed, it is important that every 
coupling step occurs in an almost quantitative yield.  
A brief overview of the more common colorimetric methods is presented in table 2.6.  
Picric acid58 and bromophenol blue59 are two colorimetric tests allowing the detection of 
polymer-supported amines by acid/base titration. Another method relies on a two step-process 
and involves attachment of a reporter followed by a selective detachment and quantitation. The 
dimethoxytrityl (DMT) cation test60 and the ‘nitrophenylisothiocyanate-O-trityl’ (NPIT) test61 
are illustrative examples. The most popular examples of colorimetric tests with visual detection 
are the ninhydrin test62, the increasingly used 2,4,6-trinitrobenzenesulfonic acid (TNBS) test63 
and the recently described ‘4-N,N’-dimethylaminoazobenzene-4’-isothiocyanate’ (DABITC)  
test.64 
 
 
 
 
 
 
 
                                                                 
58 Gisin, B.F. Anal. Chim. Acta 1972, 58, 248. 
59 Krchnak, V.; Vagner, J.; Safar, P.; Lebl, M. Collect. Czech. Chem. Commun. 1988, 53, 2542. 
60 Reddy, M.P.; Voelker, P.J. Int. J. Peptide Protein Res. 1988, 31, 345. 
61 Chu, S.S.; Riech, S.H. Bioorg. Med. Chem. Lett. 1995, 1053. 
62 Kaiser, E.; Colescott, R.L.; Bossinger, C.D.; Cook, P.I. Anal. Biochem. 1981, 117, 147. 
63 Hancock, W.S.; Battersby, J.E. Anal. Biochem. 1976, 71, 260. 
64 Shah, A.; Rahman, S.S.; De Biasi, V.; Camilleri, P. Anal. Commun. 1997, 34, 325. 
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Table 2.6: Overview of monitoring methods for solid phase peptide synthesis 
Test Features 
Ninhydrin62 Qualitative detection and quantitative determination by UV 
Picric acid58 
 
TNBS63 
Bromophenol blue59 
DMT60 
 
Chloranil 
NPIT61 
 
DABITC64 
Quantitative determination by acid/base titration followed by UV 
measurement 
Visual detection of primary amines (orange) 
Visual detection of free amines (blue) by acid/base titration 
Quantitative determination by a tritylation-detritylation process 
followed by UV measurement 
Visual detection of free amines (blue) 
Qualitative and quantitative determination by a tritylation-
detritylation process followed by UV measurement 
Visual detection of primary and secondary amines (orange) 
 
However, these latter tests are not devoid of some drawbacks. In particular, the ninhydrin test 
cannot be used for coupling to proline; the TNBS test gives erroneous results in the case of 
sterically hindered amines. So, there is still a great demand for novel sensitive colorimetric 
tests to monitor coupling efficiency in a simple and reliable way.  
 
2.3.2 A new colorimetric test65…. 
Our newly developed substrate I.16a (NF31) appeared to be also very useful in the detection of 
solid-phase bound amines.  
 
O2N N
N N
O
O
O
NO2
NF31
 
 
 
                                                                 
65 Madder, A.; Farcy, N.; Hosten, N.G.C.; De Muynck, H.; De Clercq, P.J.; Barry, J.; Davis, A.P. Eur. J. Org. 
Chem. 1999, 2787.  
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This new test is based on the reaction of unreacted solid-phase bound amines with NF31, 
resulting in a transfer of colour to the bead. After thorough washing, beads containing free 
amino functions appear as red spheres whereas completely coupled beads remain colourless. 
Longer reaction times or lower temperatures do not influence the outcome of the test. So far, 
solid supports that have been tested include TentaGel-NH2, Novagel and Wang resins. 
To be useful as a new colorimetric test, the sensitivity of the assay needed to be evaluated. 
Therefore, a series of resin samples of known free amine content was prepared by treatment of 
Wang-Gly-NH2 with a mixture of Fmoc-Ala and Boc-Ala in different proportions. After selective 
removal of the Fmoc protecting group, beads were obtained with a free amine content of 50, 20, 
10, 5, 2 % (see experimental part). The different samples were treated with both the NF31 
test and the TNBS test for visual comparison. From figure 2.3, it can be seen that the NF31 
test, due to the appearance of a distinct red colour in presence of free amino groups is more 
sensitive than the TNBS test. Since resins often become yellow when exposed to chemicals, the 
detection of 5% free amine using the TNBS test remains difficult. 
 
NF31 test 
 
 
       50%             20%                10%                 5%                  2%               0% 
 
TNBS test 
 
 
Figure 2.3 
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An important feature of the NF31 test is its high reactivity towards sterically hindered amines. 
The following experiment illustrates this feature (figure 2.4). Derivative II.17a was obtained by 
coupling of TentaGel-NH2 with steroid-based scaffold I.13.66  
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Figure 2.4 
 
The free amino function on position 3 in II.17a (R1 = H) reacts with the TNBS reagent yielding 
orange beads. However, the TNBS test on amine II.17c, obtained by capping of the free amine 
in II.17a and deprotection of the Boc-protected amine II.17b on position 12, did not lead to 
orange beads probably due to sterical hindrance. In contrast, treatment of the same resin with 
NF31 resulted in intense red coloured beads proving the presence of free amines. Finally, 
another feature of the NF31 test is based on the possibility to follow coupling reactions to 
proline. Whereas ninhydrin and TNBS tests give negative results with proline, treatment of 
TentaGel-Pro-NH with NF31 leads to red beads. 
 
                                                                 
66 Hilde De Muynck, PhD-thesis 'Ontwikkeling van modelverbindingen voor Serine Proteasen via 
combinatorische tecknieken', 2000. 
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2.4 Conclusion 
In the first part of this work, we synthesised successfully three Disperse Red 1 derivatives 
I.16, each of them presenting a different sensitivity towards hydrolysis. The most reactive p-
nitrophenyl ester I.16a is actually commercially available and is applied in two areas: 1) it is 
used as a new test-substrate41 for the visual detection of active catalysts during the screening 
of combinatorial libraries; 2) it is used as a new colorimetric test65 for the detection of solid-
phase bound amines. Furthermore, the NF31 test is particularly useful in the case of sterically 
hindered amines and for coupling reactions to proline, cases where other colorimetric tests fail.
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3 The tripodal scaffold 
 
3.1 A new tripodal scaffold 
“Smaller, disordered peptides may contain all the functional groups of the enzyme active site, 
but even if the peptide is capable of assuming a catalytic conformation, it is conceivable, given 
the enormous magnitude of shape space accessible to a peptide of even thirty amino acid 
residues, that the age of the planet would elapse before the desired conformations were to be 
assumed. In short, all the major features of enzymatic catalysis are likely to be deeply flawed or 
entirely missing in peptides without fixed conformation”.35e This is the reason why a multipodal 
scaffold is an essential element to mimic enzymes. The role of the scaffold is to mimic the 
three-dimensional structure of the enzyme by creating a fixed conformation in order to bring 
the peptide strands in proximity. One of the most important features of a scaffold is the 
presence of several orthogonal functionalities, allowing for the generation of independent 
strands in order to create an appropriate environment for catalysis similar to the active site of 
the enzyme.  
 
In the literature, only a few scaffolds that allow for the independent generation of peptide 
strands have been described. The cholic acid derivative III.1 developed by Still (figure 3.1) is 
the most famous example of a polyfunctional template which enables the generation of two 
parallel and different peptide strands.67 Kemp’s acid III.269b and the triazacyclophane III.369i 
are two other illustrative examples of conformationally constrained scaffolds. Both possess 
orthogonal protecting groups allowing for the independent introduction of parallel-oriented 
chains. A main feature of most scaffolds described in literature so far, is their rigidity and the 
limited free rotation of the peptide strands.68  
                                                                 
67 (a) Boyce, R.; Li, G.; Nestler, P.; Suenaga, T.; Still, W.C. J. Am. Chem. Soc. 1994, 116, 7955; (b) Cheng, Y.; 
Suenaga, T.; Still, W.C. J. Am. Chem. Soc. 1996, 118, 1813. 
68 (a) Pátek, M.; Drake, B.; Lebl, M. Tetrahedron Lett. 1994, 35, 9169; (b) Kocis, P.; Issakova, O.; Sepetov, 
N.; Lebl, M. Tetrahedron Lett. 1995, 36, 6623; (c) Wess, G.; Bock, K.; Kleine, H.; Kurz, M.; Guba, W.; 
Hemmerle, H.; Lopez-Calla, E.; Baringhaus, K.-H.; Glombik, H.; Enhsen, A.; Kramer, W. Angew. Chem. Int. Ed. 
Engl. 1996, 35, 2222; (d) Wunberg, T.; Kallus, C.; Opatz, T.; Henke, S.; Schmidt, W.; Kunz, H. Angew. Chem. 
Int. Ed. Engl . 1998, 37, 2503; (e) Broderick, S.; Davis, A.P.; Williams, R.P. Tetrahedron Lett. 1998, 39, 
6083; (f) Barry, J. F.; Davis, A. P.; Pérez-Payan, M. N. Tetrahedron Lett. 1999, 40, 2849; (g) Kallus, C.; 
Opatz, T.; Wunberg, T.; Schmidt, W.; Henke, S.; Kunz, H. Tetrahedron Lett. 1999, 40, 7783; (h) 
Pattarawarapan, M.; Burgess, K. Angew. Chem. Int. Ed. Engl. 2000, 39, 4299; (i) Opatz,T.; Liskamp, R.M.J. 
Org. Lett. 2001, 3, 3499. 
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Until now, the availability of orthogonally protected flexible scaffolds is quite limited. The 
polymethylene derivative III.4 (figure 3.1) developed by Nestler is an example.69 However, due 
to the very high flexibility of this methylene moiety, it is unlikely that the peptide chains will 
adopt a parallel orientation as observed for the rigid cholic derivative III.1. In a comparative 
study, the latter flexible chain turned out to be less efficient than rigid analogue III.1.   
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Figure 3.1 
 
In our strategy towards the development of artificial hydrolases, a new scaffold had to be 
designed. In addition to our former work on a rigid dipodal scaffold, the development of a 
flexible tripodal scaffold was obvious. Indeed, flexible scaffolds compared to the rigid ones will 
have a better chance of being able to catalyse a reaction as they will be able to attain a greater 
diversity in conformation. On the other hand, the flexibility has to be limited in order to 
generate parallel peptide strands. The structure of the new flexible scaffold we designed is 
presented in figure 3.2.  
                                                                 
69 (a) Nestler, H.P. Mol. Div. 1996, 2, 35; (b) Seneci, P.; Sizemore, C.; Islam, K.; Kocis, P. Tetrahedron Lett. 
1996, 37, 6319; (c) Heinonen, P.; Rosenberg, J.; Lönnberg, H. Eur. J. Org. Chem. 2000, 21, 3647; (d) Virta, 
P.; Rosenberg, J.; Karskela, T.; Heinonen, P.; Lönnberg, H. Eur. J. Org. Chem. 2001, 18, 3467. 
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The tripodal template III.5 possesses a chemical structure 
that should allow for the generation of three parallel-
oriented peptide strands. It was predicted and confirmed 
via modelling studies that the three benzylic chains adopt a 
parallel orientation.66 On the other hand, due to its 
flexibility, the peptide strands should have enough freedom 
to adopt the best conformation for catalysis. 
OH
O
O
O
OP 1
OP2
OP3
III.5  
Figure 3.2 
 
Furthermore, the protecting groups (figure 3.3) were chosen in such a way that they enable a 
selective deprotection: the tetrahydropyranyl (THP) ether is an acid labile protecting group and 
is cleaved under mild hydrolytic conditions, the 3,4-dimethoxyphenylmethyl (DMPM) ether on 
the other hand is removed under oxidative conditions and finally, the tert-butyldiphenylsilyl 
(TBDPS) ether is deprotected with fluoride anion. 70 
Next to the three orthogonally protected hydroxyl functions, the free hydroxyl function in 
scaffold III.5 will allow the coupling to a solid support.  
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Figure 3.3 
                                                                 
70 Schelbaas, M.; Waldmann, H. Angew. Chem. Int. Ed. Engl. 1996, 35, 2056. 
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3.2 Synthesis of the tripodal scaffold III.6 
The flexible tripodal scaffold III.6 was successfully synthesised, in its racemic form, starting 
from the commercially available pentaerythritol via consecutive Williamson ether syntheses with 
the building blocks III.7, III.8 and III.9 as outlined in the retrosynthetic scheme 3.1. 
O
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O
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Scheme 3.1 
 
The benzylic bromides III.7, III.8 and III.9 were prepared as described in scheme 3.2. The 
commercially available 4-methylphenylacetic acid was brominated in the presence of a catalytic 
amount of AIBN to afford compound III.10.71 Subsequently, carboxylic acid III.10 was 
reduced with borane-methyl sulfide complex to form alcohol III.11.72 The introduction of the 
three protecting groups was performed according to known procedures.73 Nevertheless, some 
problems were encountered in the introduction of the DMPM group to prepare building block 
III.8. Acceptable results were only obtained when alcohol III.11 was reacted with an excess of 
acetimidate III.12 in the presence of a catalytic amount of PPTS to afford III.8 in 69% yield. 
                                                                 
71 Mitchell, A.R.; Kent, S.B.H. Engelhard, M.; Merrifield, R.B. J. Org. Chem. 1978, 43, 2845. 
72 Praly, J.P.; Descotes, G. Tetrahedron Lett. 1987, 28, 1405.  
73 (a) THP: Miyashita, N.; Yoshikoshi, A.; Grieco, P.A. J. Org. Chem. 1977, 42, 3772; (b) DMPM: Nakajima, 
N.; Saito, M.; Ubukata, M. Tetrahedron Lett. 1988, 39, 5565; (c) TBDPS: Guindon, Y.; St Denis, Y.; 
Daigneau, S.; Morton, H.E. Tetrahedron Lett. 1986, 27, 1237. 
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Br
OR
HOOC
a c or d or e
a) Br2, AIBN, CCl4, 62%; 
b) BH3.SMe2, THF, 86%; 
c) THP: PPTS, dihydropyran, CH2Cl2, 88%
d) DMPM: acetimidate III.12, PPTS, CH2Cl2, 69%
e) TBDPS: TBDPSCl, DIPEA, DMF, 71%
MeO
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b
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III.8 R = DMPM
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Scheme 3.2 
 
The synthesis of the scaffold III.6 started from the commercially available pentaerythritol. 
The first benzylic chain was introduced in a three-step sequence involving temporary protection 
of one of the hydroxymethyl groups as a tert-butyldiphenylsilylether to afford triol III.13.74 
Subsequently, a classical Williamson ether synthesis with benzyl bromide III.7 led to the 
formation of III.14. Finally, alcohol III.15 was obtained by deprotection of the silyl ether in 
III.14 with TBAF. The two other benzylic chains were introduced in a similar way by ether 
formation with benzyl bromides III.8 and III.9 to form derivatives III.16 and I.14 in 32% 
and 49% yield respectively. The remaining alcohol function was finally treated with succinic 
anhydride to form target molecule III.6 in 90% yield. The succinic moiety serves as a spacer 
for attachment of III.6 to the solid phase. Incorporation of a spacer is expected to facilitate 
the connection to the solid support by increasing the distance between the polymer and the 
attachment point of the scaffold III.6. 
 
                                                                 
74 Hanessian, S.; Parbhanjan, H.; Qiu, D.; Nambiar, S. Can. J. Chem. 1996, 74, 1731. 
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Scheme 3.3 
 
With the scaffold in hand, we were eager to start exploring the solid phase chemistry part of 
this work. After attachment of scaffold III.6 on the solid phase, we were particularly 
interested in the selective deprotection of the protecting groups THP, DMPM and TBDPS. 
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3.3 Study of the selective deprotection of the THP, DMPM and TBDPS 
protecting groups 
Carboxylic acid III.6 was first coupled to the solid phase TentaGel-NH2 using EDC as coupling 
reagent in the presence of a catalytic amount of DMAP (scheme 3.4). The resin was then treated 
with a large excess of acetylimidazole to cap any remaining free amino functions to form 
polymer-supported scaffold III.17. The structure of the tripodal scaffold III.6 will be 
symbolised as presented in scheme 3.4.  
, EDC, DMAP, CH2Cl2; b) AcIm, CH2Cl2NH2
a, b
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Scheme 3.4 
 
TentaGel resin75, which presents excellent swelling properties in polar and non-polar solvents, 
was chosen as solid support. Its solution-like behaviour allows for 13C gel phase NMR monitoring 
in order to determine the success or failure of a chemical transformation.76 It has to be 
mentioned that this technique does not require any special instrumentation.77  
In figure 3.4a, the 13C gel phase NMR spectrum of the polymer-supported III.17 in CD2Cl2 is 
presented. Some characteristic peaks were very helpful to control the success of the following 
reactions. The peak at 100 ppm represents the acetal carbon of the THP protecting group. The 
                                                                 
75 TentaGel resin consists of grafted polyethylene glycol chains on a cross-linked polystyrene polymer. 
76 Bayer, E. Angew. Chem. Int. Ed. Engl. 1991, 30, 113. 
77 Look, G.C.; Holmes, C.P.; Chinn, J.P.; Gallop, M.A. J. Org. Chem. 1994, 59, 7588. 
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peaks at 112 ppm and 121 ppm are characteristic peaks for the DMPM ether and the peaks at 135 
ppm (Ph) and 28 ppm (tert-Bu) are associated with the TBDPS ether.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: 13C gel phase NMR in CD2Cl2 
 
For the selective deprotection of the THP-protecting group in III.17, several reaction 
conditions were tested as presented in table 3.1. The use of excess PPTS78a in a mixture of 
methanol/1,4-dioxane at room temperature failed to give any deprotection of the THP group. On 
the other hand, a stronger acid such as PTSA78b led to the deprotection of both THP and DMPM 
                                                                 
78 (a) Miyashita, N.; Yoshikoshi, A.; Grieco, P.A. J. Org. Chem. 1977, 42, 3772; (b) Gala, D.; Steinman, M.; 
Jaret, R.S. J. Org. Chem. 1986, 51, 4488; (c) Bernady, K.F.; Floyd, M.B.; Poletto, J.F.; Weiss, M.J. J. Org. 
Chem. 1979, 44, 1438. 
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ethers. Using a solution of acetic acid in dichloromethane and water at 55 °C led to a complete 
deprotection of the THP group to form alcohol III.18.78c  
 
table 3.1
OTHP OTBDPS
O CONHspacer
III.17
ODMPM OH OTBDPS
O CONHspacer
III.18
ODMPM
 
Table 3.1: Selective deprotection of the tetrahydropyranyl protecting group 
Reagent Eq. or 
concentration 
Solvent (ratio %) Time, Temp. Results 
PPTS 
PPTS 
PPTS 
4 
6 
15 
 
MeOH / 1,4-dioxane (50/50) 
 
Overnight, r.t. 
 
- 
PTSA 4  MeOH Overnight, r.t. Deprotection of 
THP and DMPM 
AcOH 40% CH2Cl2  / H2O (35/25) Overnight, r.t. - 
AcOH 80% CH2Cl2  / H2O (15/5) Overnight, r.t. - 
AcOH 95% H2O (5) Overnight, r.t. - 
AcOH 80% CH2Cl2  / H2O (15/5) 6 times 2h 
4 h, 55-60 °C 
Deprotection 
THP 
 
To estimate the efficiency of a reaction on solid-phase one usually employs a colorimetric test. 
For the specific detection of free alcohol functions on solid support, several methods have been 
described in the literature and were evaluated to follow the formation of polymer-supported 
alcohol III.18. 79  
1) The method described by Riguera  involves the transformation of the alcohol group into a 
tosylate followed by its displacement by p-nitrobenzylpyridine (PNBP) to form a pyridinium salt 
(scheme 3.5).79a After treatment with a base, a strongly coloured salt III.19 is obtained. This 
test has been reported to be successful in monitoring the transformation of a THP ether into 
the alcohol. 
 
                                                                 
79 (a) Kuisle, O.; Lolo, M.; Quiñoá, E.; Riguera, R. Tetrahedron 1999, 55, 14807; (b) Attardi, M.E.; Falchi, A.; 
Taddei, M. Tetrahedron Lett. 2000, 41, 7395; (c) Burkett, B.A.; Brown, R.C.D.; Meloni, M.M. Tetrahedron 
Lett. 2001, 42, 5773. 
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Scheme 3.5 
 
2) The test of Taddei79b relies on the reaction of 2,4,6-trichloro-[1,3,5]-triazine (TCT) with a 
free alcohol function resulting in 2-alkoxy-4,6-dichloro-[1,3,5]-triazine III.20. Treatment of 
III.20 with the red coloured dye Alizarin yellow R (5-(4-nitrophenyl-azo)salicylic acid, sodium 
salt) (scheme 3.6) results in the formation of the red coloured compound III.21. 
3) The most recent test is one developed by Brown.79c The reaction of diphenyldichlorosilane 
with polymer-supported alcohols leads to the formation of the polymer-supported 
diphenylsilylchloride ether III.22 as intermediate. Subsequent treatment of III.22 with 
methyl red (2-(4-(dimethylamino)phenyl-azo)benzoic acid, sodium salt) affords tethered dye 
III.23 and results in a strong orange colouration of the beads. 
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Scheme 3.6 
 
The colorimetric tests of Riguera and Taddei were used to monitor the formation of polymer-
supported alcohol III.18 but the results were disappointing. In our hands, only negative or 
ambiguous results were obtained. 
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On the other hand, monitoring the deprotection using 13C gel phase NMR was examined and 
appeared to be the most reliable method. After deprotection of the THP group, the 13C NMR 
spectrum (figure 3.4b) shows that the peak at 100 ppm, characteristic for the THP group 
disappeared whereas the characteristic peaks corresponding to the DMPM and TBDPS ethers 
are still present.  
In addition, FTIR spectroscopy was also useful and showed clearly the appearance of an alcohol 
function.80 
 
After the successful selective removal of the THP protecting group, the coupling of  FmocGlyOH 
on the free hydroxyl function of the polymer-supported compound III.18 was tested.  
When Fmoc-protected amino acids are coupled on a polymer-supported compound, the yield of 
the coupling step can be determined by measuring the amount of fulvene-piperidine adduct 
present in the solution via UV/VIS spectroscopy.81 The adduct is formed via an E1CB reaction 
after treatment of the Fmoc-containing solid support with piperidine (scheme 3.7) and has 
characteristic absorptions at 290 nm and 300 nm. The yield of the reaction (equation (1)) is 
given by the ratio of the measured loading (calculated from the Lambert-Beer equation (2)) to 
the theoretical loading (corresponding to 100% reaction yield). 
 
                                                                 
80 One of the most common methods is the use of FTIR spectra of potassium bromide pellet: (a) Crowley, 
J.I.; Rapoport, H. J. Org. Chem. 1980, 45, 3215; (b) Hauske, J.R.; Dorff, P. Tetrahedron Lett. 1995, 36, 
1589. 
81 (a) Meienhofer, J.; Waki, M.; Heimer, E.P.; Lambros, T.J.; Makofske, R.C.; Chang, C-D Int. J. Prot. Res . 
1979, 13, 35; (b) Chang, C-D.; Waki, M.; Ahmad, M.; Meienhofer, J.; Lundell, E.O.; Haug, J.D. Int. J. Prot. 
Res. 1979, 15, 59. 
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H
H
N
AAH2NCO2 +
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N
fulvene-piperidine adduct
lmax = 290 and 300 nm
+
AAO NH
O
 
 
Experimental 
Loading (mmol/g)
A  x V (ml pip./ DMF)
e (ml / mmol)  x m (g)
= equation (2)
Yield (%) =
theoretical  loading
experimental loading
equation (1)
e : absorption of 1 mmol of Fmoc-chromophore at l nm
V : volume of solution 20% pip./DMF
m: weight of resin
A : absorbance value of the solution
x 100
 
 
Scheme 3.7 
 
When DIC was used as the coupling reagent in the presence of HOBt or in the presence of the 
more reactive additive HOAt, poor results were obtained even after repetitive couplings. As 
mentioned in the work of Still, 67 the coupling of amino acids on a free hydroxyl function requires 
a more reactive reagent such as an acid chloride. Thus, the coupling reaction of the acid chloride 
FmocGlyCl on polymer-supported III.18 (scheme 3.8) resulted in a quantitative conversion as 
determined by UV/VIS spectroscopy. After deprotection of the Fmoc-protecting group with a 
solution of 20% piperidine in DMF, the free amino function was capped with an excess of 
acetylimidazole to form III.24. 
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Scheme 3.8 
 
Subsequently, the deprotection of the 3,4-dimethoxybenzyl ether (DMPM) was examined. After 
treatment of resin III.24 with an excess of dichlorodicyanoquinone (DDQ),82 analysis of the 13C 
NMR spectrum of resin III.25 (figure 3.4c) shows that the characteristic peaks of the DMPM 
protecting group at 112 ppm and 120 ppm had disappeared whereas the silyl ether was still 
intact. The deprotected resin III.25 was coupled with the acid chloride FmocPheCl (scheme 
3.9). Removal of the Fmoc-protecting group and capping of the free amino function with 
acetylimidazole afforded resin III.26.  
 
                                                                 
82 Oikawa, Y.; Tanaka, T.; Horita, K.; Yoshioka, T.; Yonemitsu, O. Tetrahedron Lett. 1984, 25, 5393. 
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Scheme 3.9 
 
Finally, the silyl ether was deprotected by reaction of III.26 with a solution of TBAF in THF 
(scheme 3.9) to form resin III.27. As indicated by the 13C NMR spectrum (figure 3.4d), the 
characteristic peaks of the TBDPS at 28 ppm (tert-Bu) and 135 ppm (Ph) disappeared. The acid 
chloride FmocAlaCl was successfully coupled to deprotected resin III.27, the Fmoc-protecting 
group was removed and the free amino functions were capped with acetylimidazole to afford 
III.28. At this stage, the cleavage from the solid phase was the only way to prove the structure 
of compound III.28 followed by analysis using traditional analytical methods. However, due to 
the absence of any cleavable linker, the compound could not be released from the solid phase. 
That is the reason why we turned our attention to the use of a cleavable linker. 
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3.4 Conclusion 
Tripodal scaffold III.6 was synthesised in a five-step sequence in 4.1% overall yield and was 
successfully coupled to the polymer-support TentaGel-NH2 resin. Furthermore, the deprotection 
of the three protecting groups (THP, DMPM and TBDPS) was successfully performed in a 
selective and efficient way. 13C gel phase NMR was the most suitable and reliable method to 
monitor these deprotections. The coupling of amino acids on the free hydroxyl function was 
examined and required the use of the reactive acid chlorides in order to obtain high coupling 
yields as determined by UV/VIS spectroscopy. 
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4 The incorporation of a cleavable linker 
 
4.1 Introduction 
Our initial experiments on solid phase revealed some difficulties in the monitoring of the 
deprotection and coupling steps on scaffold III.6. Therefore, as outl ined in figure 4.1, the 
introduction of a linker is a solution to this problem. A linker is defined as the ‘link’ between the 
solid support and the scaffold and allows for the cleavage of the compounds attached on the 
solid support. In addition, the linker is a key fragment in the planning of a synthetic scheme: it 
needs to be stable towards the chemistry performed and it has to be possible to cleave the 
product from the solid phase with high efficiency at the end of the synthesis. Moreover, the 
synthesis of the linker, if not commercially available, needs to be straightforward. Over the past 
15 years, about 2000 linkers have been developed.83 The choice of a suitable cleavable linker for 
a specific synthesis is of major importance. 
 
O
O
O
O
OTHP
ODMP M
OTBDPS
linkerspacer
linker
scaffold
cleavage
scaffold
linker
+
cleavage
 
Figure 4.1 
 
In this chapter, the efficiency of several types of linkers described in the literature is 
examined. 
 
                                                                 
83 Reviews about linkers: (a) James, I.W. Tetrahedron 1999, 55, 4855; (b) Gordon, K.; Balasubramanian, S. 
J. Chem. Technol. Biotechnol. 1999, 74, 835; (c) Guillier, F.; Orain, D.; Bradley, M. Chemical Reviews 2000, 
100, 2091. 
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4.2 The Rink Linker: an acid labile linker 
In the 60’s, Merrified resin was the main solid support used for peptide synthesis and the 
cleavage of the peptide from the Merrifield resin required hydrogen fluoride. In 1973, Wang 
described an acid labile linker that requires 95% trifluoroacetic acid as cleavage conditions. 
Therefore, the development of highly acid labile linker IV.1 by Rink (figure 4.2) in 1987 was 
announced as a first important step in the field.84 The acid sensibility of the Rink linker is 
explained by the presence of the methoxy groups in ortho and para positions that stabilise the 
carbocation formed during the cleavage. A solution of 25% trifluoroacetic acid in 
dichloromethane is sufficient to release the compounds from the polymer.  
 
NH2OMe
MeO O
H
N
Rink  linker
IV.1
O
 
 
Figure 4.2 
 
The possibility of using the Rink linker in our synthesis was examined. Carboxylic acid III.6 was 
coupled on commercially available polymer-supported Rink linker IV.1, using carbodiimide DIC as 
coupling reagent in the presence of HOAt (scheme 4.1). Any free amino functions left on the 
Rink linker were capped with a solution of acetic anhydride. Then, the THP protecting group in 
compound IV.2 was cleaved with an aqueous solution of 80% acetic acid at 60 °C to afford 
alcohol IV.3. Subsequently, the resin was exposed to 25% trifluoroacetic acid as described in 
the literature to release the scaffold from the solid support. However, instead of obtaining the 
desired alcohol IV.4, a complex mixture was obtained. This observation led us to the hypothesis 
that our scaffold might be unstable under strong acid conditions due to the presence of the 
benzyl ethers functions. 
                                                                 
84 (a) Rink, H. Tetrahedron Lett. 1987, 28, 3787; (b) Bernatowicz, M.S.; Daniels, S.B.; Köster; H. 
Tetrahedron Lett. 1989, 30, 4645. 
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Scheme 4.1 
 
To confirm this hypothesis, the non-solid phase-bound scaffold I.14 was treated with a series 
of solutions containing 50, 20, 10 and 5% trifluoroacetic acid (scheme 4.2). In each case, 
according to thin layer chromatographic analysis, complex mixtures were obtained. From these 
observations, we decided to avoid linkers involving cleavage with strong acids and we turned our 
attention to the so-called safety-catch linkers and photolabile linkers. 
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decomposition
OH
O
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O
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Scheme 4.2 
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4.3 The Kenner linker: a safety-catch linker 
Over the last 10 years, a great deal of attention has been paid to the development of the so-
called safety-catch linkers. Safety-catch linkers rely on a two-step cleavage process. The robust 
linker may be transformed after the synthesis into a more labile version, which can be cleaved 
under mild conditions. An example is outlined in scheme 4.3. The first step involves activation of 
the linker by oxidation of the sulfide to the sulfone and the second one involves the actual 
cleavage using a base. 
 
S
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S
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Scheme 4.3 
 
The first safety-catch linker was described by Kenner in 1971 and involves a polymer-supported 
sulfonamide IV.5 (figure 4.3) that shows high stability to both acidic and basic conditions.85 
After the coupling step, (scheme 4.4), activation of IV.6 occurs by treatment of the resin with 
diazomethane or iodoacetonitrile to form the labile resin IV.7. Nucleophilic displacement with 
an amine or alcohol provides the amide or ester IV.8 respectively. 
 
HN
O
SH2N
O
O
Kenner 
linker
IV.5  
Figure 4.3 
 
                                                                 
85 (a) Kenner, G.W.; McDermott, J.R.; Shepard, R.C. J. Chem.Soc., Chem. Commun. 1971, 636; (b) Backes, 
B.J; Ellman, J.A. J. Am. Chem. Soc. 1994, 116, 11171; (c) Backes, B.J.; Virgilio, A.A.; Ellman, J.A. J. Am. 
Chem. Soc. 1996, 118, 3055; (d) Backes, B.J.; Ellman, J.A. J. Org. Chem. 1999, 64, 2322. 
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Scheme 4.4 
 
Due to its particular stability towards acids and bases, Kenner’s linker IV.5 could be a suitable 
linker. The coupling of the commercially available Kenner’s linker IV.5 with the carboxylic acid 
III.6 was performed using EDC as coupling reagent in the presence of a catalytic amount of 
DMAP (scheme 4.5). The efficiency of the coupling was monitored using two colorimetric tests. 
The NF31 test was successful to control the success of the coupling reaction whereas the 
commonly used 2,4,6-trinitrobenzenesulfonic acid (TNBS) test failed, probably due to the low 
nucleophilicity of the sulfonamide IV.5. In order to test the cleavage conditions, polymer-bound 
scaffold IV.9 was activated with iodoacetonitrile in presence of diisopropylethylamine in DMSO 
followed by treatment with a large excess of benzylamine. Disappointingly, only some traces of 
the amide IV.10 were released from the solid support. 
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Scheme 4.5 
Part 4: The incorporation of a cleavable linker   55
The low cleavage yield is probably explained by an acylation reaction of the acylsulfonamide IV.9 
that occurred during the capping of the free remaining amino functions with an excess of acetic 
anhydride (step b) (scheme 4.5). In this way, compound IV.11 is blocked from activation and 
cleavage (scheme 4.6).  
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Scheme 4.6 
 
As a result of these disappointing experiments, we turned our attention to the photolabile 
linkers. 
 
4.4 Photolabile linkers 
Even if photolabile linkers are not as commonly used as either acid labile or base labile linkers, 
their success in solid phase organic synthesis has increased.86 Photolabile linkers offer a mild 
and orthogonal cleavage method that takes place under neutral conditions upon UV irradiation. 
However, the main drawback of photolabile linkers is the difficulty to achieve good yields for 
cleavage in combination with a short irradiation time. Photolytic reactions are significantly longer 
for polymer bound substrates than for compounds in solution because of shadowing effects of 
the resin and swelling properties of the support. In the 1970’s, Rich was the first in developing 
the o-nitrobenzyl linkers IV.12 and IV.13 on polystyrene as light-sensitive linkers.87 
Unfortunately, they still required long irradiation time (18-24 h) and only moderate yields were 
obtained.  
 
                                                                 
86 Pillai, V.N.R. Synthesis, 1980, 1. 
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Figure 4.4 
 
Since then, several modifications have been brought to the original structure IV.12 in order to 
increase the cleavage yield and reduce the cleavage time.88 The most efficient photolabile linker 
IV.14 reported so far is based on a veratryl derivative.89 The incorporation of additional alkoxy 
groups onto the benzene ring enhances the cleavage rate due to a dramatic increase in 
absorbance in the deprotection wavelength region centered near 365 nm. On the other hand, it 
has been found that the presence of an a-methyl group, which leads to the formation, after 
cleavage, of a solid-supported ketone rather than a solid-supported aldehyde gives superior 
yields (scheme 4.7). In the case of linker IV.13, after cleavage, the product can be reattached 
to the solid support through the reactive aldehyde group.  
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Scheme 4.7 
                                                                                                                                                                                                          
87 (a) Rich, D.H.; Gurwara, S.K. J. Chem. Soc., Chem. Commun. 1973, 610; (b) Rich, D.H.; Gurwara, S.K. J. Am. 
Chem. Soc. 1975, 97, 1575. 
88 (a) Rodebaugh, R.; Fraser-Reid, B.; Geysen, H.M. Tetrahedron Lett. 1997, 38, 7653; (b) Åkerblom, A.B. 
Molecular Diversity 1999, 4, 53. 
89 (a) Holmes, C.P.; Jones, D.G. J. Org. Chem. 1995, 60, 2318; (b) Teague, S.J. Tetrahedron Lett. 1996, 32, 
5751. (c) Holmes, C.P. J. Org. Chem. 1997, 62, 2370. 
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Because of their reported high efficiency, linkers IV.14a and IV.14b were tested in our 
project. In first instance, since we received a sample of linker V.15 from Dr. Bart Ruttens 
(Laboratory of Prof. Dr. Johan Van Der Eycken), the polymer-supported alcohol derivative 
IV.14a was examined. After hydrolysis of ester IV.15, acid IV.16 (scheme 4.8) was coupled on 
the solid support NovaGel using carbodiimide DIC as coupling reagent in the presence of HOBt 
to afford IV.14a. NovaGel resin is an interesting solid support because of its higher loading 
capacity compared to TentaGel resin and presents the same swelling properties.90The structure 
of IV.14a will be later symbolized as shown in scheme 4.8. 
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Scheme 4.8 
 
Subsequently, the coupling of the scaffold III.6 on the polymer supported alcohol IV.14a was 
attempted. Following the method of Sieber, the carboxylic acid III.6 was activated with 2,6-
dichlorobenzoylchloride (scheme 4.9) in the presence of an excess of pyridine followed by the 
addition of the solution to the solid-supported alcohol IV.14a. The coupling reaction was 
monitored using the colorimetric DMTCl test.60 However, the qualitative DMTCl test currently 
used to detect the presence of free alcohol function remained strongly positive even after a 
second coupling. The free alcohol functions were acylated with a solution of acetic anhydride 
followed by irradiation of the resin at 365 nm. Even after 3 h of irradiation, no compound III.6 
was detected according to thin layer chromatography and 1H NMR. The absence of coupling is 
probably at the origin of this failure.  
                                                                 
90 Catalog Novabiochem, 2000, S1-S4 
Part 4: The incorporation of a cleavable linker   58
Another coupling procedure based on the use of DIC as coupling reagent in presence of a 
catalytic amount of DMAP was tested. After a second coupling, the free hydroxyl functions were 
capped with a solution of acetic anhydride and the resin IV.17 was irradiated for 3 h affording 
only traces of carboxylic acid III.6.  
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d) IV.14a, 2,6-dichlorobenzoyl chloride, pyridine, DMF
IV.17
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Scheme 4.9 
 
However, the acid III.6 was obtained in a pure form according to 1H NMR, indicating that no 
decomposition or side-reactions took place during the irradiation, which was quite promising. On 
the other hand, the low yield may be explained by a slow photolytic rate or may be the result of 
a low coupling yield between acid III.6 with alcohol IV.14a which is the most probable 
explanation. 
To clarify these hypotheses, we turned our attention to the o-nitrobenzyl support IV.14b. In 
contrast to linker IV.14a, linker IV.14b possesses a protected amino function. The coupling of 
III.6 on the resulting amino function was expected to occur faster and to be more efficiently 
monitored using the common colorimetric TNBS and NF31 tests.  
Photolabile linker IV.14b was synthesised, according to literature procedures in a very efficient 
way from the commercially available acetovanillone in a seven-step sequence (scheme 4.10).89b 
Acetovanillone reacted with methyl 4-bromobutyrate in presence of potassium carbonate to 
form intermediate IV.18. Without any purification, this keto-ester was immediately treated 
with hydroxylamine hydrochloride to afford oxime IV.19 in 97% yield. The reduction of oxime 
IV.19 into the amine IV.20 was carried out under hydrogen atmosphere in methanol in the 
presence of 10% palladium on charcoal and hydrochloric acid. After protection of the primary 
amine, the nitrogroup was introduced on the benzene ring by treatment of the 
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trifluoroacetamide IV.21 with a solution of 65% of nitric acid to form intermediate IV.22. 
Afterwards, the trifluoroacetamide function and the methylester function in compound IV.22 
were hydrolysed with sodium hydroxide allowing for the introduction of the Fmoc-group leading 
to linker IV.23. Finally, the linker was coupled to the solid phase TentaGel-NH2 using DIC as 
coupling reagent in the presence of HOBt to form IV.14b.  
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Scheme 4.10 
 
With the polymer-supported photolabile linker IV.14b in hand, the efficiency of this linker in 
our synthesis was examined. After deprotection of the Fmoc-protecting group (scheme 4.11), the 
scaffold III.6 was coupled to the resulting amine, affording compound IV.24. The deprotection 
and coupling steps were monitored using the TNBS and NF31 tests. Both tests indicated a 
successful coupling. Moreover, the NF31 test appeared to be more sensitive to control the 
completeness of the coupling reaction involving the scaffold III.6 with the sterically hindered 
amine.  
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Scheme 4.11 
 
The success of the coupling could also be deduced from the 13C gel phase NMR spectrum of the 
polymer-supported scaffold IV.24 (figure 4.6a). As mentioned previously, several characteristic 
peaks in the NMR spectrum were very useful to indicate the success of the coupling reaction. 
The peak at 100 ppm represents the carbon acetal of the THP protecting group. The peaks at 
112 ppm and 121 ppm prove the presence of the DMPM ether and the peaks at 28 (tert-Bu) ppm 
and 135 ppm (Ph) are characteristic for the TBDPS ether.  
At this point, the photolytic release of the scaffold was investigated. When the resin IV.24 was 
exposed to UV-light (365 nm) in 1,4-dioxane, poor results were obtained. Although the 
literature89b claims that the addition of 2-aminoethanol or hydrazine to the solution could 
improve the yield, only impure products were obtained. The best result for the photolytic 
cleavage was obtained when a suspension of resin IV.24 in 1,4-dioxane in the presence of 1% of 
DMSO was irradiated for 3 h affording compound IV.25 in 86% yield. 
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4.5 Study of the selective deprotection of the THP, DMPM and TBDPS 
protecting groups 
The reaction conditions described in the previous chapter were applied to deprotect the THP, 
DMPM and TBDPS protecting groups selectively. After each deprotection, each compound was 
cleaved from the polymer-support and its structure was controlled using 1H NMR spectroscopy 
and ES-MS.  
In a first stage, the deprotection of the THP protecting group was successfully performed using 
two methods (scheme 4.12). The first one involves treatment of the resin IV.24 with a solution 
of 80% of acetic acid at 60 °C to form alcohol IV.26 in a selective way. Another method to 
deprotect selectively the THP protecting group consists in using an excess of PPTS in ethanol at 
55 °C for 15 h. Qualitative monitoring of this deprotection step using 13C gel phase NMR (figure 
4.6b) indicated a complete and selective deprotection. The peak at 100 ppm characteristic for 
the THP group had disappeared whereas the peaks at 110 ppm and 120 ppm characteristic for 
the DMPM ether and the peaks at 28 ppm and 135 ppm characteristic for the TBDPS protecting 
group, remained intact.  
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a
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a) THP deprotection: 1) AcOH / CH2Cl2 / H2O: 80 / 15 / 5, 60 °C, 28 h
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c
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Scheme 4.12 
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Subsequently, after capping the free hydroxyl function (scheme 4.12), resin IV.27 was 
irradiated with UV light for 6 h leading to the release of compound IV.28 in 55% yield after 
column chromatography. The yield involving a six-step sequence, was calculated based on the 
original loading of the commercial resin. The latter was determined using two quantitative 
methods: Fmoc UV/VIS spectroscopy and the picric acid test (see experimental part for more 
details).  
 
Figure 4.6 
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Subsequently, the selective deprotection of the DMPM ether was examined. Resin IV.27 was 
treated with dichlorodicyanoquinone at room temperature for 15 h, as described in the previous 
chapter, followed by capping of the free hydroxyl function with acetic anhydride. 13C NMR 
analysis indicated a successful selective deprotection of the DMPM ether function. After 
cleavage of the resin by irradiation with UV light, analysis via electron spray mass spectrometry 
showed that next to the deprotected ether IV.29, cleavage of the benzyl ethers present in the 
scaffold had occurred as shown in scheme 4.13. This side-reaction could not be detected via 13C 
NMR spectroscopy indicating the usefulness of incorporating a cleavable linker. 
 
a) DMPM deprotection: DDQ, CH2Cl2 / H2O: 19 / 1, r.t., overnight;
OCO(CH2)2CONH2
O
O
O
OAc
OAc
OTBDPS
cleavage cleavage
a, b, c
b) Ac2O, DIPEA, DMAP; c) hn (365 nm), 1,4-dioxane / 1% DMSO
OAc OTBDPS
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hn2
IV.27
OAc OTBDPS
O spacer
OAc
CONH2
IV.29
IV.29
 
 
Scheme 4.12 
 
Finally, also the deprotection of the TBDPS ether was tested on compound IV.24 using a solution 
of TBAF in tetrahydrofuran (scheme 4.14). After capping of the free hydroxyl function as the 
acetate and UV irradiation, no product IV.30 was obtained from the photolytic cleavage. As 
described in the literature, the basicity of the fluoride ions is responsible for the destruction 
of the o-nitrobenzyl unit of the photolabile linker.69a 
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Scheme 4.13 
 
Because of the difficulties encountered in controlling the orthogonal deprotection conditions on 
solid support, we decided to first optimise the deprotection of the DMPM and TBDPS ethers in 
solution. Therefore, we synthesised model compound IV.31 (scheme 4.14). Starting from 
compound IV.22, after hydrolysis of the trifluoroacetamide and of the methyl ester, the 
resulting amino function was protected as a Boc carbamate affording acid IV.32 in 70% overall 
yield. Coupling of IV.32 with n-butylamine led to the formation of amide IV.33 in 46% yield. 
After deprotection of the Boc protecting group with a solution of TFA, the scaffold was 
successfully coupled to amine IV.34 using a classical coupling procedure with EDC and DMAP to 
form model compound IV.31 in 78% yield.  
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Scheme 4.14 
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Compound IV.31 was used to study and optimise the reaction conditions for the deprotection of 
the DMPM and TBDPS protecting group. In the case of the DMPM ether, the different 
conditions we tested are summarised in table 4.1. When compound IV.31 was treated with CAN , 
no deprotection was observed. The use of the lewis acid SnCl4 at –78 °C for 2 h in presence of 
thiophenol gave no reaction. Increasing the temperature to –50 °C for 15 h led to the 
deprotection of the THP ether. When a small excess of DDQ was added to a solution of 
compound IV.31 in a mixture CH2Cl2 / H2O at 5 °C for 1 h, some cleavage of the benzyl ethers 
present in the tripodal scaffold was still observed. Decreasing the temperature to 0 °C and 
shortening the reaction time to 30 min led to a selective and complete deprotection of the 
DMPM ether. Alcohol IV.35 was obtained in 60% yield.  
 
IV.31
table 4.1
IV.35
H
N
O
NH(CH2)3CH3
NO2
OMe
3
O
O spacer
OTHP OTBDPSOH
 
Table 4.1: Selective deprotection of the DMPM ether in model compound IV.31 
 Conditions Results 
1 CAN (2 eq.) - 
2 SnCl4 (1.5 eq.), PhSH, -78 °C, 
(2 h), then –50 °C, 15 h 
Deprotection of THP and DMPM ethers 
3 DDQ (1.5 eq.), 5 °C, 1 h Cleavage of the benzyl ethers (scheme 4.12) 
4 DDQ (1.5 eq.), 0 °C, 30 min. IV.35 (60%): selective deprotection DMPM 
 
Similarly, the deprotection of the TBDPS ether function in compound IV.31 was investigated in 
solution. When compound IV.31 was treated with an excess of TBAF, hydrolysis of the ester 
function present between the scaffold and the spacer was observed leading to the formation of 
alcohol I.14 as a side-product, next to the desired product IV.36. Decreasing the reaction time 
gave a small improvement. A possible explanation for this hydrolysis is the presence of 
hydroxide ions in the solution of tetrabutylammonium fluoride, which is highly hygroscopic. This 
side reaction could be avoided by the addition of acetic acid which led successfully to alcohol 
IV.36 in 90% yield. 
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IV.31
IV.36
table 4.2
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Table 4.2: Selective deprotection of the TBDPS ether in model compound IV.31 
 Conditions Results 
1 TBAF (3 eq.), THF, overnight IV.36 + I.14: 1 / 1 
2 TBAF (3 eq.), THF, 1 h 30 IV.36 + I.14: 7 / 3 
3 TBAF (3 eq.), AcOH (3 eq.), THF, overnight IV.36 (90%) 
 
The newly optimised reaction conditions for the deprotection of the DMPM and TBDPS ethers 
were next tested on our solid-supported scaffold IV.24. The polymer-supported compound 
IV.24 was treated with a small excess of dichlorodicyanoquinone (DDQ) for 30 min at 0 °C. 
Unfortunately, 13C gel phase NMR analysis still indicated incomplete deprotection. However, in 
our case, increasing the reaction time to 1 h was sufficient to form the alcohol in a complete and 
selective way, as shown by 13C NMR gel phase NMR (figure 4.6c): the peaks at 110 ppm and 121 
ppm disappeared whereas the THP and TBDPS protecting groups are still present. After capping 
of the free alcohol function with a solution of acetic anhydride, the resin was exposed to UV 
light for 9 h to afford the acetate IV.37 as the sole product in 62% yield after column 
chromatography.  
 
Similarly, deprotection of the TBDPS ether on solid support was examined by reaction of IV.24 
with a solution of TBAF in THF in the presence of one equivalent of acetic acid overnight. Since 
the deprotection was incomplete according to 13C gel phase NMR, the reaction was repeated 
overnight leading successfully to alcohol IV.38. 13C gel phase NMR (figure 4.6d) confirmed the 
selective deprotection of the TBDPS ether. The peaks at 28 ppm (tert-Bu) and at 135 ppm (Ph) 
disappeared whereas the DMPM and THP protecting groups remained intact. Capping of the 
hydroxyl function as the acetate and irradiation of the resin for 8 h afforded acetate IV.38 in 
56% yield. Other reagents such as NH4F,91a HF.pyr.,91b-d and TASF (tris-(dimethylamino)sulfur 
                                                                 
91 (a) Zhang, W.; Robins, M.J. Tetrahedron Lett. 1992, 33, 1177; (b) Newton, R.F.; Reynolds, D.P. 
Tetrahedron Lett. 1979, 41, 3981; (c) Nicolaou, K.C.; Seitz, S.P.; Pavia, M.R. J. Am. Chem. Soc. 1981, 103, 
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trimethylsilyldifluoride)91e were also successful in the selective deprotection of the TBDPS 
group in compound IV.24. 
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e) NH4F, MeOH, overnight (2x); f) HF.pyr., THF, overnight; g) TASF, DMF, 3 h  
 
Scheme 4.15 
 
4.6 Conclusion 
In this chapter, linkers of different types were tested. The use of the Rink linker and the 
Kenner linker gave poor results. On the other hand, photolabile linkers gave promising results. 
After coupling of the scaffold to the solid-supported linker IV.14b, the conditions for the 
photolytic cleavage were optimised. This linker is stable and the polymer-supported scaffold 
IV.24 was nicely cleaved from the solid phase. Subsequently, the selective deprotection of the 
three protecting groups (THP, DMPM and TBDPS) was optimised.92 Furthermore, in this chapter 
the necessity of using a cleavable linker was shown. It has been proven that qualitative methods 
such as 13C gel phase NMR are useful to monitor solid-phase reactions but are not always 
                                                                                                                                                                                                          
1222; (d) Nicolaou, K.C.; Randall, J.L.; Furst, G.T. J. Am. Chem. Soc. 1985, 107, 5556; (e) Scheidt, K.A.; 
Chen, H.; Follows, B.C.; Chemler, S.R.; Coffey, S.; Roush, W.R. J. Org. Chem. 1998, 63, 6436. 
92 Farcy N.; De Muynck, H.; Madder, A.; Hosten, N.; De Clercq, P.J. Org. Lett. 2001, 4299. 
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sufficient enough in the detection of side reactions. At this stage, the final goal, the synthesis 
of a library, could be envisaged. 
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5 Efforts towards the synthesis of a tripodal library  
 
5.1 Introduction 
After a careful choice of the cleavable linker and the optimisation of the selective 
deprotections on solid-phase bound scaffold IV.24, we describe here our efforts towards the 
synthesis of a tripodal library.  
Our strategy for the synthesis of the library V.1 is outlined in scheme 5.1. Using solid-phase 
bound scaffold IV.24 as a template, the selective deprotection of the three protecting groups 
(THP, DMPM and TBDPS) enables an independent and consecutive construction of three peptide 
chains. Each strand is generated using the ‘split and mix’ protocol with a pool of three amino 
acids. For each strand, one residue of the catalytic triad, serine, histidine or aspartate is 
included in the pool. Except for these three essential amino acids, all others are randomly chosen 
among the non-functionalised side-chain amino acids. 
Since Fmoc/tert-Bu strategy (see part 1) will be used for the synthesis of the library, Fmoc 
amino acids containing an acid labile protecting group on the side-chain will be selected for the 
catalytic triad. This explains why the THP group in IV.24, which is cleaved under acidic 
conditions, has to be removed first. Subsequently, construction of the first peptide strand using 
the 'split and mix' protocol with three amino acids including serine, leads to the formation of 
the first 9 members. Next, 81 (32 x 32) members are obtained after deprotection of for instance 
the DMPM ether, and generation of the second peptide strand using three other amino acids 
including histidine. Finally, the TBDPS ether will be removed and the last chain will be 
constructed including aspartate among the three amino acids used as building blocks. At this 
stage, the library will contain 729 (32 x 32 x 32) members. 
Upon removal of the side-chain protecting groups the library can be tested towards hydrolytic 
activity. The p-nitrophenyl ester I.16a (NF31) and the more challenging p-nitroanilide I.16b 
are potential test substrates for the screening procedure. All members of the tripodal library 
are expected to show a different reactivity towards the substrates resulting in the appearance 
of more or less coloured red beads. As such, it should be possible to isolate the most active 
member of the library, to cleave off the product and to submit it to MS-MS tandem mass 
spectrometry to determine the sequence of the active member.93 However, the determination of 
                                                                 
93 For single bead MS-MS analysis see: (a) Vanhoenacker, G.; Liu, L.; Lynen, F.; Madder, A.; De Clercq, P.; 
Sandra, P. J. Separation Science accepted; (b) Madder, A.; Li, L.; De Muynck, H.; Farcy, N.; Van Haver, D.; 
Fant, F.; Vanhoenacker, G.; Sandra, P.;  Davis, A.P.; De Clercq, P.J. J. Comb. Chem. submitted. 
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the sequence using this method implies that all amino acids used for the construction of each 
peptide strand have a different molecular weight. 
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Scheme 5.1 
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5.2 Choice of the suitable side-chain protecting groups  
A last aspect that needed to be evaluated was the choice of the side-chain protecting groups of 
the amino acids serine, histidine and aspartate. The principle of orthogonality between all the 
different protecting groups present in the scaffold and in the amino acids directed our choices. 
Acid labile protecting groups were chosen to protect the serine and histidine side-chains. Since 
our tripodal scaffold is unstable under strongly acidic conditions (TFA), high acid labile side-
chain protecting groups are preferred. That is the reason why we selected trityl side-chain 
protected serine and methyltrityl side-chain protected histidine.94  Although these protecting 
groups, according to the literature, are usually removed with a solution of 5% TFA, we believed 
that weaker acids could be as efficient as TFA. To control the complete deprotection on solid 
support of the trityl and methyltrityl groups, polymer-supported compounds V.2 and V.3 were 
synthesised. Thus, treatment of V.2 with a solution of 80% chloroacetic acid in a mixture 
CH2Cl2/H2O (3/1) led to successful deprotection affording compounds V.4 and V.5. After 
cleavage of the dipeptide from Wang resin, the complete deprotection was confirmed from 1H 
NMR or/and ES-MS on the basis of the absence of aromatic peaks derived from trityl and 
methyltrityl groups. 
 
GlySerNHAc
OTrt
GlyHisNHAc
NMtt
a) ClCH2COOH / CH2Cl2 / H2O: 80 / 15 / 5, 21 h; b) TFA / CH2Cl2 / H2O: 95 / 2.5 / 2.5
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OH
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NH
V.2
V.3
V.6
V.7
a
GlySerNHAc
OH
GlyHisNHAc
NH
V.4
V.5
b
 
 
Scheme 5.2 
 
Concerning the side-chain protecting groups of aspartic acid, all commercially available Na Fmoc 
protected aspartic acids contain a benzyl, allyl, adamantyl or tert-Bu ester protected side-chain. 
These protecting groups are removed under hydrogenolysis, palladium treatment or in presence 
of strong acid, respectively. All these deprotection conditions are expected to cause some 
damages to the benzyl ethers present in the scaffold. That is the reason why we turned our 
attention to an alternative protecting group, the trimethylsilylethyl ester (TMSE).95 The 
                                                                 
94 Barlos, K.; Chatzi, O.; Gatos, D.; Stavropoulos, G.; Tsegenidis, T. Tetrahedron Lett. 1991, 32, 475. 
95 (a) Sieber, P. Helv. Chim. Acta  1977, 60, 2711; (b) Marlowe, C.K. Bioorg. Med. Chem. Lett. 1993, 3, 437. 
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deprotection of the TMSE functionality is usually carried out with a solution of 1 M TBAF in 
DMF for 20 min or with TASF reagent ((tris-(dimethylamino)sulfur trimethylsilyldifluoride).91e 
The TMSE group was expected to be stable during the synthesis of the library and to be 
removed smoothly at the end.  
The trimethylsilylethyl ester V.8 was prepared in a three-step sequence from the commercially 
available aspartic acid a-benzylester. Reaction with FmocOSu led to the introduction of the 
Fmoc-group to give V.9. Esterification with 2-(trimethylsilyl)ethanol using DCC as coupling 
reagent in the presence of DMAP afforded ester V.10 in 70% yield. Finally, the benzyl group 
was removed by hydrogenolysis to afford compound V.8 in 98% yield.  
Once the side-chain protection scheme of serine, histidine and aspartate was optimised, the 
synthesis of our first library was attempted. 
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Scheme 5.3 
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5.3 Synthesis of a dipodal library using the ‘IRORI’ technique 
 
5.3.1 Introduction of the ‘IRORI-technique’ 
The parallel and the ‘split and mix’ synthesis are two methods to achieve high productivity in 
combinatorial library synthesis. Parallel synthesis delivers discrete compounds in milligram 
quantities but suffers from the disadvantage of producing only a limited number of products per 
unit time and per reaction. The ‘split and mix’ technique addresses this problem of parallel 
synthesis but yields a mixture of compounds that needs to be deconvoluted.96 A hybrid 
technique, the IRORI method as developed by Nicolaou97 in 1995, addresses the disadvantages 
of both parallel and ‘split-and mix’ synthesis. In this technique, resin beads and a radio-
frequency (RF) tag are enclosed in a porous microreactor for solid-phase reactions. The RF 
(radio-frequency) tag is a semiconductor device capable of receiving, storing and emitting 
radiofrequency signals. To each tag is assigned one compound of the library at the beginning of 
the synthesis meaning that for a library of n members, n microreactors containing n RF tags 
need to be used.  
By a process called ‘directed sorting’, microreactors rather than individual solid phase resin 
beads are split and pooled. The principle of ‘directed sorting’ is illustrated in figure 5.1 for a 
library of 9 compounds. In the first step called ‘sorting step’, each microreactor containing the 
RF tag and the resin is placed on the reading station, each tag is read and all microreactors are 
split into three groups. Each group corresponds to a unique radiofrequency tag (i.e. a, b or c) 
corresponding to the building block to be added to that group (i.e. A, B or C). The reactions are 
carried out separately with each group. Afterwards, the microreactors are mixed together. The 
pool is then sorted and split again in three groups according to the second set of radiofrequency 
signals (a, b or c) corresponding to the next set of building blocks to be introduced (A, B or C). 
The chemical reactions are performed in each reaction vessel. This process is repeated until the 
synthesis is complete. At this stage, the identity of the compounds in each microreactor can be 
easily deduced by reading the RF tag. 
                                                                 
96 For more informations about the recursive deconvolution see: Erb, E.; Janda, K.D.; Brenner, S. Proc. Natl. 
Acad. Sci. USA 1994, 91, 11422. 
97 Nicolaou, K.C.; Xiao, X.-Y.; Parandoosh, Z.; Senyei, A.; Nova, M.P. Angew. Chem. Int. Ed. Engl. 1995, 34, 
2289.  
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Figure 5.1: Directed-sorting 
 
For a successful synthesis of combinatorial libraries using this technique, the bead size of the 
polymer support is critical. The size of the microreactor pores is 75 mm. It is therefore 
recommended to use beads with a diameter of at least 130 mm to avoid any loss of resin through 
the walls of the microreactor.  
This new technique is a powerful synthetic tool for the generation of large discrete compound 
libraries (table 5.1). As an example, the ‘IRORI’ technique requires only 40 reactions to 
synthesise 10 000 discrete compounds in a four-step sequence with 10 building blocks for each 
step. In comparison, it requires at least 11 110 and up to 40 000 reactions in parallel synthesis. 
However, taking into consideration that for each compound of the library is assigned one radio-
frequency tag, the most important limiting aspect of the ‘IRORI’ technique in the synthesis of 
large libraries is the cost of the RF tags. 
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Table 5.1: Synthesis of 10 000 compounds 
Method Compound form Quantity Number of reactions 
Parallel 
Split-and Mix 
IRORI 
Discrete 
Mixture 
Discrete 
Milligrams 
Nanograms 
Milligrams 
11 110-40 000 
40 
40 
 
5.3.2 Synthesis of a dipodal library using the ‘IRORI’ technique 
In collaboration with Prof. Dr. A. Berkessel (Cologne, Germany), we planned the synthesis of a 
small dipodal library V.11 containing 81 members using the IRORI technique. As presented in 
figure 5.2, only the two most important amino acids of the catalytic triad, serine and histidine 
were incorporated, each of them in a separate peptide strand. As such, FmocSer(OTrt)OH, 
FmocPheOH and FmocValOH were used as building blocks for the synthesis of the first peptide 
strand and FmocHis(NMtt)OH, FmocAlaOH and FmocLeuOH for the construction of the second 
one. 
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Figure 5.2 
 
The synthesis of the library is summarised in scheme 5.3. After deprotection of the THP 
protecting group, the acid chloride FmocGlyCl was coupled. The resin was distributed among 81 
microreactors, each of them labelled with an RF tag coding for the designated compound. The 81 
microreactors were divided between three reaction vessels (27 microreactors per vessel) using 
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the ‘directed-sorting’ principle (vide supra). In each vessel, serine, phenylalanine or valine was 
coupled using PyBOP as coupling reagent in the presence of 3% N-methylmorpholine in 
dimethylformamide.98 It has to be mentioned that the use of voluminous microreactors results in 
much more diluted solutions and longer reaction times (twice as long as compared to coupling 
reactions on loose resin). After deprotection of the Fmoc protecting group, the microreactors 
were sorted again in three reaction vessels for the next coupling step. In each vessel, serine, 
phenylalanine or valine was coupled. Finally, the Fmoc group was removed followed by capping of 
the free amino function with an excess of acetylimidazole. At this stage, 9 members were 
obtained. 
 
OTHP OTBDPS
O spacer
ODMPM
hn2
a) AcOH / CH2Cl2 / H2O: 80 / 15 / 5, 60 °C, 16 h; b) FmocGlyCl, DIPEA, CH2Cl2; 
c) 20% pip. / DMF; d) AA1,2,3, PyBop, 3% NMM, DMF; e) AcIm, CH2Cl2; f) DDQ, 
CH2Cl2 / H2O: 19 / 1, 2 h, 0 °C; g) AA4,5,6, PyBop, 3% NMM, DMF
O OTBDPS
O spacer
ODMPM
hn2      a, b,
(c, d) 2x, c, e
Gly
AA1,2,3
AA1,2,3
NH
Ac
O OTBDPS
O spacer
O
hn2
Gly
AA1,2,3
AA1,2,3
NH
Ac
Gly
AA4,5,6
AA4,5,6
NH
Ac
      f, b, 
(c, g) 2 x, c, e
V.11
81 members
IV.24
9 members
 
 
Scheme 5.4 
 
Subsequently, all 81 microreactors were collected in a common flask and the DMPM ether was 
removed (scheme 5.4) using dichlorodicyanoquinone at 0 °C for 2 h. Similar to the first peptide 
chain, the construction of the second using the ‘IRORI directed split and mix’ protocol was 
performed with the second set of amino acids, histidine, alanine or leucine. The efficiency of all 
                                                                 
98 Coste, J.; Le-Nguyen, D.; Castro, B. Tetrahedron Lett. 1990, 31, 205. 
Part 5: Efforts towards the synthesis of a tripodal library    
   
77
 
coupling reactions was successfully monitored in a qualitative way using the colorimetric TNBS 
and NF31 tests.  
To allow the screening of the library, in the next step, the side-chain protecting groups trityl 
and methyltrityl were removed using a solution of 80% chlororacetic acid in a mixture of 
dichloromethane/water (3/1). At this stage, a representative sample (9 members) V.12a-i was 
selected from the library, submitted to photolytic cleavage and analysed (scheme 5.4). 
Unfortunately, the evaluation of the members by ES-MS revealed a lower molecular weight than 
expected corresponding to cleavage of the first introduced peptide strand affording compounds 
V13a-i. The origin of the hydrolysis of the ester bond during the synthesis of the library 
remains unexplained.  
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Scheme 5.5 
 
As a result of the apparent sensitivity of the ester bonds, it was expected that the 
transformation of the alcohol functions of the scaffold into amines could be the solution of this 
problem. This alternative pathway is explained in the next section. 
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5.4 Transformation of IV.24 into an amine-functionalised tripodal scaffold 
For the transformation of the alcohol functions of scaffold IV.24 into amino functions, two 
strategies were taken into consideration. The first strategy involved the reaction of the 
polymer-supported alcohol functions of IV.24 with a protected (PG) symmetrical aziridine 
derivative as outlined in scheme 5.6. 
 
OH OTBDPS
O spacer
ODMPM
hn2
IV.26
N
PG
O OTBDPS
O spacer
ODMPM
hn2
NHPG
PG (protecting group)
deprotection and coupling
 of amino acids
V.14a: PG = Fmoc
V.14b: PG = Alloc
 
Scheme 5.6 
 
We have chosen aziridines V.14 protected as Fmoc or as Alloc since the deprotection of these 
protecting groups on solid phase are known to occur efficiently. Our attempts to synthesise 
aziridines V.14 from commercially available 2-aminoethanol are presented in scheme 5.7. The 
free amino function was first protected with a Fmoc or Alloc group to form protected amino 
alcohol V.15a and V.15b in 98% and 76% yield respectively. Subsequently, the alcohol functions 
were transformed into good leaving groups to form the mesylate V.16a and the tosylate V.16b 
in high yield. Unfortunately, treatment of alcohol V.16a with potassium tert-butoxide or with 
lithium hexamethyldisilazane (LiHMDS) at –78 °C in tetrahydrofuran gave no ring closure but 
only Fmoc deprotection.99 Moreover, when the latter conditions were applied to the tosylate 
V.16b, no aziridine formation was observed either. In an alternative attempt, treatment of 
V.15a with diethylazodicarboxylate (DEAD) in presence of triphenylphosphine under Mitsonubu 
reaction conditions only resulted in the isolation of the diethylazodicarboxylate derivative V.17.  
                                                                 
99 Greene, T.W.; Wuts, P.G. ‘Protective groups in organic synthesis’, third edition, 2001.: The Fmoc-
protecting group is claimed to be stable to potassium tert-butoxide at low temperature. 
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Scheme 5.7 
 
The formation of V.17, resulting from a nucleophilic substitution of the mesylate by 
diethylazodicarboxylate has been described in the literature.100 In this article, the authors claim 
that unsubstituted aziridine derivatives can only be synthesised in a very low yield (10%), 
whereas good yields of aziridine can be obtained if there is at least one substituent attached to 
either one of the two carbon atoms of the aziridine ring. We therefore concluded that this 
strategy was not suitable for the synthesis of an amino-functionalised scaffold.  
 
In the second strategy, we planned the transformation of the alcohol functions of scaffold 
IV.24 into azides, and subsequent reduction into the corresponding amines. As such, after 
removal of the THP protecting group of compound IV.24 with PPTS at 55 °C for 15 h, the 
resulting alcohol IV.26 was reacted with diphenylphosphorazidate ((PhO)2PON3) in the presence 
of DBU (scheme 5.8) to transform in one step the alcohol function into the corresponding azide 
V.18.101 When the reaction was carried out at room temperature, instead of azide V.18 only 
intermediate V.19 was formed. Increasing the temperature did not give any improvement. 
However, when intermediate V.19 was heated in the presence of a large excess of sodium azide 
in DMPU for 20 h, only partial conversion to azide V.18 was observed.  
                                                                 
100 Pfister, J.R. Synthesis 1984, 969. 
101 Thompson, A.S.; Humphrey, G.R.; DeMarco; A.M.; Mathre, D.J.; Grabowski, E.J.J. J. Org. Chem. 1993, 58, 
5886. 
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Scheme 5.8 
 
Another method involves the transformation of alcohol IV.26 into tosylate V.20 (scheme 5.9) 
followed by treatment with sodium azide in DMPU to form azide V.18. Concerning the reduction 
of azide V.18 to amine V.21, due to the presence of benzyl ethers in the tripodal scaffold and 
an ester function between the scaffold and the spacer, neither hydrogenolysis nor reduction 
with lithium aluminium hydride could be used for this step. The alternative Staudinger method, 
involving the use of triphenylphosphine or trimethylphosphine only afforded complex reaction 
mixtures.102 
                                                                 
102 (a) Staudinger, H.; Meyer, J. Helv. Chim. Acta 1919, 2, 635; (b) Vaultier, M.; Knouzi, N.; Carrié, R. 
Tetrahedron Lett. 1983, 24, 763. 
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Scheme 5.9 
 
In view of these disappointing results, our last tentative consisted in the reaction of alcohol 
IV.26 with isocyanate V.22 which led to the formation of the carbamate V.23 (scheme 5.10) in 
88% yield as determined by UV/VIS spectroscopy. Isocyanate V.22 was obtained from 
acylazide V.24 via a Curtius rearrangement in toluene at 65 °C. However, to our surprise, after 
photolytic cleavage of a sample of V.23, ES-MS analysis revealed this carbamate bond to be 
unstable. Only traces of carbamate V.23 were observed next to a major proportion of starting 
material IV.26. The unstability of the carbamate bond can be issue from the photolytic cleavage 
or from the conditions used during the ES-MS analysis. Since we were unable to confirm the real 
origin of the failures of these strategies, no further efforts were undertaken for the synthesis 
of an amine-based scaffold.  
At this stage, the use of the alcohol based scaffold was reconsidered. To retrace the origin of 
the above observed loss of one peptide strand (see synthesis of the dipodal library), a member 
of the library was resynthesised. After each coupling step, a resin sample was submitted to 
photolytic cleavage and carefully analysed by mass spectrometry.  
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Scheme 5.10 
 
5.5 Synthesis of one member of the tripodal library 
As a final stage before the actual synthesis of our tripodal library, we decided to complete the 
synthesis of one representative member. This synthetic exercise would serve as a final test to 
check all previously optimised process parameters, being: 
1) the stability of the scaffold during the library synthesis (stability of the benzyl ethers); 
2) the orthogonal deprotection of the scaffold protecting groups (THP, DMPM and TBDPS); 
3) the usefulness of the photolabile linker for the analysis of intermediates and final 
products by ES-MS; 
4) the monitoring of the completeness of the coupling steps using the colorimetric TNBS 
and NF31 tests; 
5) the stability of the glycine ester function towards hydrolytic cleavage during the 
synthesis of the peptide strands (hydrolysis of this ester has been previously observed 
during the dipodal library synthesis); 
6) the stability of the serine, histidine and aspartic acid side-chain protecting groups 
during the synthesis of the library and the completeness of their final deprotection; 
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7) Evaluation of MS and NMR techniques in the determination of the peptide sequence of 
the final product. 
 
The synthesis of the member of the library is outlined in scheme 5.11. After deprotection of the 
THP protecting group using PPTS in ethanol at 55 °C, the first peptide strand was constructed 
by reaction of the free alcohol function with FmocGlyCl in 95% yield followed by consecutive 
coupling of FmocSer(OTrt)OH and FmocPheOH using the traditional DIC/HOBt methodology. 
Finally, after removal of the last Fmoc protecting group, the free amino functions were capped 
with an excess of  acetylimidazole to form resin V.25. The structure of V.25, after photolytic 
cleavage, was confirmed by ES-MS, 1H NMR, COSY NMR, TOCSY NMR and ROESY NMR. 
Subsequently, the DMPM ether was removed using dichlorodicyanoquinone at 0 °C for 1 h and the 
second peptide strand including histidine was generated following the same strategy using the 
amino acids FmocHis(NMtt)OH and FmocAlaOH affording V.26. The photolytic cleavage of this 
dipodal member indicated the presence of both peptide strands meaning that no hydrolysis of 
the glycine ester bonds had occurred.103 Finally, after deprotection of the TBDPS ether with a 
solution of TBAF in the presence of acetic acid, the third and last peptide chain containing 
FmocAsp(COO(CH2)2SiMe3)OH and FmocValOH was synthesised. Unfortunately, despite the 
success of the dipodal derivative V.26, the steps leading to the construction of the third 
peptide strands appeared not to be compatible with the already present functionalities. Careful 
1H NMR analysis of the photolytically cleaved V.27 revealed the deprotection of the side-chain 
protecting trityl and methyltrityl groups.  
                                                                 
103 It has to be noted that the 1H NMR of the cleaved compound from resin V.26 was not pure enough to 
attribute all peaks but we could clearly observe that the glycine ester bonds were intact due to the 
presence of trityl and methyltrityl peaks in the spectrum.  
In addition, the limited mass-ion detection of our ES-MS equipment is 2000 g/mol and does not allow the 
detection of the high molecular weight of the product issue from the cleavage of resin V.26 (2013 g/mol). 
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Scheme 5.11 
 
As a possible explanation, the deprotection of the trityl and methyltrityl groups might have 
occurred during the coupling of FmocGlyCl due to the presence of some remaining thionyl 
chloride from the preparation of the acid chloride of glycine. Another hypothesis for the 
removal of the trityl and methyltrityl group might be the long exposure time of resin V.26 to 
acetic acid used as a co-solvent during the TBDPS deprotection step. To solve these problems, 
we decided to investigate another coupling method to couple glycine on the hydroxyl function and 
to avoid the use of acetic acid during the deprotection of the TBDPS ether.  
Concerning the coupling of glycine on the hydroxyl function in IV.24, another efficient method 
was found to be the traditional methodology DIC/HOBt in the presence of diisopropylethylamine 
and a catalytic amount of DMAP.104 Using this new method for the coupling of glycine, we were 
able to synthesise again successfully our dipodal member V.26. After removal of the trityl and 
                                                                 
104 The amount of DMAP needs to be carefully controlled to avoid deprotection fo the Fmoc protecting 
group and dicoupling. 
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methyltrityl group in a sample of resin V.26, the resulting product was cleaved by photolysis and 
analysed by ES-MS. 
At this stage, for the deprotection of the TBDPS ether several new reaction conditions were 
screened (table 5.2). The use of ammonium fluoride led to hydrolysis of an ester bond in resin 
V.26. This side-reaction can be explained by the release of ammonia in the solution, which is 
nucleophilic enough to hydrolyse the ester bond. When potassium fluoride or cesium fluoride 
were used, only some traces of TBDPS deprotection were observed. On the other hand, the 
widely used hydrogen fluoride (70%). pyridine was efficient in the cleavage of the TBDPS ether 
but apparently too acidic since the trityl and methyltrityl groups were also deprotected. Finally, 
the less known TASF reagent (tris(dimethylamino)sulfur (trimethylsilyl)difluoride) was 
successful and led to a clean deprotection of the TBDPS ether after 3 h at room temperature. 
 
O OTBDPS
O spacer
O
hn2
Gly
Ser(OTrt)
Phe
NH
Ac
Gly
His(NMtt)
Ala
NH
Ac
V.26  
Table 5.2: Deprotection of the TBDPS ether in compound V.26 
 Conditions  Results 
1 NH4F, MeOH Cleavage of the ester 
2 KF (10 eq.), 18-crown-6, THF, r.t.  No reaction 
3 CsF (10 eq.), THF, r.t. Trace of deprotection 
4 HF.pyr. (10 eq.), THF, 4 h Trityl and Methyltrityl deprotection 
5 TASF (2 eq.) in DMF, 3 h, r.t. Selective deprotection of the TBDPS ether 
 
Once the TBDPS ether removed, the third and last peptide was constructed following the same 
strategy with the amino acids FmocAsp(COO(CH2)2SiMe3)OH and FmocValOH.  
To prove the success of the synthesis, a sample of the polymer-supported tripodal member V.27 
was cleaved (scheme 5.12) and the resulting compound V.28 was analysed by 1H NMR. The 
structure of the tripodal member was confirmed with the help of 1H NMR, COSY NMR, TOCSY 
NMR, ROESY NMR.  
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Scheme 5.12 
 
The 1H-1H COSY NMR shows the scalar coupling interactions between geminal and/or vicinal 
protons in one specific amino acid such as NH ® Ha and Ha ® Hb. These are called the direct 
connections. On the other hand, the 1H-1H TOCSY spectrum gives correlations between any 1H 
resonances of a spin system provided they can be linked by an uninterrupted chain of scalar 
couplings. The transfer of magnetisation occurs from NH ® Ha ® Hb ® Hg. These are called 
the indirect connections.  
In the ROESY spectrum, the NOE effect is used to show correlations between protons which 
are close together in space (distance < 500 pm). The NOE contacts between the amide, a- and b-
protons can be used for the determination of the amino acid sequence. According to statistic 
analysis, the simultaneous observation of a NOE contact connecting the Ha and Hb of one 
residue with the NH of another one (N terminal ® C terminal) indicates that these residues are 
sequential with more than 95% probability. As illustration, the expected NOE interactions for 
the sequence -Val-Asp-Gly3- are presented in figure 5.3. 
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Figure 5.3: NOE's contacts in the ROESY spectrum for the sequence 
-Val-Asp-Gly3- 
 
The structure of compound V.28 was confirmed as follows (figure 5.4): the Hg of the valine 
residue is identified in the TOCSY spectrum at 0.75 ppm. The assigment of the Ha- and Hb- are 
deduced from the TOCSY spectrum as indicated. On the other hand, the ROESY spectrum shows 
a cross-peak between the Ha of valine with the amide proton of aspartic acid at 8.14 ppm. Two 
other sequential interactions are present also between the Hb and Hg of valine with the amide 
proton of aspartic acid. Concerning the valine residue, the last cross peak corresponds to an 
interaction between the methyl from the N-terminal acetyl group at 1.8 ppm to the amide proton 
of valine at 7.86 ppm. The presence of a glycine residue next to aspartic acid was confirmed by 
the cross-peak interaction between the Ha of aspartic acid and the amide proton of glycine at 
7.90 ppm. The sequence Me-Val-Asp-Gly3- was proven to be present in compound V.28. The same 
strategy was followed to confirm the two other sequences to be consistent with -Phe-Ser-Gly1- 
and -Ala-His-Gly2. The position of all intra residue scalar coupling correlations and sequential 
NOE interactions are labelled on the TOCSY and ROESY spectra respectively (figure 5.4). 
 
Part 5: Efforts towards the synthesis of a tripodal library    
   
88
 
O O
O spacer
O
hn2
Gly1
Ser(OTrt)
Phe
NH
Ac
Gly2
His(NMtt)
Ala
NH
Ac
Gly3
Asp(COOR)
Val
NH
Ac
R = -(CH2)2SiMe3
V.27
O O
O spacer
O
hn2
Gly1
Ser(OH)
Phe
NH
Ac
Gly2
His(NH)
Ala
NH
Ac
Gly3
Asp(COOR)
Val
NH
Ac
V.29
a
O O
O spacer
O
CONH2
Gly1
Ser(OH)
Phe
NH
Ac
Gly2
His(NH)
Ala
NH
Ac
Gly3
Asp(COOR)
Val
NH
Ac
b
R = -(CH2)2SiMe3
V.30 R = -(CH2)2SiMe3
a) ClCH2COOH / CH2Cl2 / H2O: 80 / 15 / 5, 6 h, overnight, r.t.; b)  hn (365 nm), CH3CN, 3 h  
 
Scheme 5.13 
 
Subsequently, the side-chain protecting groups of serine, histidine were removed (scheme 5.13) 
using a solution of chloroacetic acid to form resin V.29. This resin was cleaved by photolysis to 
form successfully compound V.30, which was analysed by ES-MS (figure 5.5). The peaks at 868, 
1691 and 1713 g/mol correspond to the doubly charged adduct, the proton adduct and the sodium 
adduct respectively. An incomplete deprotection of the TBDPS ether explains the presence of 
the peak at 1538 g/mol corresponding to some remaining compound V.26. In the future, a longer 
reaction time for the TBDPS deprotection could solve this problem.  
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Figure 5.5 
 
Finally, resin V.29 was treated with fluoride anions to remove the side-chain protecting group of 
aspartic acid. However, the use of TBAF is known to affect the o-nitrobenzyl moiety blocking 
any possible further photolytic cleavage.69a When TBAF was used in the presence of acetic acid, 
only starting product was observed. Finally, the previously successful TASF reagent failed to 
deprotect the TMSE group.  
 
5.6 Conclusion 
After ‘trial and error’, we succeeded in the synthesis of a tripodal  member of the library. All 
the difficulties of the orthognal protection scheme were overcome. All reactions on solid 
support were optimised. Our scaffold is a suitable template for the future construction of 
combinatorial tripodal libraries.  
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6 General conclusion and perspectives  
 
In this work we presented our efforts towards the development of a new catalyst for the 
hydrolysis of amide bonds, based on the well-known serine-protease a-chymotrypsin, using 
combinatorial techniques (scheme 6.1). Even if the efficiency of a-chymotrypsin has inspired 
scientists in the design of artificial enzymes, no efficient model has been reported so far using 
combinatorial techniques. This PhD work involved the development of a tripodal library designed 
as such that each residue of the catalytic triad serine, histidine and aspartate were 
incorporated in one of the three peptide strands. The role of the scaffold is to induce the 
proximity between the three different peptide chains. By the synthesis of hundreds of 
compounds, the use of combinatorial chemistry gives a greater chance of finding one or several 
catalysts possessing hydrolytic activity. 
 
Asp O
O
NNH H O
Ser
R-NH
R'
O
RNH2 R'COOH+
catalytic triad
AA1
AA2
AA3
AA4
AA5
AA6
AA7
AA8
AA9
scaffold
AspSer His
a-chymotrypsin
His
 
Scheme 6.1 
 
To attain this goal, tripodal scaffold III.6, was synthesised from the commercially available 
pentaerythritol (scheme 6.2) in 4.1% overall yield. This scaffold possesses three hydroxyl 
functions orthogonally protected and a carboxylic acid function allowing for the coupling to the 
polymer support. The polymer support used wasTentaGel-NH2. 
 
 
Part 6: General conclusion and perspectives        
   
91
 
O
O
O
O
THPO
ODMPM
OTBDPS
spacer COOH
III.6
OH
HO OH
OH
pentaerythritol
 
 
Scheme 6.2 
 
To facilitate the solid-phase chemistry part of this work, a cleavable linker was included in the 
synthesis enabling the release of the compounds attached on the solid support and allowing for 
the analysis of the products using classical analytical methods such as 1H NMR and ES-MS. The 
use of the o-nitrobenzyl photolabile linker derivative IV.23 developed by Holmes was the most 
efficient. After coupling of acid linker IV.23 to TentaGel and deprotection of the Fmoc-group, 
the scaffold was successfully coupled to the polymer support. The optimisation of the photolytic 
cleavage was performed on solid-phase bound scaffold IV.24. The best results were obtained 
when resin IV.24 in suspension in 1,4-dioxane in presence of 1% dimethylsulfoxide was 
irradiated for 9 h affording compound IV.25 in 86% yield. 
 
The next aspect, which was evaluated, concerned the selective deprotection of the three 
protecting groups, THP, DMPM and TBDPS. This allowed later for the independent generation of 
three peptide strands. The deprotection of the THP group was performed using a solution of 
80% acetic acid at 60 °C or with the help of PPTS at 55 °C. In the case of the removal of the 
DMPM ether in IV.24, complete and selective deprotection was achieved using 
dichlorodicyanoquinone (DDQ) at 0 °C for 1 h. Longer reaction time or higher temperature led to 
cleavage of the benzyl ethers present in scaffold III.6. Concerning the deprotection of the 
TBDPS ether, the procedure using tetrabutylammonium fluoride failed. However, the use of 
TBAF in presence of acetic acid led to a successful and selective deprotection. Although the on-
resin deprotection could be followed by 13C gel phase NMR, we wished to control the efficiency 
and the reproducibility of the above procedure in a quantitative way. Therefore, in each case, 
after deprotection, the free hydroxyl function was capped as the acetate, and the resulting 
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intermediate was subjected to photocleavage. The released acetates IV.28, IV.37 and IV.38 
were obtained in 55%, 62%, and 56% respectively.  
At this stage, we succeeded in the choice of a suitable cleavable linker for our synthesis, in the 
optimisation of the photolysis conditions and in the selective deprotection of the three 
protecting groups. 
 
NHFmoc
O
MeO
OH
NO2
IV.23
3
O
O
O
O
O
OTHP
ODMPM
OTBDPS
spacer hn2
hn2
1. Selective deprotection: a, b 
or  c
2. Ac2O, DIPEA, DMAP
3. hn (365 nm), 1,4-dioxane / 
1% DMSO
O
O
O
O
OR1
OR2
OR3
spacer CONH2
R1 R2 R3
THP
Ac
THP
THP
DMPM
DMPM
Ac
DMPM
TBDPS
TBDPS
TBDPS
Ac
IV.24
a) AcOH / CH2Cl2 / H2O: 80 / 15 / 5, 60 °C, 16 h; b) DDQ, CH2Cl2 / H2O: 19 / 1, 1 h, 0 
°C; c) TBAF, AcOH, molecular sieves (400 pm), THF or NH4F, MeOH or HF/pyr., THF 
or TASF, DMF.
3 steps
IV.25
IV.37
IV.38
IV.28
 
 
Scheme 6.3 
 
Once the selective deprotection of the three protecting groups was achieved, the ultimate goal, 
the synthesis of a library could be envisaged. Since the Fmoc/tert-Bu stragegy was used, Na 
Fmoc protected amino acids containing acid labile protected side-chains were used. The 
commercially available FmocSer(OTrt)OH and FmocHis(NMtt)OH were chosen. The high acid 
sensitive trityl and methyltrityl groups were completely removed by a solution of 80% 
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chloroacetic acid. In the case of aspartic acid, the trimethylsilylethyl ester (TMSE) was 
selected. The TMSE group can be deprotected, according to the literature using 
tetrabutylammonium fluoride or with the TASF reagent. Compound V.8 could be prepared in a 
three-step sequence from the commercially available aspartic acid a-benzylester in 70% overall 
yield.  
C
Me
TBAF, DMF, 1h
Trt =
Mtt =
 ClCH2COOH / CH2Cl2 / H2O
        
        80        /    15     /   5
 ClCH2COOH / CH2Cl2 / H2O
        
        80        /    15     /   5
 r.t.
 r.t.
FmocSer(OTrt)OH
FmocHis(NMtt)OH
Deprotection
TASF, DMF, 3 hFmocAsp(COO(CH2)2SiMe3)OH
V.8
 
 
Figure 6.1 
 
As a final stage before the actual synthesis of our tripodal library, we decided to complete the 
synthesis of one representative member. After removal of the THP group, glycine was coupled 
using traditional DIC/HOBt methodology in the presence of diisopropylethylamine and a catalytic 
amount of DMAP. The efficiency of the coupling reaction on the hydroxyl function was 
monitored quantitatively using Fmoc UV/VIS spectroscopy. The first peptide chain was 
constructed using FmocSer(OTrt)OH and FmocAlaOH following the DIC/HOBt protocol. After 
removal of the Fmoc protecting group, the free amino functions were capped with an excess of 
acetylimidazole. Subsequently, the DMPM ether was removed using dichlorodicyanoquinone at 0 
°C for 1 h and the second peptide strand was generated following the same strategy using the 
amino acid building blocks FmocHis(NMtt)OH and FmocAlaOH. The TBDPS ether was 
deprotected with the TASF (tris-(dimethylamino)sulfur trimethylsilyldifluoride) reagent, the 
third peptide chain containing FmocAsp(COO(CH2)2SiMe3)OH and FmocValOH was generated to 
form tripodal member V.27. The structure of resin V.27 was confirmed after photolytic 
cleavage with the help of NMR experiments including TOCSY NMR, ROESY NMR and COSY 
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NMR. The completeness of all the coupling reactions was monitored using the colorimetric TNBS 
and NF31 tests. 
The side-chain protecting groups of serine and histidine were removed (scheme 6.4) using a 
solution of chloroacetic acid. After photolytic cleavage, the structure of tripodal member V.30 
was confirmed by ES-MS analysis and NMR analysis.  
 
O
O
O
O
O O
spacer hn2
Gly
Ser
Phe
NH
Ac
Gly
His
Ala
NH
Ac
O
V.27
(TrtO)
Gly
Asp(COO(CH2)2SiMe3)
Val
NH
Ac(MttN)
O
O
O
O
O O
spacer CONH2
Gly
Ser
Phe
NH
Ac
Gly
His
Ala
NH
Ac
O
V.30
Gly
Asp
Val
NH
Ac
HO
HN
(COO(CH2)2SiMe3)
a) side-chain
 deprotection
b) hn (365 nm), 
1,4-dioxane / 1% DMSO
 
 
Scheme 6.4 
 
In the future, the synthesis of a tripodal library using the ‘split and mix’ protocol will lead to a 
mixture of several hundreds of compounds. Subsequently, the library will be screened for 
hydrolytic activity towards a chosen substrate. For this step, several test substrates built up 
from the commercially available Disperse Red 1 were synthesised. Each of them contains an 
ester or amide bond representing a different reactivity towards hydrolysis: the most reactive p-
nitrophenyl ester I.16a, the p-nitroanilide I.16b and the amide I.16c. Upon exposure of the 
library to the dye I.16, the catalyst will react with the substrate and the colour will be 
transferred to the bead. This technique enables an easy visual detection of the polymer-bound 
active catalyst upon screening of the library. 
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AA1
AA2
AA3
AA4
AA5
AA6
AA7
AA8
AA9
scaffold
AspSer His
Library
Screening
visual detection
  
Figure 6.2 
 
The most reactive p-nitrophenyl ester I.16a is actually commercially available and has already 
found a few applications: 1) it is used as a new test-substrate for the visual detection of active 
catalysts among the mixture of hundreds of compounds during the screening of combinatorial 
libraries; 2) it is widely used as a new colorimetric test for the detection of solid-phase bound 
amines. The NF31 test is particularly useful in the case of sterically hindered amines and for 
coupling reactions to proline derivatives, cases where other colorimetric tests fail. 
 
O2N N
N N
O
X
O
DR1
OPhNO2(p)
NHPhNO2(p)
NHCH2CH2OPhNO2(p)
I.16
a   X =
b   X =
c   X =
= NF31
 
 
Figure 6.3 
 
Following a ‘trial and error’ strategy, we optimised all reaction conditions to synthesise one 
member of our tripodal library. However, the presence of the ester bonds is the major drawback 
of this scaffold. The lesson, which can be drawn from the observed unstability of these glycine 
ester functions is that our future investigations have to be oriented to the synthesis of a more 
stable amino-functionalised scaffold. In this thesis, we proved that our tripodal scaffold III.6 
is a suitable template for the future construction of combinatorial tripodal libraries. The way is 
now clear for my successors to synthesise thousands of tripodal members. 
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7 Experimental part 
 
7.1 Products, methods, chromatography, and spectroscopy 
All experiments involving air moisture sensitive materials were carried out under inert 
atmosphere (nitrogen or argon). Tetrahydrofuran (THF) and diethyl ether were distilled from 
sodium benzophenone ketyl prior to use. Pyridine, triethylamine, diisopropylethylamine were 
distilled over calcium hydride before use. Methanol was dried on magnesium. 1,4-Dioxane was 
distilled from sodium borohydride. Dimethylsulfoxide and dimethylformamide were purchased 
from Biosolve (extra-dry). All reagents and solvents were used as received without further 
purification unless otherwise noted. 
The reactions were followed by thin layer chromatography on glass plates precoated with silica 
gel (60F254, 0.25 mm). All compounds were purified by column chromatography on silica gel 
(Merck silica gel 60F254). Infrared spectra were obtained on a Perkin-Elmer 1600 series FTIR 
spectrophotometer using KBr plates and are reported in cm-1. Ultraviolet spectra were obtained 
on a Varian Cary 3E UV/VIS spectrophotometer. Mass spectra were recorded on a AEI MS-50, a 
Finnigan 400 or a Hewlett-Packard 5988 A mass spectrometer. The electrospray spectra were 
recorded using a LCQ ion trap mass spectrometer equipped with a ESI source (ThermoFinnigan, 
San Jose, Ca, USA). The 1H NMR spectra were recorded at 500 MHz on a Bruker AM-500 or at 
200 MHz on a Varian Gemini-200. The chemical shifts are given in ppm and the coupling constant 
in Hertz (Hz). The 13C NMR spectra were recorded on a Varian Gemini-200 at 50 MHz. The 
abbreviations used are: s (singlet), d (doublet), t (triplet), q (quadruplet). Elementary analyses 
were performed in the S.I.A.R.-institute of the Université Pierre et Marie Curie in Paris 
(France). 
The reaction on solid phase were performed with a shaker (Selecta). The Perkin-Elmer Lambda 
3UV/VIS spectrophotometer was used to determine the yield of the coupling reactions of amino 
acids on polymer-support unless otherwise noted. The pictures were taken with a Leitz 
microscope camera, Laborlux 12 Pol S, equipped with a JVC colour video camera. All solid phases 
and amino acids were purchased from Rapp polymer or Novabiochem.  
Photolyses were carried out at a distance of 1 cm using a 450 W ACE GLASS incorporated 7225-
34 UV lamp set at 365 nm. For small quantities of resin (2 mg), photolysis was carried out at a 
distance of 1 cm using a 4 W Bioblock Scientific compact UV lamp set at 365 nm (relative 
intensity at 15 cm of 340 mW/cm2).  
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7.2 Experimental data of part 2 
 
Synthesis of Methyl-5-{N-ethyl-N-[4-(4-nitrophenyl)azophenyl]}amino-3-oxapentanoate II.13 
 
O2N N
N N
OH
Disperse Red 1
DR1
NaH, Bu4NI
BrCH2COOMe
O
DR1
O
OMe
O
II.13 (34%)
O
Br
II.14 (15%)
+
DR1
 
 
A solution of Disperse Red 1 (5.0 g, 15.90 mmol) in dry tetrahydrofuran (70 ml) was added at 0 
°C to a suspension of sodium hydride (60% dispersion in oil) (1.0 g, 25.50 mmol) in dry 
tetrahydrofuran (20 ml). After 1 h at room temperature, a solution of bromomethyl acetate 
(1.78 ml, 18.10 mmol) in dry tetrahydrofuran (20 ml) and tetrabutylammonium iodide (59.0 mg, 
0.16 mmol) were added. The mixture was stirred at room temperature overnight. After 
evaporation of the tetrahydrofuran, the residue was dissolved in dichloromethane. The organic 
phase was then extracted with water and the combined organic phases were dried over 
anhydrous magnesium sulfate. After filtration and evaporation under reduced pressure, the 
crude mixture was chromatographed on silica gel (isooctane / ethyl acetate: 8 / 2 to 7 / 3) to 
provide 2.1 g methyl ester II.13 (34%) with 1.0 g of the transesterification product II.14 
(15%) and 2.1 g of starting material (42%). 
 
Spectra of methyl ester II.13: 
 
Bruto formula: C19H22N4O5 
M.W.: 386.4 g/mol 
m.p.: 101 °C (recrystallization from isopropanol) 
Rf (toluene / ethyl acetate: 1 / 1) = 0.68 
IR (film) 2916 (m), 1749 (s), 1601 (w), 1510 (s), 1212 (m), 1144 (s), 868 (m), 833 (m), 723 (w)    
cm-1. 
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1H NMR (500 MHz, CDCl3) d 8.32 (2H, m), 7.91 (2H, m), 7.89 (2H, m), 6.81 (2H, m), 4.13 (2H, s), 
3.77 (2H, t, J = 6.0 Hz), 3.75 (3H, s), 3.70 (2H, t, J = 6.0 Hz), 3.57 (2H, q, J = 7.0 
Hz), 1.16 (3H, t, J = 7.0 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 170.6 (C), 156.8 (C), 151.3 (C), 147.2 (C), 143.5 (C), 126.2 (CH), 
124.6 (CH), 122.6 (CH), 111.3 (CH), 69.0 (CH2), 68.5 (CH2), 51.9 (CH3), 50.0 (CH2), 45.9 
(CH2), 12.1 (CH3) ppm. 
ES-MS: m/z 387 [M + H]+ 
Anal. Calcd for C19H22N4O5: C 59.06, H 5.74, N 114.50. Found: C 59.16, H 5.77, N 14.35. 
 
Spectra of II.14 : 
 
Bruto formula: C18H19N4O4Br 
M.W.: 435.3 g/mol 
m.p.: 72 °C 
Rf (toluene / ethyl acetate: 1 / 1) = 0.80 
IR (KBr) 2923 (m), 1737 (m), 1602 (s), 1513 (s), 1389 (m), 1343 (m), 1277 (m), 1142 (m), 1097 (m), 
1000 (w), 851 (m), 825 (m), 754 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 8.33 (2H, m), 7.92 (4H, m), 6.81 (2H, m), 4.41 (2H, t, J = 6.2 Hz), 
3.83 (2H, s), 3.73 (2H, t, J = 6.2 Hz), 3.55 (2H, q, J = 7.1 Hz), 1.27 (3H, t, J = 7.1 Hz) 
ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 167.2 (C), 156.7 (C), 151.0 (C), 147.5 (C), 143.9 (C), 126.3 (CH), 
124.7 (CH), 122.7 (CH), 111.5 (CH), 63.0 (CH2), 48.5 (CH2), 45.8 (CH2), 25.4 (CH2), 12.1 
(CH3) ppm. 
ES-MS: m/z 435 [M + H]+, 436 [M + H]+ (Br isotope) 
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Synthesis of Ethyl-5-{N-ethyl-N-[4-(4-nitrophenyl)azophenyl]}amino-3-oxapentanoate II.15 
 
O2N N
N N
OH
Disperse Red 1
Rh2(OAc)4
N2CHCOOEt DR1
O
O
O
II.15
57%
 
 
To a solution of Disperse Red 1 (6.28 g, 20 mmol) and rhodium (II) acetate (150 mg, 0.34 mmol) 
in a mixture of dry dichloromethane (100 ml) and dry toluene (100 ml) was added at 40 °C a 
solution of ethyl diazoacetate (8.4 ml, 80 mmol) in toluene (40 ml) over a one-hour period. The 
reaction mixture was then stirred overnight at room temperature. Half of the solvent was 
removed under reduced pressure and the residue was purified by chromatography over a 10 cm 
diameter G2 fritted disc filtering column filled with silica gel, using a gradient of 10% to 25% 
ethyl acetate in toluene. The fractions containing the desired compound were concentrated to 
20 ml and to the warm solution was slowly added 200 ml of pentane. After refrigeration 
overnight, the precipitate was filtered and washed with 10% diethyl ether in pentane, yielding  
4.56 g (57%) of II.15 as a bright red powder. 
 
Bruto formula: C20H24N4O5 
M.W.: 400.4 g/mol 
m.p.: 80 °C 
Rf (toluene / ethyl acetate: 1 / 1) = 0.75 
IR (film) 2974 (w), 2902 (w), 1759 (s), 1603 (s), 1518 (s), 1392 (m), 1340 (m), 1209 (m), 1138 (s), 
1106 (w), 1032 (w), 964 (w), 858 (m), 826 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 8.32 (2H, m), 7.92 (2H, m), 7.89 (2H, m), 6.78 (2H, m), 4.22 (2H, q, 
J = 7.1 Hz), 4.11 (2H, s), 3.78 (2H, t, J = 6.0 Hz), 3.69 (2H, t, J = 6.0 Hz), 3.57 (2H, q, 
J = 7.1 Hz), 1.28 (3H, t, J = 7.1 Hz), 1.25 (3H, t, J = 7.1 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 170.1 (C), 156.8 (C), 151.4 (C), 147.3 (C), 143.6 (C), 126.3 (CH), 
124.7 (CH), 122.6 (CH), 111.3 (CH), 69.0 (CH2), 68.7 (CH2), 60.9 (CH2), 50.1 (CH2), 46.0 
(CH2), 14.2 (CH3), 12.2 (CH3) ppm. 
ES-MS: m/z 401 (30) [M + H]+, 423 [M + Na]+ 
Anal. Calcd for C20H24N4O5: C 59.99, H 6.04, N 13.99. Found: C 60.12, H 6.08, N 13.82. 
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Synthesis of 5-{N-Ethyl-N-[4-(4-nitrophenyl)azophenyl}amino-3-oxapentanoic acid II.12 
 
DR1
O
O
O
II.15
KOH, MeOH
reflux
DR1
O
OH
O
II.12
97%
 
 
To a solution of II.15 (5 g, 12.5 mmol) in methanol (300 ml) and toluene (70 ml) was added 
potassium hydroxide (4.1 g, 72.5 mmol) and the resulting mixture was refluxed under nitrogen 
for 1.5 h. The mixture was concentrated to 50 ml under reduced pressure, acidified with a 
solution (25 ml) of 10% hydrochloric acid chloride and further diluted with 120 ml of water. The 
aqueous phase was extracted four times with dichloromethane; the combined organic extracts 
were washed with water and dried over anhydrous magnesium sulfate. After filtration and 
concentration to 25 ml, 120 ml of diethyl ether were slowly added and the mixture was 
refrigerated overnight after which 4.5 g of the carboxylic acid II.12 precipitated as a dark-red 
powder (97%) 
 
Bruto formula: C18H20N4O5 
M.W.: 372.4 g/mol 
m.p.: 161 °C 
Rf (dichloromethane / methanol: 9 / 1) = 0.48 
UV (CH2Cl2): lmax1 = 297 nm,  lmax2 = 478 nm 
IR (KBr) 2925 (s), 2854 (m), 1721 (m), 1597 (s), 1513 (s), 1384 (m), 1337 (m), 1239 (w), 1134 (s), 
1104 (m), 855 (w), 824 (m) cm-1. 
1H NMR (500 MHz, DMSO-d6) d 8.36 (2H, m), 7.93 (2H, m), 7.83 (2H, m), 6.89 (2H, m), 4.08 (2H, 
s), 3.68 (2H, m), 3.65 (2H, m), 3.55 (2H, q, J = 7.0 Hz), 1.16 (3H, t, J = 7.1 Hz) ppm. 
13C NMR (50 MHz, DMSO-d6) + DEPT d 171.8 (C), 156.3 (C), 151.8 (C), 146.8 (C), 142.7 (C), 126.2 
(CH), 125.1 (CH), 122.6 (CH), 111.6 (CH), 68.2 (CH2), 67.9 (CH2), 49.5 (CH2), 46.3 (CH2), 
12.0 (CH3) ppm. 
ES-MS: m/z 373 [M + H]+ 
Anal. Calcd for C18H20N4O5: C 58.06, H 5.41, N 15.05. Found: C 57.65, H 5.58, N 15.22. 
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Synthesis of 4-nitrophenyl-5-{N-ethyl-N-[4-(4-nitrophenyl)azo]phenyl}amino-3-oxapentanoate 
I.16a 
DR1
O
OH
O
II.12
p-nitrophenol DR1
O
O
O
I.16a NO2
93%
POCl3
-15°C
 
 
To a solution of carboxylic acid II.12 (2.2 g, 5.9 mmol) and p-nitrophenol (0.84 g, 6.0 mmol) in 
pyridine (100 ml) and dichloromethane (120 ml) at -15 °C was added a solution of phosphorous 
oxychloride (POCl3) (1.0 ml, 10.8 mmol) in dichloromethane (10 ml) over a one-hour period under 
vigorous stirring. After 4 h at –15 °C, the reaction mixture was poured into a mixture of 
dichloromethane and ice cold water (200 ml). The aqueous phase was extracted with 
dichloromethane and the combined organic layers were washed with an aqueous saturated 
solution of sodium bicarbonate and with water. After drying over anhydrous magnesium sulfate, 
the solvent was removed in vacuo and the residue was dissolved in warm acetone (50 ml). After 
diluting with diethyl ether (20 ml), pentane was added (150 ml) very slowly. Refrigeration 
overnight, filtration and washing with pentane afforded 2.7 g (93%) of I.16a (NF31) as an 
intense red powder. 
 
Bruto formula: C24H23N5O7 
M.W.: 493.5 g/mol 
m.p.: 125 °C 
Rf (toluene / ethyl acetate: 1 / 1) = 0.70 
UV (CH2Cl2): lmax1 = 276 nm,  lmax2 = 480 nm 
IR (film) 2964 (w), 1778 (m), 1604 (s), 1588 (s), 1522 (s), 1490 (m), 1411 (w), 1389 (m), 1337 (s), 
1260 (m), 1206 (m), 1120 (s), 954 (w), 916 (w), 854 (m), 818 (m), 804 (m), 755 (w), 819 
(w) cm-1. 
1H NMR (500 MHz, CDCl3) d 8.33 (2H, d, J = 8.9 Hz), 8.28 (2H, d, J = 9.1 Hz), 7.92 (2H, d, J = 
8.9 Hz), 7.89 (2H, d, J = 9.2 Hz, m), 7.29 (2H, d, J = 9.1 Hz), 6.79 (2H, d, J = 9.2 Hz), 
4.41 (2H, s), 3.88 (2H, t, J = 5.8 Hz) 3.74 (2H, t, J = 5.8 Hz), 3.59 (2H, q, J = 7.1 Hz), 
1.27 (3H, t, J = 7.1 Hz) ppm. 
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13C NMR (50 MHz, CDCl3) + DEPT d 167.9 (C), 156.7 (C), 154.6 (C), 151.2 (C), 147.3 (C), 145.5 (C), 
143.6 (C), 126.2 (CH), 125.3 (CH), 124,7 (CH), 122.6 (CH), 122.2 (CH), 111.3 (CH), 69.4 
(CH2), 68.4 (CH2), 50.1 (CH2), 46.1 (CH2), 12.2 (CH3) ppm. 
ES-MS: m/z 494 [M + H]+, 516 [M + Na]+ 
Anal. Calcd for C24H23N5O7: C 58.42, H 4.70, N 14.19. Found: C 58.26, H 4.90, N 14.01. 
 
Synthesis of 4-nitrophenyl-5-{N-ethyl-N-[4-(4-nitrophenyl)azo]phenyl}amino-3-oxapentamide 
I.16b 
 
DR1
O
OH
O
II.12
p-nitroaniline
     POCl3
-15 °C, 3 h
DR1
O
NH
O
I.16b NO2
57%
 
 
To a solution of II.12 (0.54 g, 1.45 mmol) and p-nitroaniline (0.2 g, 1.45 mmol) in pyridine (55 ml) 
was added dropwise at -15 °C phosphorous oxychloride (POCl3) (0.15 ml, 1.60 mmol) under 
vigorous stirring. The mixture was stirred at –15 °C for 3 h and was poured into a mixture of 
dichloromethane and ice cold water (50 ml). The aqueous phase was extracted with 
dichloromethane and the combined organic layers were washed with an aqueous saturated 
solution of sodium bicarbonate and with water. After drying over anhydrous magnesium sulfate, 
the solvent was removed in vacuo and the residue was purified by column chromatography 
(dichloromethane / isooctane: 8 / 2 to 1 / 0) affording 0.41 g of p-nitroanilide derivative I.16b 
in 57% yield. 
 
Bruto formula: C24H24N6O6 
m.p.: 176 °C 
M.W.: 492.5 g/mol 
Rf (toluene / ethyl acetate: 1 / 1) = 0.26 
UV (CH2Cl2): lmax1 = 304 nm,  lmax2 = 470 nm 
IR (KBr) 2915 (w), 1711 (w), 1600 (m), 1584 (m), 1529 (m), 1507 (s), 1411 (w), 1379 (m), 1337 (s), 
1245 (m), 1136 (m), 1103 (s), 1081 (m), 1015 (w), 856 (w), 821 (w), 754 (w), 693 (w)   
cm-1. 
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1H NMR (500 MHz, CDCl3) d 8.36 (2H, d, J = 9.0 Hz), 8.30 (1H, s), 8.05 (2H, d, J = 9.1 Hz), 7.94 
(4H, dd, J = 9.2 Hz), 7.35 (2H, d, J = 9.1 Hz), 6.95 (2H, d, J = 9.2 Hz), 4.14 (2H, s), 
3.88 (2H, m) 3.78 (2H, m), 3.59 (2H, q, J = 7.1 Hz), 1.30 (3H, t, J = 7.1 Hz) ppm. 
13C NMR (50 MHz, DMSO-d6) + DEPT d 169.1 (C), 156.2 (C), 151.7 (C), 146.8 (C), 144.6 (C), 142.7 
(C), 142.4 (C), 126.2 (CH), 125.0 (CH), 124 9 (CH), 122.5 (CH), 119.3 (CH), 111.7 (CH), 
70.3 (CH2), 68.6 (CH2), 49.3 (CH2), 45.2 (CH2), 12.0 (CH3) ppm. 
ES-MS: m/z 493 [M + H]+, 515 [M + Na]+ 
Anal. Calcd for C24H24N6O6: C 58.53, H 4.91, N 17.05. Found: C 58.09, H 4.98, N 16.50. 
 
Synthesis of 4-nitrophenoxyethanamine II.10 
 
H2N
OH
1) DMSO, NaH
2) Cl NO2
H2N
O NO2
II.10
44%
 
 
A suspension of sodium hydride (60% dispersion in oil) (0.83 g, 20.0 mmol) in dimethylsulfoxide 
(10 ml) was heated at 40 °C for 30 min. After cooling to room temperature, 2-aminoethanol (1.20 
ml, 20.0 mmol) and p-chloronitrobenzene (3.03 g, 20.0 mmol) were added. After 20 min stirring, 
the mixture was diluted in 150 ml dichloromethane. The organic phase was washed twice with a 4 
N aqueous solution of hydrochloric acid. The aqueous phase was washed with dichloromethane. 
After adding 150 ml of ethyl acetate to the aqueous phase, the solution was cooled to 6-8 °C and 
basified to pH = 11 under vigorous stirring with an aqueous solution of 8 N of sodium hydroxide. 
After washing with water, the organic phase was dried over anhydrous magnesium sulfate, , 
filtered and evaporated under reduced pressure to afford 1.6 g of amine II.10 (44%).  
 
Bruto formula: C8H10N2O3 
M.W.: 182.2 g/mol 
m.p.: 30 °C 
Rf (toluene / ethyl acetate: 1 / 1) = 0.26 
IR (film) 3364 (w), 3113 (w), 2940 (w), 2873 (w), 1607 (s), 1593 (s), 1509 (s), 1459 (w), 1343 (s), 
1299 (m), 1264 (s), 1175 (m), 1112 (s), 1010 (w), 846 (m), 753 (m) cm-1. 
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1H NMR (500 MHz, CDCl3) d 8.21 (2H, d, J = 9.2 Hz), 6.97 (2H, d, J = 9.2 Hz), 4.09 (2H, t, J = 
5.0 Hz), 3.15 (2H, t, J = 5.0 Hz), 1.41 (2H, s) ppm. 
13C NMR (50 MHz, CDCl3) d 163.8 (C), 141.2 (C), 126.7 (CH), 114.3 (CH), 70.9 (CH2), 41.0 (CH2) 
ppm. 
 
Synthesis of 2-(2-{ethyl-[4-(4-nitro-phenylazo)-phenyl]-amino}-ethoxy)-N-[2-(4-nitro-phenoxy)-
ethyl-acetamide I.16c 
 
DR1
O
O
O H
II.12
II.10
POCl3, -15 °C, 3 h
DR1
O
NH
O
O NO2I.16c
66%
 
 
To a solution of II.12 (0.7 g, 1.9 mmol) and 4-nitrophenoxyethanamine (0.34 g, 1.9 mmol) in 
pyridine (70 ml) at -15 °C was added phosphorous oxychloride (POCl3) (0.35 ml, 3.8 mmol) under 
vigorous stirring. The mixture was stirred at –15 °C for 3 h. The reaction mixture was then 
poured into a mixture of dichloromethane and ice cold water (100 ml). The aqueous phase was 
extracted with dichloromethane and the combined organic layers were washed with an aqueous 
saturated solution of sodium bicarbonate and with water. After drying over anhydrous 
magnesium sulfate, the solvent was removed in vacuo and the residue was purified by column 
chromatography (dichloromethane / methanol: 99 / 1) to provide 0.67 g of the amide I16c as a 
dark red powder (66%). 
 
Bruto formula: C26H28N6O7 
M.W.: 536.5 g/mol 
m.p.: 135 °C 
Rf (toluene / ethyl acetate: 1 / 1) = 0.14 
UV (CH2Cl2): lmax1 = 293 nm,  lmax2 = 475 nm 
IR (KBr) 2923 (w), 1685 (s), 1606 (s), 1507 (s), 1466 (w), 1392 (m), 1337 (s), 1251 (s), 1146 (m), 
1110 (s), 1060 (m), 981 (w), 868 (w), 822 (m), 752 (w), 691 (w) cm-1. 
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1H NMR (500 MHz, CDCl3) d 8.33 (2H, d, J = 8.9 Hz), 8.15 (2H, d, J = 9.2 Hz), 7.91 (2H, d, J = 
8.9 Hz), 7.88 (2H, d, J = 8.9 Hz), 6.86 (2H, d, J = 9.2 Hz), 6.81 (2H, d, J = 8.9 Hz), 
6.76 (1H, t, J = 5.5), 4.01 (2H, s), 4.00 (2H, t, J = 5.4 Hz), 3.77 (2H, t, J = 5.4 Hz) 
3.74 (2H, t, J = 5.4 Hz), 3.63 (2H, dt, J = 5.5 Hz), 3.54 (2H, q, J = 7.1 Hz), 1.25 (3H, t, 
J = 7.1 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 169.5 (C), 163.8 (C), 156.5 (C), 151.0 (C), 147.5 (C), 143.7 (C), 
141.7 (C), 126.1 (CH), 125.7 (CH), 124,7 (CH), 122.6 (CH), 114.3 (CH), 111.5 (CH), 70.5 
(CH2), 69.5 (CH2), 67.1 (CH2), 49.8 (CH2), 45.6 (CH2), 38.0 (CH2), 12.1 (CH3) ppm. 
ES-MS: m/z 537 [M + H]+ 
Anal. Calcd for C26H28N6O7: C 58.20, H 5.26, N 15.67. Found: C 58.30, H 5.57, N 15.75. 
 
A new colorimetric test for solid-phase bound amines 
 
OH
Wang resin
+ FmocGlyOH
DIC, HOBt
DMF
OGlyNHFmoc
 
 
Diisopropylcarbodiimide (0.8 ml, 4.95 mmol), hydroxybenzotriazole (0.67 g, 4.95 mmol) and 4-
dimethylaminopyridine (61 mg, 0.495 mmol) were added to a solution of amino acid FmocGlyOH 
(1.47 g, 4.95 mmol) in a mixture of dichloromethane/dimethylformamide (2/1). The carboxylic 
acid was activated for 30 min. The solution was then added to the Wang resin (1.5 g, 1.65 mmol, 
1.1 mmol/g) and the mixture was shaken overnight at room temperature. After filtration, the 
resin was washed with dimethylformamide (3 x 15 ml), methanol (3 x 15 ml) and dichloromethane 
(3 x 15 ml). The possible free remaining amino functions were capped with a solution of acetic 
anhydride (0.93 ml, 9.9 mmol), diisopropylethylamine (1.70 ml, 9.9 mmol) and 4-
dimethylaminopyridine (1.2 g, 9.9 mmol) in dichloromethane (15 ml). After filtration, the resin 
was washed with dimethylformamide (3 x 15 ml), methanol (3 x 15 ml) and dichloromethane (3 x 
15 ml). 
 
Deprotection of the Fmoc-protecting group 
 
OGlyFmoc
20% pip. / DMF
OGlyNH2
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The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml).  
 
Synthesis of a series of resin samples of known free amine content: 
 
OGlyNH2 +
FmocAlaOH
BocAlaOH
+
OGlyAla Fmoc
OGlyAla Boc
DIC
HOBt
 
 
The general coupling procedure is the following: 
To a cooled (0 °C) solution of amino acids FmocAlaOH (2.5 eq.) and BocAlaOH (2.5 eq.) in 0.7 ml 
of dimethylformamide/dichloromethane (2/5) were added diisopropycarbodiimide (5 eq.) and 
hydroxybenzotriazole (5 eq.). The mixture was stirred 10 min at 0 °C and 10 min at room 
temperature. The solution was added to the WangGlyNH2 resin (20 mg, 0.017 mmol, 0.841 
mmol/g, 1 eq.) and the suspension was shaken overnight at room temperature. After filtration, 
the resin was washed with dimethylformamide (3 x 2 ml), methanol (3 x 2 ml) and 
dichloromethane (3 x 2 ml). 
 
 
Ratio Fmoc/Boc 
FmocAlaOH 
(mg, mmol) 
BocAlaOH 
(mg, mmol) 
 
DIC 
 
HOBt 
50 / 50 13.2 mg,  
0.0425 mmol 
8.0 mg, 
0.0425 mmol 
20 / 80 5.3 mg, 
0.0170 mmol 
12.9 mg,  
0.0680 mmol 
10 / 90 2.6 mg, 
0.0085 mmol 
14.5 mg,  
0.0765 mmol 
5 / 95 1.3 mg, 
0.0043 mmol 
15.3 mg, 
0.0808 mmol 
2 / 98 0.5 mg,  
0.0017 mmol, 
15.8 mg, 
0.8330 mmol 
 
 
 
 
13.3 ml,  
0.085 mmol 
 
 
 
 
11.5 mg, 
0.085 mmol 
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OGlyAla Fmoc
OGlyAla Boc
20% pip / DMF
OGlyAla NH2
OGlyAla NHBoc
 
 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). The 
resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 
x 5 ml). Both colorimetric TNBS and NF31 tests were performed and were compared. 
 
TNBS test: 63 3 drops of a solution of 10% diisopropylethylamine in dimethylformamide and 3 
drops of a solution of 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) in dimethylformamide were 
added to few beads. The appearance of an orange colour shows the presence of remaining 
uncoupled amino functions whereas white beads prove the completeness of the coupling. 
NF31 test: 65 Few beads were suspended in 100 ml of a 0.002 M solution of NF31 in acetonitrile. 
After heating for 10 minutes at 70 °C, the beads were washed with dimethylformamide, 
methanol and dichloromethane. Beads containing free amino functions appear as red beads while 
completely coupled beads remain colourless. 
 
7.3 Experimental data of part 3 
 
Bromination of 4-methylphenylacetic acid: Synthesis of acid III.10 
 
COOH
Br2, AI BN
CCl4
COOH
Br
62%
III.10
 
 
To a solution of 4-methylphenylacetic acid (25 g, 0.17 mol) in carbon tetrachloride (300 ml) were 
added bromine (8.7 ml, 0.17 mol) and 2,2’-azobisisobutyronitrile (catalytic amount). The solution 
was irradiated with a sodium lamp (400 W) and was heated to 40 °C. After 5 min, white crystals 
precipitated. The mixture was cooled to 0 °C and the crystals were filtered and washed with 
carbontetrachloride. The residue was recrystallized from ethyl acetate to provide 24 g of 
carboxylic acid III.10 (62%). 
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Bruto formula: C9H9O2Br 
M.W.: 229.1 g/mol 
m.p.: 180 °C 
Rf (toluene / ethyl acetate: 8 / 2) = 0.20 
IR (film) 3027 (s), 2972 (s), 1699 (s), 1516 (w), 1408 (s), 1343 (m), 1244 (m), 1184 (m), 1093 (w), 
894 (m), 838 (m), 780 (s), 675 (s), 602 (s) cm-1. 
1H NMR (500 MHz, CD3OD) d 7.36 (2H, m), 7.26 (2H, m), 4.50 (2H, s), 3.60 (2H, s) ppm. 
13C NMR (50 MHz, CDCl3 + few drops DMSO-d6) + DEPT d 173.0 (C), 135.9 (C), 134.6 (C), 129.4 
(CH), 128.8 (CH), 40.6 (CH2), 33.0 (CH2) ppm. 
MS (m/z): 230 (M+?Br81), 228 (M+?Br79), 150 (13), 150 (19), 149 (100), 131 (5), 104 (42), 77 (26), 
63 (9), 45 (20).  
 
Reduction of the carboxylic acid III.10 into alcohol III.11 
 
COOH
Br
BH3.SMe2
Br
OH
THF
III.11
86%
III.10
 
 
To a cooled (0 °C) solution of carboxylic acid III.10 (20.0 g, 0.087 mol) in dry tetrahydrofuran 
(120 ml) was added dropwise borane-dimethylsulfide complex (12.3 ml, 0.13 mol). The solution 
was stirred at 0 °C for 2 h and at room temperature for 2 h. Water was added slowly and 
tetrahydrofuran was evaporated under reduced pressure. The aqueous phase was extracted with 
ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered and 
evaporated. The residue was chromatographed on silica gel (ethyl acetate / isooctane: 4 / 6) to 
afford 16 g of alcohol III.11 (86%). 
 
Bruto formula: C9H11OBr 
M.W.: 215.1 g/mol 
m.p.: 76°C 
Rf (isooctane / ethyl acetate: 6 / 4) = 0.28 
IR (film) 3395 (m), 3333 (m), 2950 (m), 1513 (w), 1477 (w), 1418 (w), 1228 (m), 1201 (m), 1100 
(m), 1044 (s), 836 (m), 766 (m) cm-1. 
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1H NMR (500 MHz, CDCl3) d 7.35 (2H, m), 7.22 (2H, m), 4.49 (2H, s), 3.86 (2H, t, J = 6.5 Hz) 
2.87 (2H, t, J = 6.5 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 138.9 (C), 135.9 (C), 129.4 (CH), 129.2 (CH), 63.4 (CH2), 38.8 
(CH2), 33.4 (CH2) ppm. 
MS (m/z):  216 (M+?Br81), 214 (M+?Br79), 135 (100), 105 (63), 104 (54), 91 (10), 77 (22), 63 (10), 
51 (13). 
 
Synthesis of building block III.7 
 
Br
OH
III.11
DHP
PPTS
Br
OTHP
III.7
88%
 
 
Dihydropyran (5.10 ml, 0.056 mol) and pyridinium p-toluenesulfonate (1.25 g, 0.005 mol) were 
added to a solution of alcohol III.11 (10 g, 0.047 mol) in dry dichloromethane (40 ml). The 
solution was stirred overnight at room temperature. The mixture was extracted with a saturated 
aqueous solution of sodium bicarbonate and with brine. The organic phase was dried over 
anhydrous magnesium sulfate, was filtered and evaporated under reduced pressure. The residue 
was purified by column chromatography (isooctane / ethyl acetate: 9 / 1) providing 12.4 g of 
protected alcohol III.7 (88%). 
 
Bruto formula: C14H19O2Br 
M.W.: 299.1 g/mol 
Rf (toluene / ethyl acetate: 8 / 2) = 0.69 
IR (film) 2941 (s), 2868 (m), 1514 (w), 1439 (w), 1352 (w), 1229 (w), 1200 (m), 1120 (s), 1077 (m), 
1031 (s), 972 (m), 907 (w), 869 (w), 814 (w), 606 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.31 (2H, ABd, JAB = 8.0 Hz), 7.22 (2H, ABd, JAB = 8.0 Hz), 4.59 (1H, 
m), 4.48 (2H, s), 3.94 (1H, dt, J = 9.7, 7.2 Hz), 3.73 (1H, m), 3.62 (1H, dt, J = 9.7, 7.2 
Hz), 3.45 (1H, m), 2.91 (2H, t, J = 7.1 Hz), 1.80 (1H, m), 1.69 (1H, m), 1.54 (4H, m) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 139.5 (C), 135.5 (C), 129.3 (CH), 128.9 (CH), 98.6 (CH), 67.9 
(CH2), 62.1 (CH2), 35.9 (CH2), 33.6 (CH2), 30.5 (CH2), 25.3 (CH2), 19.4 (CH2) ppm. 
MS (m/z): 299 (M+?Br81), 297 (M+?Br79), 117 (80), 85 (100), 67 (71), 41 (30). 
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Synthesis of building block III.8 
 
 Synthesis of acetimidate III.12 
 
MeO
MeO
OH
NaH
CCl3CN
MeO
MeO
O
CCl3
NH
III.12
97%
 
 
A solution of 3,4-dimethoxybenzyl alcohol (25 g, 0.149 mol) was slowly added to a suspension of 
sodium hydride (60% dispersion in oil) (1.19 g, 0.030 mol). The solution was then cooled to 0 °C 
and trichloroacetonitrile (17.6 ml, 0.175 mol) was added dropwise. The mixture was stirred 1 h at 
0 °C and 2 h at room temperature. Pentane (50 ml) containing 1 ml of methanol was added 
followed by activated carbon. The mixture was stirred one hour before being filtered over 
celite. The celite was then washed with pentane. The organic phase was evaporated under 
reduced pressure affording 45 g of trichloroacetimidate III.12, which was used without 
further purification (97%). 
 
Bruto formula: C11H12NO3Cl3 
M.W.: 312.6 g/mol 
Rf (toluene / ethyl acetate: 8 / 2) = 0.59 
IR (film) 3330 (w), 2935 (w), 1662 (s), 1593 (w), 1518 (s), 1463 (m), 1420 (w), 1267 (s), 1240 (m), 
1160 (m), 1079 (m), 1028 (m), 828 (w), 796 (s), 648 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 8.37 (1H, s), 6.98 (2H, m), 6.86 (1H, d, J = 8.1 Hz), 5.28 (2H, s), 3.88 
(6H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 162.4 (C), 149.0 (C), 148.9 (C), 127.8 (C), 120.6 (CH), 111.1 
(CH), 110.8 (CH), 91.4 (C), 70.7 (CH2), 55.8 (CH3) ppm. 
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 Synthesis of building block III.8 
 
Br
OH
III.11 III.8
acetimidate
PPTS
Br
ODMPM69%
     III.12
 
 
To a solution of alcohol III.11 (6.5 g, 0.030 mol) and pyridinium p-toluenesulfonate (3.8 g, 0.015 
mol) in dichloromethane (48 ml) was added trichloroacetimidate III.12 (18.8 g, 0.06 mol). The 
solution was stirred overnight at room temperature.  After addition of an aqueous saturated 
solution of sodium bicarbonate, the mixture was extracted with dichloromethane, dried over 
magnesium sulfate and filtered. The residue was purified by column chromatography (20% ethyl 
acetate in toluene / pentane: 1 / 1) to afford 7.6 g of benzylbromide III.8 (69%). 
 
Bruto formula: C18H21O3Br 
M.W.: 365.3 g/mol 
Rf (toluene / ethyl acetate: 8 / 2) = 0.61 
IR (film) 2935 (m), 2857 (m), 1593 (m), 1516 (s), 1464 (m), 1419 (m), 1264 (s), 1237 (s), 1157 (s), 
1094 (m), 1028 (s), 809 (m), 607 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.31 (2H, ABd, JAB = 8.0 Hz), 7.20 (2H, ABd, JAB = 8.0 Hz), 6.82 (3H, 
m), 4.48 (2H, s), 4.45 (2H, s), 3.87 (3H, s), 3.84 (3H, s), 3.66 (2H, t, J = 6.9 Hz), 2.91 
(2H, J = 6.9 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 148.9 (C), 148.4 (C), 139.5 (C), 135.6 (C), 130.7 (C), 129.3 
(CH), 128.9 (CH), 120.0 (CH), 110.7 (CH), 72.8 (CH2), 70.5 (CH2), 55.8 (CH3), 55.7 
(CH3), 35.9 (CH2), 33.5 (CH2) ppm. 
MS (m/z):  366 (M+?Br81), 364 (M+?Br79), 151 (100), 104 (18), 77 (12), 65 (8). 
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Synthesis of building block III.9 
 
Br
OH
III.11
TBDPSCl
DIPEA
Br
OTBDPS
III.9
71%
 
 
 
tert-Butyldiphenylsilyl chloride (25.6 g, 0.093 mol) and diisopropylethylamine (28.4 ml, 0.163 
mol) were added to a solution of alcohol III.11 (10 g, 0.047 mol) in dimethylformamide (50 ml). 
The mixture was stirred at room temperature for 4 h. The mixture was added to ice and was 
extracted with diethylether. The organic phase was dried over anhydrous magnesium sulfate, 
filtered and evaporated under reduced pressure. The crude oil was purified by column 
chromatography (diethylether / isooctane: 1 / 9) to give 15 g of building block III.9 (71%). 
 
Bruto formula: C25H29SiOBr 
M.W.: 453.5 g/mol 
Rf (diethyl ether / isooctane: 1 / 9) = 0.58 
IR (film) 3047 (w), 2930 (m), 2857 (m), 1742 (w), 1427 (m), 1266 (w), 1111 (s), 823 (m), 702 (s), 
505 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.60 (4H, dd, J = 6.6, 1.4 Hz), 7.42 (2H, m), 7.37 (4H, m), 7.30 (2H, 
ABd, J = 8.0 Hz), 7.16 (2H, ABd, JAB = 8.0 Hz), 4.59 (2H, s), 3.85 (2H, t, JAB = 6.8 Hz), 
2.87 (2H, t, J = 6.8 Hz), 1.04 (9H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 139.6 (C), 135.5 (CH), 135.3 (C), 133.7 (C), 129.6 (CH), 128.5 
(CH), 127.6 (CH), 64.9 (CH2), 46.9 (CH2), 38.9 (CH2), 26.8 (CH2), 19.1 (C) ppm. 
MS (m/z): 351 (57), 247 (20), 217 (100), 181 (42), 117 (64), 91 (54), 57 (44). 
 
Mono-TBDPS protection of pentaerythritol: synthesis of triol III.13 
 
HO OH
HO OH
TBDPSCl
Imidazole
HO OH
TBDPSO OH68%
pentaerythritol III.13
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To a solution of pentaerythritol (25 g, 0.184 mol) and imidazole (13.8 g, 0.202 mol) in 
dimethylformamide (1.2 l) was added dropwise tert-butyldiphenylsilyl chloride (26.8 g, 0.098 
mol). The mixture was stirred for 60 h at room temperature. After addition of water, the 
solution was extracted with ethyl acetate. The organic phase was washed with water, dried over 
anhydrous magnesium sulfate, filtered and evaporated. The remaining dimethylformamide was 
removed with the Kugelrhor under reduced pressure. The oil was purified by HPLC (ethyl acetate 
/ isooctane: 1 / 1) to provide 25 g of mono-protected triol III.13 (68%). 
 
Bruto formula: C21H30SiO4 
M.W.: 374.2 g/mol 
m.p.: 50 °C 
Rf (ethyl acetate / isooctane: 1 / 1) = 0.25 
IR (film) 3386 (s), 2930 (m), 2857 (m), 1472 (m), 1428 (s), 1390 (w), 1361 (w), 1113 (s), 1036 (m), 
824 (m), 740 (m), 702 (s), 504 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.64 (4H, dd, J = 8.0, 1.3 Hz), 7.41 (6H, m), 3.71 (6H, m), 3.63 (2H, 
m), 2.75 (3H, s), 1.07 (9H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 135.6 (CH), 132.5 (C), 130.0 (CH), 127.9 (CH), 65.3 (CH2), 64.7 
(CH2), 64.3 (CH2), 45.6 (C) 26.9 (CH3), 19.1 (CH2) ppm. 
MS (m/z):  233 (10), 199 (100), 181 (19), 139 (76), 105 (25), 91 (91), 57 (51).  
 
Alkylation of III.13 with benzylbromide III.7: Synthesis of diol III.14  
 
HO OH
TBDPSO O
OTHP
HO OH
TBDPSO OH
benzylbromide III.7
NaH, Bu4NI
43%III.13 III.14
 
 
A solution of triol III.13 (20 g, 0.053 mol) in dry tetrahydrofuran (32 ml) was added to a 
suspension of sodium hydride (60% dispersion in oil) (1.64 g, 0.041 mol) in tetrahydrofuran (80 
ml). The mixture was refluxed for 30 min. and cooled at 10 °C. A solution of benzyl bromide 
III.7 (12.3 g, 0.041 mol) in tetrahydrofuran (20 ml) was added followed by tetrabutylammonium 
iodide (738 mg, 0.002 mol). The mixture was refluxed overnight. A solution of saturated aqueous 
solution of ammonium chloride was added and tetrahydrofuran was evaporated. The aqueous 
phase was extracted with ethyl acetate. The combined organic layers were dried over anhydrous 
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magnesium sulfate, filtered and evaporated under reduced pressure. The crude oil was purified 
by column chromatography (ethyl acetate / toluene: 1 / 9 to 5 / 5) to obtain 10.5 g of diol III.14  
(43%). 
 
Bruto formula: C35H48SiO6 
M.W.: 592.9 g/mol 
Rf (ethyl acetate / isooctane: 1 / 1) = 0.62 
IR (film) 3449 (m), 2938 (s), 2857 (s), 1472 (w), 1428 (m), 1362 (w), 1113 (s), 1079 (m), 1031 (s), 
820 (m), 703 (m), 505 (m) cm-1. 
1H NMR (500 MHz, CD3OD) d 7.66 (4H, dd, J = 8.0, 1.3 Hz), 7.40 (2H, m), 7.33 (4H, m), 7.21 (2H, 
ABd, JAB = 8.2 Hz), 7.20 (2H, ABd, JAB = 8.2 Hz), 4.58 (1H, m), 4.46 (2H, s), 3.90 (1H, 
dt, J = 9.7, 7.0 Hz), 3.71 (1H, m), 3.70 (2H, s), 3.67 (4H, s), 3.60 (1H, dt, J = 9.7, 7.0 
Hz), 3.55 (2H, s), 3.43 (1H, m), 2.87 (2H, t, J = 6.9 Hz); 1.80 (1H, m), 1.65 (1H, m), 1.51 
(4H, m), 1.01 (9H, s) ppm. 
13C NMR (50 MHz, CD3OD) d 19.5, 19.2, 25.4, 26.8, 30.6, 36.0, 45.6, 62.2, 64.9, 68.2, 71.6, 73.6, 
98.7, 127.6, 127.8, 127.9, 129.0, 129.9, 132.8, 135.6, 138.7, 145.9 ppm. 
ES-MS: m/z 615 [M + Na]+, 631 [M + K]+ 
 
Deprotection of theTBDPS ether: Synthesis of III.15 
 
HO OH
TBDPSO O
OTHP
HO OH
HO O
III.15 OTHP
TBAF
83 %
III.14
 
 
To a solution of diol III.14 (20 g, 0.034 mol) in dry tetrahydrofuran (130 ml) was added 
dropwise a solution 1 M of tetrabutylammonium fluoride in tetrahydrofuran (51 ml, 0.051 mol). 
The mixture was stirred overnight. After evaporation of the tetrahydrofuran under reduced 
pressure, the crude oil was purified by column chromatography (ethyl acetate / toluene: 8 / 2 to 
pure ethyl acetate). 10 g of desired triol III.15 was obtained (83%). 
 
Bruto formula: C19H30O6 
M.W.: 354.2 g/mol 
Rf (dichloromethane / methanol: 9 / 1) = 0.30 
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IR (film) 3407 (s), 2941 (m), 2868 (m), 1515 (w), 1365 (w), 1199 (m), 1119 (w), 1031 (s), 812 (w) 
cm-1. 
1H NMR (500 MHz, CD3OD) d 7.25 (2H, ABd, JAB = 8.1 Hz), 7.22 (2H, ABd, JAB = 8.1 Hz), 4.58 
(1H, m), 4.47 (2H, s), 3.89 (1H, dt, J = 9.7, 7.0 Hz), 3.69 (1H, m), 3.61 (6H, s), 3.60 
(1H, m), 3.48 (2H, s), 3.42 (1H, m), 2.86 (2H, t, J = 6.9 Hz), 1.79 (1H, m), 1.65 (1H, m), 
1.52 (4H, m) ppm. 
13C NMR (50 MHz, CD3OD) + DEPT d 139.9 (C), 137.8 (C), 130.0 (CH), 128.7 (CH), 100.0 (CH), 74.4 
(CH2), 70.9 (CH2), 69.5 (CH2), 63.2 (CH2), 63.1 (CH2), 46.8 (CH2), 37.0 (CH2), 31.7 
(CH2), 26.6 (CH2), 20.4 (CH2) ppm. 
ES-MS: m/z 377 [M + Na]+, 393 [M + K]+ 
 
Alkylation with building block III.8: Synthesis of diol III.16 
 
HO OH
HO O
III.15
OTHP
NaH, Bu4NI, 32%
benzylbromide III.8
HO O
HO O
OTHP
ODMPM
III.16
 
 
A solution of triol III.15 (6 g, 0.017 mol) in dry tetrahydrofuran (12 ml) was added to a 
suspension of sodium hydride (60% dispersion in oil) (0.68 g, 0.017 mol) in tetrahydrofuran (42 
ml). The mixture was refluxed for 30 min. and cooled at 10 °C. A solution of benzyl bromide 
III.8 (6.21 g, 0.017 mol) in tetrahydrofuran (30 ml) was added followed by tetrabutylammonium 
iodide (332 mg, 0.009 mol). The mixture was refluxed overnight. A solution of saturated aqueous 
solution of ammonium chloride was added and tetrahydrofuran was evaporated. The aqueous 
phase was extracted with ethyl acetate. The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered and evaporated under reduced pressure. The crude oil was purified 
by column chromatography (ethyl acetate / toluene: 1 / 9 to 5 / 5) to obtain 3.5 g of diol III.16 
(32%). 
 
Bruto formula: C37H50O9 
M.W.: 638.8 g/mol 
Rf (ethyl acetate / isooctane: 1 / 1) = 0.28 
IR (film) 3458 (m), 2938 (s), 2863 (s), 1593 (w), 1516 (s), 1464 (w), 1419 (m), 1363 (m), 1363 (m), 
1264 (s), 1238 (m), 1137 (m), 1083 (s), 1030 (s), 812 (m) cm-1. 
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1H NMR (500 MHz, CD3OD) d 7.18 (8H, m), 6.83 (3H, m), 4.55 (1H, m), 4.43 (4H, s), 4.42 (2H, s), 
3.87 (1H, dt, J = 9.6, 7.0 Hz), 3.78 (3H, s), 3.73 (3H, s), 3.67 (1H, m), 3.65 (2H, t, J = 
6.8 Hz), 3.62 (4H, s), 3.57 (1H, dt, J = 9.6, 6.8 Hz), 3.48 (2H, s), 3.47 (2H, s), 3.39 
(1H, m), 2.86 (2H, t, J = 6.9 Hz), 2.83 (2H, t, J = 6.9 Hz), 1.77 (1H, m), 1.62 (1H, m), 
1.48 (4H, m) ppm. 
APT NMR (125 MHz, CD3OD) d 149.1 (C), 148.7 (C), 138.5 (C), 138.4 (C), 136.5 (C), 136.4 (C), 131.2 
(C), 128.7 (CH), 128.6 (CH), 127.4 (CH), 127.3 (CH), 120.2 (CH), 111.3 (CH), 111.2 (CH), 
98.7 (CH), 72.9 (CH2), 72.3 (CH2), 70.6 (CH2), 69.4 (CH2), 69.3 (CH2), 68.1 (CH2), 61.9 
(CH2), 61.8 (CH2), 55.1 (CH3), 55.0 (CH3), 45.5 (CH2), 35.7 (CH2), 35.6 (CH2), 30.4 
(CH2), 25.2 (CH2), 19.1 (CH2) ppm. 
ES-MS: m/z 661 [M + Na]+, 677 [M + K]+ 
 
Synthesis of tripodal scaffold I.14 
 
OH
O
O
O
OTHP
ODMPM
OTBDPS
I.14
III.16
NaH, Bu4NI, 49%
benzylbromide III.9
 
 
A solution of diol III.16 (1 g, 1.57 mmol) in dry tetrahydrofuran (1.7 ml) was added to a 
suspension of sodium hydride (60% dispersion in oil) (0.63 g, 1.60 mmol) in tetrahydrofuran (6 
ml). The mixture was refluxed for 30 min. and cooled to 10 °C. A solution of benzyl bromide 
III.9 (0.711 g, 1.57 mmol) in tetrahydrofuran (2 ml) was added followed by tetrabutylammonium 
iodide (33 mg, 0.089 mmol). The mixture was refluxed overnight. A solution of saturated aqueous 
solution of ammonium chloride was added and tetrahydrofuran was evaporated. The aqueous 
phase was extracted with ethyl acetate. The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered and evaporated under reduced pressure. The crude oil was purified 
by column chromatography (ethyl acetate / isooctane: 4 / 6) to obtain 0.8 g of tripodal scaffold 
I.14 (49%). 
Part 7: Experimental part      
   
117
 
Bruto formula: C62H78O10Si 
M.W.: 1011.39 g/mol 
Rf (ethyl acetate / hexane: 4 / 6) = 0.30 
IR (film) 3518 (s), 2934 (s), 1515 (s), 1463 (m), 1428 (m), 1361 (m), 1265 (s), 1090 (s), 1030 (s) 
738 (m), 704 (m) cm-1. 
1H NMR (500 MHz, CD2Cl2) d 7.60 (4H, dd, J = 7.9, 1.3 Hz), 7.41 (2H, m), 7.37 (4 H, m), 7.22 (10 
H, m), 7.15 (2H, d, J = 8.0 Hz), 6.83 (3H, m), 4.58 (1H, m), 4.46 (2H, s), 4.44 (4H, s), 
4.43 (2H, s), 3.91 (1H, dt, J = 9.7, 7.0 Hz), 3.86 (2H, t, J = 6.8 Hz), 3.82 (3H, s), 3.80 
(3H, s), 3.76 (1H, m), 3.71 (2H, d, J = 6.3 Hz), 3.67 (2H, t, J = 6.9 Hz), 3.60 (1H, dt, J 
= 9.7, 7.0 Hz), 3.55 (2H, s), 3.54 (4H, s), 3.48 (1H, m), 2.90 (2H, t, J = 6.9 Hz), 2.88 
(2H, t, J = 6.9 Hz), 2.87 (2H, t, J = 6.9 Hz), 1.80 (1H, m), 1.67 (1H, m), 1.52 (4H, m), 
1.03 (9H, s) ppm. 
APT NMR (125 MHz, CD2Cl2) d 148.7 (C), 146.4 (C), 138.8 (C), 138.7 (C), 138.6 (C), 136.4 (C), 136.3 
(C), 135.6 (CH), 133.8 (C), 131.3 (C), 129.6 (CH), 129.2 (CH), 129.0 (CH), 127.6 (CH), 
127.5 (CH), 120.0 (CH), 111.3 (CH), 111.1 (CH), 98.7 (CH), 73.4 (CH2), 73.3 (CH2), 72.7 
(CH2), 70.9 (CH2), 68.0 (CH2), 65.2 (CH2), 62.1 (CH2), 55.8 (CH3), 55.7 (CH3), 45.1 
(CH2), 38.9 (CH2), 36.0 (CH2), 30.8 (CH2), 26.6 (CH3), 25.6 (CH2), 19.6 (CH2), 19.1 (CH2) 
ppm. 
ES-MS: m/z 1033 [M + Na]+, 1050 [M + K]+ 
 
Synthesis of carboxylic acid III.6 
 
OTHP OTBDPS
OH
III.6
ODMPM DMAP, CH2Cl2
90%
succinic anhydride
OTHP OTBDPS
OCO(CH2)2COOH
ODMPM
I.14
 
 
To a solution of the tripodal scaffold I.14 (0.5 g, 0.495 mmol) in dichloromethane (35 ml) were 
added succinic anhydride (0.513 g, 4.95 mmol) and 4-dimethylaminopyridine (724 mg, 5.93 mmol). 
The solution was stirred at room temperature for 4 h. The mixture was extracted with an 
aqueous saturated solution of ammonium chloride. The organic phase was dried over anhydrous 
magnesium sulfate, filtered and evaporated. The oil was purified by column chromatography 
(isooctane / ethyl acetate: 6 / 4) affording 0.5 g of acid III.6 (90%). 
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Bruto formula: C66H82O13Si 
M.W.: 1111.46 g/mol 
Rf (isooctane / ethyl acetate: 4 / 6) = 0.34 
IR (film) 3400 (s), 2922 (s), 2853 (s), 1738 (w), 1712 (w), 1656 (w), 1630 (w), 1512 (w), 1456 (w), 
1425 (w), 1359 (w), 1256 (w), 1153 (w), 1092 (w), 1025 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.60 (4H, dd, J = 7.8, 1.2 Hz), 7.41-7.33 (6H, m), 7.18 (10H, m), 7.09 
(2H, d, J = 7.9 Hz), 6.82 (3H, m), 4.61 (1H, t, J = 3.3 Hz), 4.47 (2H, s), 4.42 (3H, s), 
4.41 (3H, s), 4.22 (2H, s), 3.92 (1H, m), 3.87 (3H, s), 3.84 (3H, s), 3.82 (2H, t, J = 7 
Hz), 3.79 (1H, m), 3.66 (2H, t, J = 7.0 Hz), 3.66 (1H, m), 3.60 (1H, m), 3.49 (4H, s), 
3.47 (2H, s), 2.90 (2H, t, J = 6.8 Hz), 2.89 (2H, t, J = 7.1 Hz), 2.83 (2H, t, J = 7.0 Hz), 
2.48 (2H, t, J = 5.3 Hz), 2.45 (2H, t, J = 5.3 Hz), 1.80 (1H, m), 1.70 (1H, m), 1.55 (4H, 
m), 1.02 (9H, s) ppm. 
13C NMR (50 MHz, CDCl3) d 176.6, 171.7, 148.8, 148.4, 138.2, 138.0, 136.3, 136.3, 135.4, 133.6, 
130.8, 129.5, 129.0, 128.8, 128.7, 127.5, 127.4, 127.3, 120.1, 110.9, 110.8, 98.7, 73.1, 
72.7, 70.8, 68.9, 68.2, 65.0, 64.0, 62.1, 55.8, 55.6, 44.5, 38.9, 35.9, 30.6, 29.0, 28.6, 
28.2, 26.7, 26.3, 19.4, 19.0 ppm. 
ES-MS: m/z 1133 [M + Na]+ 
Anal. Calcd for C66H82O13Si: C 71.36, H 7.44. Found: C 70.72, H 7.63. 
 
Synthesis of solid phase bound scaffold III.17 
 
OTHP OTBDPS
O COOHspacer
III.6
ODMPM OTHP OTBDPS
O CONHspacer
III.17
ODMPM
NH2
EDC, DMAP
 
 
1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (18 mg, 0.095 mmol) and 4-
dimethylaminopyridine (0.5 mg, 0.004 mmol) were added to a solution of acid III.6 (27 mg, 
0.024 mmol) in dry dichloromethane (1.5 ml) and the mixture was stirred for 30 min at room 
temperature. The solution was added to the resin (100 mg, 0.019 mmol, 0.19 mmol/g) and the 
suspension was shaken overnight at room temperature. The resin was then washed with 
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dimethylformamide (3 x 2 ml), methanol (3 x 2 ml) and dichloromethane (3 x 2 ml). The coupling 
was performed twice. 
The completeness of the coupling was controlled using the colorimetric TNBS test which 
resulted in white beads. 
 
Capping of the remaining free amino functions 
 
Acetylimidazole (21 mg, 0.19 mmol) was added to a suspension of resin III.17 (100 mg, 0.016 
mmol, 0.16 mmol/g) in dry dichloromethane (1 ml). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 2 ml), 
methanol (3 x 2 ml) and dichloromethane (3 x 2 ml). A sample of the resin was submitted to the  
colorimetric TNBS test and colourless beads were observed. 
 
IR (KBr) 3018 (m), 2944 (s), 2880 (s), 1732 (w), 1669 (w), 1600 (w), 1558 (w), 1489 (m), 1452 (s), 
1357 (w), 1288 (m), 1246 (m), 1146 (s), 1098 (s), 1024 (s), 951 (m), 903 (m), 840 (m), 
808 (m), 761 (m), 697 (s) cm-1. 
13C NMR (50 MHz, CD2Cl2) d 173.8, 172.4, 150.6, 139,8, 138,0, 136.9, 135.2, 132.5, 131.0, 130.6, 
130.3, 129.4, 129.1, 129.0, 128.9, 121.4, 112.6, 100.1, 74.6, 74.1, 71.0 (polyethylene 
glycol peak), 69.5, 66.7, 63.5, 57.1, 46.0, 41.8, 40.7, 37.4, 32.2, 30.5, 28.0, 27.0, 21.0, 
20.3 ppm. 
 
Deprotection of the THP protective group in resin III.17 
 
OTHP OTBDPS
O CONHspacer
III.17
ODMPM
AcOH / CH2Cl2 / H2O
80     /    15       /   5
60 °C, 4 h
6 x 2 h
OH OTBDPS
O CONHspacer
III.18
ODMPM
 
 
Resin III.17 (100 mg, 0.016 mmol, 0.16 mmol/g) was treated with a solution of AcOH / H2O / 
CH2Cl2 in the ratio 80 / 5 / 15 at 60 °C for 4 h. This procedure was repeated 6 times 2 h to 
obtain a complete deprotection. The resin was washed with dichloromethane (3 x 2 ml), methanol 
(3 x 2 ml), 5% of diisopropylethylamine in dichloromethane (3 x 2 ml), dimethylformamide (3 x 2 
ml), methanol (3 x 2 ml), dichloromethane (3 x 2 ml) and was dried for 4 h under vacuum. 
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IR (KBr) 3585 (m), 3025 (w), 2841 (m), 1732 (m), 1668 (m), 1600 (w), 1516 (m), 1454 (s), 1346 
(m), 1298 (m), 1236 (m), 1146 (s), 1110 (s), 1027 (m), 947 (m), 866 (w), 758 (m), 698 (s), 668 (m) 
cm-1. 
13C NMR (50 MHz, CD2Cl2) d 173.8, 172.3, 150.6, 140.0, 138.0, 136.9, 135.3, 131.3, 131.0, 130.6, 
130.0, 129.9, 129.8, 129.0, 121.4, 112.6, 77.1, 74.7, 74.2, 71.0 (polyethylene glycol peak), 66.8, 
64.7, 46.1, 42.2, 42.0, 40.9, 40.5, 37.6, 32.0, 30.8, 28.3, 21.0, 20.6 ppm. 
 
Synthesis of III.24 
 
 Coupling of FmocGlyCl on resin III.18 
Preparation of the corresponding acid chloride  
A solution of FmocGlyOH (57.0 mg, 0.19 mmol) and thionylchloride (140 ml, 1.9 mmol) in dry 
dichloromethane (2 ml) was heated under reflux for 2 h. The solvent was evaporated under 
reduced pressure. Dichloromethane (0.5 ml) was added followed by pentane (5 ml). The acid 
chloride precipitated, was filtered and dried under vacuum. 
 
IR (film) 3317 (w), 1799 (s), 1713 (s), 1537 (m), 1519 (m), 1449 (m), 1347 (m), 1276 (m), 1249 (m), 
1167 (w), 1044 (w), 954 (w), 759 (m), 740 (s) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.78 (2H, d, J = 7.5 Hz), 7.59 (2H, d, J = 7.5 Hz), 7.42 (2H, dd, J = 
7.5 Hz), 7.33 (2H, dd, J = 7.5 Hz), 5.41 (1H, m), 4.46 (2H, d, J = 6.8 Hz), 4.36 (2H, d, 
J = 5.6 Hz), 4.23 (1H, t, J = 6.8 Hz) ppm. 
13C NMR (50 MHz, CDCl3) d 172.1 (C), 155.9 (C), 143.5 (C), 141.3 (C), 127.8 (CH), 127.1 (CH), 124.9 
(CH), 120.0 (CH), 67.5 (CH2), 52.2 (CH2), 46.9 (CH) ppm. 
 
OH OTBDPS
O CONHspacer
III.18
ODMPM O OTBDPS
O CONHspacer
ODMPM
Gly
NHFmoc
FmocGlyCl, 
DIPEA, CH2Cl2
 
 
Diisopropylethylamine (0.033 ml, 0.19 mmol) was added to a solution of freshly prepared acid 
chloride (0.19 mmol) in dry dichloromethane (2 ml). The solution was added to resin III.18 (100 
mg, 0.016 mmol, 0.16 mmol/g) The mixture was shaken for 4 h. The coupling was repeated once 
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Loading (mmol/g) =
A x V (mL)
e (mmol-1L) x m (mg)
again overnight. After filtration, the resin was washed with dimethylformamide (3 x 2 ml), 
methanol (3 x 2 ml), and dichloromethane (3 x 2 ml). 
 
 The yield of coupling was determined using Fmoc 
UV/VIS spectroscopy at 305 nm.  
A = UV-absorbance 
 V = ml pip./DMF = 2 ml  
 m = weight (mg) 
e = 0.7 mmol-1L corresponds to the UV-absorption of 1 mmol of Fmoc-chromophore at 305 nm. 
 
Sample: m = 5.5 mg 
Absorbance: A = 0.32 
Measured loading: Loading = (A x 2) / (0.7 x m) = 0.166 mmol/g 
Calculated loading: 0.158 mmol/g 
Yield = 105% 
 
Deprotection of the Fmoc protective group 
The resin was treated with a solution of 20% piperidine in dimethylformamide for 20 min (2x). 
The resin was washed with dimethylformamide (3 x 2 ml), methanol (3 x 2 ml) and 
dichloromethane (3 x 2 ml). A sample of the resin was submitted to the colorimetric TNBS test 
and intense coloured beads were observed. 
Capping of the free amino function  
 
O OTBDPS
O CONHspacer
ODMPM
Gly
NH2
Ac2O, DMAP
DIPEA O OTBDPS
O CONHspacer
ODMPM
Gly
NH
Ac III.24
 
 
A solution of acetic anhydride (11 µl, 0.114 mmol), diisopropylethylamine (20 µl, 0.114 mmol) and 
4-dimethylaminopyridine (14 mg, 0.114 mmol) in dry dichloromethane (2 ml) was added to the 
resin (100 mg, 0.016 mmol, 0.16 mmol/g). The mixture was shaken for 20 min at room 
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temperature. After filtration, the resin was washed with dimethylformamide (3 x 2 ml), 
methanol (3 x 2 ml) and dichloromethane (3 x 2 ml). This procedure was repeated once again. A 
sample of the resin was submitted to the colorimetric TNBS test and colourless beads were 
observed. 
 
Synthesis of III.26 
 
 Deprotection of DMPM protecting group: Synthesis of III.25 
 
O OTBDPS
O CONHspacer
ODMPM
Gly
NH
Ac
O OTBDPS
O CONHspacer
OH
Gly
NH
Ac III.25
DDQ
CH2Cl2 / H2O
r.t., overnight
III.24
 
 
To a suspension of resin III.24 (100 mg, 0.016 mmol, 0.16 mmol/g) in a mixture of 
dichloromethane / water (1.4 ml / 0.1 ml) was added dichlorodicyanoquinone (6.5 mg, 0.029 mmol). 
The mixture was shaken overnight at room temperature. After filtration, the resin was washed 
with an aqueous saturated solution of sodium bicarbonate (3 x 5 ml), phenol / methanol: 1 / 1 (3 x 
5 ml), toluene (3 x 5 ml), acetonitrile (3 x 5 ml), dimethylformamide (3 x 5 ml), methanol (3 x 5 
ml), dichloromethane (3 x 5 ml).  
 
IR (KBr) 3562 (s), 3058 (m), 3026 (m), 2876 (s), 2843 (s), 1729 (w), 1651 (s), 1480 (m), 1444 (m), 
1352 (s), 1302 (m), 1145 (s), 1110 (s), 1025 (m), 945 (m), 697 (s) cm-1. 
13C NMR (50 MHz, CD2Cl2) d 136.9, 131.2, 131.0, 130.8, 130.7, 130.6, 130.4, 130.1, 130.0, 129.8, 
129.7, 129.6, 129.5, 129.1, 75.0, 71.9 (polyethyleneglycol peak), 68.6, 66.7, 64.5, 46.2, 
42.1, 40.8, 31.9, 30.8, 29.6, 28.1 ppm. 
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Coupling of FmocPheOH on resin III.25 
 
O OTBDPS
O CONHspacer
OH
Gly
NH
Ac
1) FmocPheCl,
DIPEA
2) 20% pip. / DMF
3) Ac2O, DMAP
O OTBDPS
O CONHspacer
O
Gly
NH
Ac
III.26
Phe
NH
Ac
III.25  
 
Diisopropylethylamine (0.033 ml, 0.19 mmol) was added to a solution of freshly prepared 
FmocPheCl (77.0 mg, 0.19 mmol) in dry dichloromethane (2 ml). The solution was added to resin 
(100 mg, 0.016 mmol, 0.16 mmol/g). The mixture was shaken for 4 h. The coupling was repeated 
once again overnight. After filtration, the resin was washed with dimethylformamide (3 x 2 ml), 
methanol (3 x 2 ml) and dichloromethane (3 x 2 ml). 
 
The yield of coupling was determined using Fmoc UV/VIS spectroscopy at 305 nm.  
Sample: m = 5.2 mg 
Absorbance: A = 0.239 
Measured loading: Loading = (A x 2) / (0.7 x m) = 0.131 mmol/g 
Calculated loading: 0.15 mmol/g 
Yield = 88% 
 
Deprotection of the Fmoc protective group 
The resin was treated with a solution of 20% piperidine in dimethylformamide for twice 20 min. 
The resin was washed with dimethylformamide (3 x 2 ml), methanol (3 x 2 ml) and 
dichloromethane (3 x 2 ml). A sample of the resin was submitted to the colorimetric TNBS test 
and intense coloured beads were observed. 
 
 Capping of the free amino function  
The free amino function was capped with acetic anhydride as described previously for resin 
III.24. 
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Synthesis of III.28 
 
Deprotection of TBDPS ether: Synthesis of III.27 
 
O OTBDPS
O CONHspacer
O
Gly
NH
Ac
III.26
Phe
NH
Ac
TBAF, THF
O OH
O CONHspacer
O
Gly
NH
Ac
Phe
NH
Ac
III.27
 
 
Tetrabutylammonium fluoride (57 ml, 0.057 mmol) and molecular sieves (400 pm) were added to a 
suspension of resin III.26 (100 mg, 0.016 mmol, 0.16 mmol/g) in dry tetrahydrofuran (2 ml). The 
mixture was shaken overnight at room temperature. The reaction was repeated once more 
overnight. After filtration, the resin was washed with ethanol (3 x 5 ml), dichloromethane (3 x 5 
ml), dimethylformamide (3 x 5 ml), methanol (3 x 5 ml), dichloromethane (3 x 5 ml) and was dried 
for 4 h under vacuum. 
 
13C NMR (50 MHz, CD2Cl2) d 131.9, 131.8, 130.7, 130.4, 130.2, 129.8, 129.6, 129.4, 129.3, 129.0, 
128.8, 72.1 (polyethylene glycol peak), 43.0, 42.4, 42.2, 42.0, 41.8, 41.7, 40.8, 30.2, 
26.0, 21.8, 15.5, 15.4 ppm. 
 
Coupling of FmocAlaOH on resin III.27 
 
O OH
O CONHspacer
OH
Gly
NH
Ac
1) FmocAlaCl,
DIPEA, 75%
2) 20% pip. / DMF
3) Ac2O, DMAP
O O
O CONHspacer
O
Gly
NH
Ac
III.28
Phe
NH
Ac
Phe
NH
Ac
Ala
NH
Ac
III.27
 
 
Diisopropylethylamine (0.033 ml, 0.19 mmol) was added to a solution of freshly prepared 
FmocAlaCl (0.19 mmol) in dry dichloromethane (2 ml). The solution was added to resin (100 mg, 
0.0162 mmol, 0.162 mmol/g). The mixture was shaken for 4 h. The coupling was repeated once 
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again overnight. After filtration, the resin was washed with dimethylformamide (3 x 2 ml), 
methanol (3 x 2 ml), and dichloromethane (3 x 2 ml). 
 
The yield of coupling was determined using Fmoc UV/VIS spectroscopy at 305 nm.  
Sample: m = 5.3 mg 
Absorbance: A = 0.221 
Measured loading: Loading = (A x 2) / (0.7 x m) = 0.12 mmol/g 
Calculated loading: 0.162 mmol/g 
Yield = 75% 
 
Deprotection of the Fmoc protective group 
The resin was treated with a solution of 20% piperidine in dimethylformamide for 20 min (2x). 
The resin was washed with dimethylformamide (3 x 2 ml), methanol (3 x 2 ml) and 
dichloromethane (3 x 2 ml). A sample of the resin was submitted to the colorimetric TNBS test 
and intense coloured beads were observed. 
Capping of the free amino function  
The free amino function was capped with acetic anhydride as described previously for resin 
III.24. 
 
7.4 Experimental data of part 4 
 
Coupling of acid III.6 to Rink resin IV.1: synthesis of resin IV.2 
 
H2N Rink
DIC, HOAtOTHP OTBDPS
O spacer
III.6
ODMPM
COOH
OTHP OTBDPS
O spacer
IV.2
ODMPM
Rink
IV.1
 
 
Diisopropylcarbodiimide (25 µl, 0.162 mmol) and 1-hydroxy-7-azabenzotriazole (22 mg, 0.162 
mmol) were added at 0 °C to solution of acid scaffold III.6 (0.18 g, 0.162 mmol) in dry 
dichloromethane (4 ml). The mixture was stirred at 0 °C for 20 min and at room temperature for 
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15 min. The solution was added to resin IV.1 (0.5 g, 0.105 mmol, 0.21 mmol/g) and the mixture 
was shaken overnight at room temperature. After filtration, the resin was washed with 
dimethylformamide (3 x 7 ml), methanol (3 x 7 ml) and dichloromethane (3 x 7 ml). The same 
procedure was repeated. The TNBS and NF31 tests were performed resulting both in colourless 
beads proving a complete coupling. 
 
13C NMR (50 MHz, CD2Cl2) d 170.9, 168.7, 161.4, 158.8, 157.2, 139.4, 137.4, 136.3, 134.6, 132.0, 
130.4, 130.1, 129.6, 129.2, 128.8, 128.4, 120.8, 116.8, 115.2, 112.0, 105.2, 99.9, 99.4, 
73.9, 73.4, 71.3 (polyethylene glycol peak) 69.8, 68.8, 68.3, 64.5, 64.0, 63.0, 62.8, 
56.6, 56.5, 56.2, 56.1, 45.4, 39.7, 39.6, 36.8, 31.7, 31.5, 30.2, 27.5, 26.4, 20.4, 19.8 
ppm. 
 
Coupling of acid III.6 to Kenner resin IV.5: synthesis of resin IV.9 
 
EDC, DMAP
H2N Kenner
OTHP OTBDPS
O spacer
III.6
ODMPM
COOH
OTHP OTBDPS
O spacer
IV.9
ODMPM
Kenner
IV.5
 
 
1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (60 mg, 0.312 mmol) and 4-
dimethylaminopyridine (1.5 mg, 0.012 mmol) were added to a solution of acid III.6 (90 mg, 0.078 
mmol) in dry dichloromethane (2.5 ml) and the mixture was stirred for 30 min at room 
temperature. The solution was added to resin IV.5 (300 mg, 0.078 mmol, 0.26 mmol/g) and the 
suspension was shaken overnight at room temperature. The resin was washed with 
dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 x 5 ml). The coupling 
was performed twice. 
The completeness of the coupling was controlled with the colorimetric NF31 test and white 
beads were observed. It has to be mentioned that the TNBS test cannot be used in the case of 
sulfonamides. 
The free amino functions were capped with an excess acetic anhydride in presence of 4-
dimethylaminopyridine and diisopropylethylamine as described previously. 
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Synthesis of linker IV.14a 
 
 Synthesis of carboxylic acid  IV.16 
 
OH
MeO
NO2
O
O
OMe
OH
MeO
NO2
O
O
OH
1 N NaOH
MeOH, reflux, 1 h
IV.15 IV.16
98%
 
 
An aqueous solution of 1 N sodium hydroxide (5.3 ml) was added to a solution of ester IV.15 (0.5 
g, 1.6 mmol) in methanol (13 ml). The mixture was heated under reflux for one hour. The 
methanol was evaporated under reduced pressure. The aqueous phase was acidified at 0 °C with 
an aqueous solution of 6 N hydrochloric acid and was extracted with ethyl acetate. The combined 
organic phases were dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo. 
0.47 g of acid IV.16 was obtained (98%) and was used without further purification. 
 
Bruto formula: C13H17NO7 
M.W.: 299.3 g/mol 
Rf (dichloromethane / methanol: 9 / 1) = 0.32 
IR (KBr) 3202 (m), 2949 (m), 1698 (m), 1578 (m), 1527 (m), 1446 (w), 1402 (w), 1323 (m), 1269 
(s), 1217 (m), 1100 (m), 1056 (m), 1018 (m), 898 (w), 874 (w), 819 (w), 760 (w) cm-1. 
1H NMR (500 MHz, CDCl3 + few drops DMSO-d6) d 7.80 (1H, s), 7.45 (1H, s), 5.34 (1H, q, J = 6.1 
Hz), 4.03 (2H, t, J = 6.0 Hz), 3.89 (3H, s), 2.37 (2H, t, J = 7.0 Hz), 2.02 (2H, m), 1.36 
(3H, d, J = 6.1 Hz) ppm. 
13C NMR (50 MHz, DMSO-d6) d 175.4, 153.6, 146.5, 139.0, 138.3, 109.3, 108.4, 68.4, 64.2, 56.3, 
31.4, 25.4, 24.8 ppm. 
ES-MS: m/z 322 [M + Na]+ 
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Coupling of acid IV.16 with Novagel 
 
OH
MeO
NO2
O
O
OH
NH2
OH
MeO
NO2
O
O
N
H
IV.16
DIC, HOBt
IV.14a
 
 
Diisopropylcarbodiimide (48 ml, 0.304 mmol) and 1-hydroxybenzotriazole (3 mg, 0.023 mmol) 
were added to a solution of acid IV.16 (91 mg, 0.304 mmol) in a mixture of dichloromethane (1 
ml) / dimethylformamide (1 ml). The solution was stirred for 30 min and was added to Novagel 
resin (0.2 g, 0.15 mmol, 0.76 mmol/g). The mixture was shaken overnight at room temperature. 
After filtration, the resin was washed dimethylformamide (3 x 4 ml), methanol (3 x 4 ml) and 
dichloromethane (3 x 4 ml). The same procedure was repeated once.  
The completeness of the coupling reaction was controlled using the colorimetric TNBS and NF31 
tests and colourless beads were observed. 
 
Synthesis of linker IV.14b 
 
Synthesis of methylester IV.18 
 
O
MeO
OH
Br(CH2)3COOMe
K2CO3, DMF
O
MeO
O
OMe
O
IV.18acetovanillone
92%
 
 
Methylbromobutyrate (30.2 g, 0.167 mol) and potassium carbonate (31.2 g, 0.226 mol) were 
added to a solution of acetovanillone (25 g, 0.150 mol) in dry dimethylformamide (120 ml). The 
mixture was stirred at room temperature overnight. Water was added to the mixture until all 
excess potassium carbonate was dissolved. The aqueous phase was extracted with ethyl acetate. 
The combined organic phases were dried over anhydrous magnesium sulfate, filtered and 
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evaporated under reduced pressure to provide 39 g of colourless oil (98%), which easily 
crystallizes at 4°C. 
 
Bruto formula: C14H18O5 
M.W.: 266.3 g/mol 
m.p.: 49 °C 
Rf (ethyl acetate) = 0.66 
IR (film) 2925 (m), 2848 (m), 1731 (s), 1673 (m), 1587 (m), 1512 (m), 1417 (m); 1272 (m), 1219 
(m), 1176 (m), 1150 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.52 (2H, m), 6.87 (1H, d, J = 8.3 Hz), 4.12 (2H, t, J = 6.3 Hz), 3.87 
(3H, s), 3.67 (3H, s), 2.54 (3H, s), 2.54 (2H, t, J = 7.1 Hz), 2.17 (2H, m) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 196.3 (C), 172.9 (C), 152.2 (C), 148.9 (C), 130.1 (C), 122.8 (C), 
110.9 (CH), 110.1 (CH), 67.3 (CH2), 55.5 (CH3), 51.2 (CH3), 29.9 (CH2), 25.7 (CH3), 23.9 
(CH2) ppm. 
ES-MS: m/z 267 [M + H]+ 
 
Synthesis of methyl 4-(4-(1-hydroxyiminoethyl)-2-methoxyphenoxy)butanoate IV.19 
 
O
O
OMe
MeO
N
OH
O
OMe
MeO
NH2OH.HCl
Pyr / H2O
IV.18 IV.19
3
O
3
O
97%
 
 
A solution of keto-ester IV.18 (39 g, 0.147 mol) and the chloride salt of hydroxylamine (11.3 g, 
0.162 mol) in a mixture of pyridine (86 ml) / water (43 ml) was stirred overnight. A saturated 
aqueous solution of sodium chloride (80 ml) was added and the mixture was extracted with ethyl 
acetate. The organic phases were combined, dried over anhydrous magnesium sulfate, filtered 
and evaporated under reduced pressure to afford 40 g of a light yellow solid (97%). 
 
Bruto formula: C14H19NO5 
M.W.: 281.3 g/mol 
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m.p.: 74 °C 
Rf (ethyl acetate) = 0.66 
IR (film) 2924 (m), 2873 (m), 1731 (s), 1602 (w), 1578 (w), 1514 (s), 1414 (m), 1302 (m), 1244 (m), 
1220 (s), 1179 (m), 1149 (m), 1085 (w), 997 (m), 944 (m), 868 (m), 733 (w), 515 (w)   
cm-1. 
1H NMR (500 MHz, CDCl3) d 7.23 (1H, d, J = 2.0 Hz), 7.10 (1H, dd, J = 8.4 Hz, 2.0 Hz), 6.85 (1H, 
d, J = 8.4 Hz), 4.07 (2H, t, J = 6.3 Hz), 3.87 (3H, s), 3.67 (3H, s), 2.54 (2H, t, J = 7.3 
Hz), 2.25 (3H, s), 2.15 (2H, m) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 173.6 (C), 155.6 (C), 149.2 (C), 149.4 (C), 129.4 (C), 119.1 (CH), 
112.3 (CH), 109.0 (CH), 67.7 (CH2), 55.8 (CH3), 51.6 (CH3), 30.4 (CH2), 24.3 (CH3), 12.0 
(CH3) ppm. 
ES-MS: m/z 304 [M + Na]+ 
 
 Synthesis of amine IV.20 
 
H2, Pd/C
MeOH, HCl
N
OH
O
OMe
MeO
IV.19
3
O
NH2
O
OMe
MeO
IV.20
3
O
71%
 
 
To a solution of oxime IV.19 (3 g, 11.0 mmol) in methanol (30 ml) were added 10% palladium on 
activated carbon (1.13 g, 1.1 mmol) and 1 ml of concentrated hydrochloric acid. The flask was 
degassed and placed under hydrogen. The mixture was stirred overnight at room temperature. 
The mixture was filtered over celite. The organic phase was evaporated under reduced pressure. 
The residue was taken up in 20 ml water and acidified to pH 1 with an aqueous solution 6 N 
hydrochloric acid. The aqueous phase was extracted with ethyl acetate, basified with sodium 
bicarbonate until pH 9 and extracted again with ethyl acetate. The combined organic phases 
were dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo to afford 2 g of 
amine IV.20 (71%). 
 
Bruto formula: C14H21NO4 
M.W.: 267.3 g/mol 
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Rf (CH2Cl2 / MeOH: 9 / 1) = 0.35 
IR (film) 3588 (w), 3360 (m), 2957 (m), 1732 (s), 1592 (m), 1517 (s), 1447 (m), 1369 (w), 1321 (w), 
1261 (s), 1229 (s), 1173 (s), 1140 (s), 1035 (s), 946 (w), 863 (w), 811 (w), 647 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 6.88 (1H, s), 6.80 (2H, s), 4.00 (3H, m), 3.83 (3H, s), 3.64 (3H, s), 
2.51 (2H, t, J = 7.3 Hz), 2.09 (2H, m), 1.72 (2H, s), 1.33 (3H, d, J = 6.6 Hz) ppm. 
13C NMR (50 MHz, CDCl3) d 173.4, 149.3, 146.8, 140.6, 117.4, 113.2, 109.4, 67.8, 55.7, 51.3, 50.7, 
30.2, 25.5, 24.3 ppm. 
ES-MS: m/z 290 [M + Na]+ 
 
Synthesis of methyl 4-(2-methoxy-4-(1-trifluoroacetamidoethyl)phenoxy) butanoate IV.21 
 
CF3CO)2O, pyr.
0 °C, 1 h
NH2
O
OMe
MeO
IV.20
3
O
NHCOCF3
O
OMe
MeO
IV.21
3
O
76%
 
 
To a cooled solution of amine IV.20 (0.7 g, 2.62 mmol) in dry pyridine (5.5 ml) was added 
dropwise trifluoroacetic anhydride (0.55 ml, 3.89 mmol). The mixture was allowed to react for 1 
h at 0 °C and then poured in a saturated solution of sodium chloride (30 ml), extracted with 
ethyl acetate, dried over anhydrous magnesium sulfate and evaporated under reduced pressure. 
Recrystallization from dichloromethane / pentane afforded 0.72 g of the protected amine IV.21 
(76%). 
 
Bruto formula: C16H20NO5F3 
M.W.: 363.2 g/mol 
m.p.: 85 °C 
Rf (ethyl acetate) = 0.69 
IR (KBr) 3307 (w), 2956 (m), 1714 (s), 1594 (w), 1519 (s), 1454 (m), 1422 (m), 1258 (s), 1208 (s), 
1170 (s), 1034 (m), 934 (w), 809 (w), 736 (w), 702 (w), 652 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 6.82 (3H, m), 6.56 (1H, m), 5.07 (1H, dq, J = 7.0 Hz), 4.03 (2H, t J = 
6.3 Hz), 3.84 (3H, s), 3.66 (3H, s), 2.52 (2H, t, J = 7.3 Hz), 2.12 (2H, m), 1.55 (3H, d, 
J = 6.9 Hz) ppm. 
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13C NMR (50 MHz, CDCl3) d 173.6, 149.7 148.1, 133.7, 118.2, 113.3, 110.4, 67.9, 55.9, 51.6, 49.5, 
30.4, 24.4, 20.7 ppm. 
ES-MS: m/z 362 [M - H]- 
 
Synthesis of methyl 4-(2-methoxy-5-mitro-4-(1-trifluoroacetamidoethyl)-phenoxy) butanoate 
IV.22 
 
IV.22
HNO3 (65%)
2 h, 0 °C
NHCOCF3
O
OMe
MeO
IV.21
3
O
NHCOCF3
O
OMe
MeO
3
O
NO2
66%
 
 
To a cooled (0 °C) solution of protected amine IV.21 (1.5 g, 4.13 mmol) was added slowly a 
solution of 65% of nitric acid (11.5 ml). The mixture was allowed to react for 2 h and was then 
quenched with water. The volume was adjusted to 107 ml. The mixture was kept at 4 °C overnight 
and was filtered to afford 1.1 g of a yellow powder (66%). 
 
Bruto formula: C16H19N2O7F3 
M.W.: 408.1 g/mol 
m.p.: 141 °C 
Rf (ethyl acetate) = 0.68 
IR (KBr) 3316 (w), 2949 (w), 1720 (s), 1701 (s), 1578 (w), 1549 (m), 1519 (s), 1461 (w), 1331 (m), 
1273 (s), 1214 (s), 1179 (s), 1061 (w), 938 (w), 885 (w), 703 (w), 656 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.68 (1H, s), 7.43 (1H, d, J = 7.3 Hz), 6.86 (1H, s), 5.52 (1H, dq, J = 
7.2 Hz), 4.11 (2H, t, J = 6.2 Hz), 3.92 (3H, s), 3.68 (3H, s), 2.53 (2H, t, J = 7.2 Hz), 
2.16 (2H, m), 1.60 (3H, d, J = 7.0 Hz) ppm. 
13C NMR (50 MHz, CDCl3) d 173.4, 154.0, 147.6, 140.5, 130.9, 111,0, 110.2, 68.2, 56.4, 51.7, 48.4, 
30.3, 24.2, 20.1 ppm. 
ES-MS: m/z 407 [M - H]- 
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Synthesis of 4-(4-(1-(9-fluorenylmethoxycarbonylamino)ethyl)-2-methoxy-5-nitrophenoxy) 
butanoic acid IV.23 
 
1) 1N NaOH,
MeOH
2) FmocCl
dioxane
68%
IV.22
NHCOCF3
O
OMe
MeO
3
O
NO2
IV.23
NHFmoc
O
OH
MeO
3
O
NO2
 
 
A solution of 1 N sodium hydroxide (7.3 ml, 7.3 mmol) and trifluoroacetamide IV.22 (0.9 g, 2.2 
mmol) in methanol (18.5 ml) was heated under reflux for 5 h. The methanol was evaporated in 
vacuo. 1,4-Dioxane (11.2 ml) and water (7.3 ml) were added and the pH of the solution was 
adjusted to pH = 9 with a solution 6 N hydrochloric acid. A solution of 9-fluorenylmethyl 
chloroformate (0.72 g, 2.8 mmol) in 1,4-dioxane (7.3 ml) was added. The pH was adjusted to pH = 
8 over 30 min with an aqueous solution of 1 N sodium hydroxide. After two days, the reaction 
was quenched with 7.3 ml of a solution of 1 N hydrochloric acid and the volume was adjusted to 
80 ml with water. The precipitate was filtered and dissolved in warm ethyl acetate. The organic 
phase was dried over anhydrous magnesium sulfate, filtered while hot and evaporated under 
reduced pressure. The light yellow solid was triturated in warm ether and filtered. The residue 
was recrystallized from methanol to afford 0.78 g of linker IV.23 (68%). 
 
Bruto formula: C28H28N2O8 
M.W.: 520 g/mol 
m.p.: 200 °C 
Rf (ethyl acetate) = 0.63 
IR (KBr) 3352 (m); 2934 (w), 2871 (w), 1686 (s), 1654 (s), 1578 (w), 1523 (s), 1446 (w), 1368 (m), 
1339 (m), 1268 (s), 1217 (m), 1172 (m), 1072 (m), 1017 (m), 880 (w), 856 (w), 742 (w), 
698 (w), 575 (w) cm-1. 
1H NMR (500 MHz, DMSO-d6) d 8.10 (1H, d, J = 8.2 Hz), 6.99 (2H, d, J = 7.6 Hz), 7.65 (2H, d, J 
= 7.5 Hz), 7.49 (1H, s), 7.41 (2H, td, J = 7.4, 2.2 Hz), 7.29 (2H, m), 7.25 (1H, s), 5.19 
(1H, dq, J = 7.1 Hz), 4.29 (2H, t, J = 7.1 Hz), 4.18 (1H, t, J = 6.4 Hz), 4.06 (2H, t, J = 
6.4 Hz), 3.89 (3H, s), 2.40 (2H, J = 7.3 Hz), 1.96 (2H, m), 1.42 (3H, d, J = 7.1 Hz) ppm. 
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13C NMR (50 MHz, DMSO-d6) + DEPT d 174.1 (C), 155.3 (C), 153.5 (C), 146.4 (C), 143.9 (C), 143.7 
(C), 140.7 (C), 139.9 (C), 135.5 (C), 127.6 (CH), 126.9 (CH), 125.1 (CH), 120.2 (CH), 
109.4 (CH), 108.2 (CH) 67.9 (CH2), 65.3 (CH2) 56.2 (CH3), 46.8 (CH), 46.0 (CH), 30.0 
(CH2), 24.1 (CH2), 21.9 (CH3) ppm. 
ES-MS: m/z 538 [M + NH4]+ 
 
Control of the loading of the commercial resin TentaGel 
 
a) Using Fmoc monitoring: 
 
Preparation of calibration curve: 
 
The amino acid FmocValOH (50.3 mg) was dissolved in 100 ml of a solution of 20% piperidine in 
dimethylformamide (c = 1.482 mM). The mother solution was diluted (c = 0.14, 0.11, 0.095, 0.08, 
0.05, 0.03 mM) and the absorbance of each dilution solution was measured at 300 nm. The 
calibration curve was then established. 
 
Calibration Curve for benzofulvene
y = 8,0618x - 0,047
R2 = 0,9984
0
0,2
0,4
0,6
0,8
1
1,2
0 0,05 0,1 0,15
concentration (mM)
A
b
so
rb
an
ce
 
 
 
 Synthesis of TentaGel-ValFmoc 
Diisopropylcarbodiimide (13.1 ml, 0.084 mmol) and 1-hydroxybenzotriazole (11.4 mg, 0.084 mmol) 
were added to a solution of amino acid FmocValOH (32.5 mg, 0.084 mmol) in dimethylformamide 
(2 ml). The carboxylic acid was activated for 30 min. The solution was then added to the resin 
TentaGel-NH2 (100 mg, 0.28 mmol/g) and the mixture was shaken overnight at room 
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temperature. After filtration, the resin was washed with dimethylformamide (3 x 3 ml), 
methanol (3 x 3 ml) and dichloromethane (3 x 3 ml). A sample of the resin was submitted to both 
colorimetric tests (TNBS and NF31) and intense coloured beads were observed. 
 
 Determination of the loading in a quantitative way 
 
A sample of Tentagel-ValFmoc (37.3 mg) was treated with a solution of 20% piperidine in 
dimethylformamide (2 x 20 min). The filtrates were collected and diluted to 100 ml with 
dimethylformamide.  
The absorbance of the filtrate was measured at 300 nm: A = 0.626.  
By using the calibration curve, the concentration of the piperidine-benzofulvene adduct can be 
deduced and the loading can be calculated:  
 
Loading (mmol / g) = c (mM) x V (L) / m (g). 
 
Absorbance: A = 0.626 
Volume: V = 0.1 l 
Weight of resin: m = 37.3 mg 
Concentration: c = 0.0834 mM 
Loading: loading = 0.22 mmol/g 
 
b) Using picric acid 
 
The procedure to determine the loading of the commercial resin TentaGel using picric acid is the 
following: 
 
A sample of TentaGel (60.4 mg, 0.28 mmol/g) was washed with dichloromethane (3 x 5 ml), a 
solution of 15% triethylamine in dichloromethane (3 x 5 ml), methanol (3 x 5 ml) and with 
dichloromethane (5 x 5 ml). The resin was then treated with a saturated solution of picric acid 
(2,4,6-trinitrophenol) in dichloromethane for 30 s. The resin was then washed intensively with 
dichloromethane and methanol remove the excess of picric acid until an absorbance < 0.05 of the 
filtrate was obtained at 340 nm.  
The resin was washed twice with a solution of 15% triethylamine in dichloromethane. The 
combined filtrates were diluted to 50 ml dichloromethane. 1 ml of the resulting bright yellow 
solution was diluted to 10 ml with absolute ethanol. The absorbance was measured at 358 nm and 
the substitution was calculated: 
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Loading (mmol/g) = 34.48 x A358 / m (g). 
 
Weight of resin: m = 60.4 mg 
Absorbance: A = 0.357 
Substitution: loading = 0.204 mmol/g  
 
Coupling of the photolabile linker IV.23 on TentaGel-NH2:  
 
NH2
DIC, HOBt
IV.23
NHFmoc
O
OH
MeO
3
O
NO2
IV.14b
NHFmoc
O
NH
MeO
3
O
NO2
 
 
Diisopropylcarbodiimide (27 ml, 0.174 mmol) and 1-hydroxybenzotriazole  (24 mg, 0.174 mmol) 
were added to a solution of IV.23 (90.5 mg, 0.174 mmol) in dimethylformamide (3 ml). The 
mixture was stirred for 30 min at room temperature. After addition of the solution to the resin 
(300 mg, 0.063 mmol, 0.21 mmol/g), the suspension was shaken overnight at room temperature. 
The resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). To monitor the completeness of the coupling reaction, a sample of 
the resin was submitted to both colorimetric tests (TNBS and NF31) and colourless beads were 
observed. 
 
Deprotection of the Fmoc protective group 
 
NHFmoc
O
NH
MeO
NO2
IV.14b
20% pip. / DMF
3
O
NH2
O
NH
MeO
NO2
3
O
H2N hv2
 
 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). The 
resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 
x 5 ml). Both colorimetric TNBS and NF31 tests were done and resulted in coloured beads. 
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Coupling of scaffold III.6 to polymer-supported linker IV.14b 
 
EDC, DMAP
H2N hv2
OTHP OTBDPS
O COOHspacer
III.6
ODMPM OTHP OTBDPS
O spacer
IV.24
ODMPM
hv2
 
 
1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (67 mg, 0.348 mmol) and 4-
dimethylaminopyridine (2 mg, 0.013 mmol) were added to a solution of scaffold III.6 (140 mg, 
0.126 mmol) in dichloromethane (3 ml).  After activation of the acid for 30 min at room 
temperature, the solution was added to the resin (300 mg, 0.060 mmol, 0.20 mmol/g). The 
suspension was shaken overnight at room temperature. The resin was washed with 
dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 x 5 ml). TNBS test 
and NF31 test to control the efficiency of the coupling were preformed and showed colourless 
beads. 
 
13C NMR (50 MHz, CD2Cl2) d 174.1, 173.3, 172.2, 155.2, 150.4, 148.2, 148.1, 141.6, 139.9, 137.8, 
137.0, 136.8, 135.0, 132.5, 131.1, 131.0, 130.8, 130.5, 130.2; 129.4, 129.3, 129.0, 128.9, 
121.3, 112.5, 112.4, 110.6, 99.9, 74.5, 73.9, 71.5 (polyethylene glycol peak), 66.5, 65.0, 
64.6, 63.3, 47.5, 45.8, 40.6, 40.3, 37.3, 33.6, 32.1, 31.8, 31.7, 30.4, 28.0, 26.3, 22.9, 
20.3 ppm.  
 
Cleavage of construct IV.24: Synthesis of IV.25 
 
hv (365 nm)
1,4-dioxane / DMSOOTHP OTBDPS
O spacer
IV.24
ODMPM
hv2
OTHP OTBDPS
O spacer
IV.25
ODMPM
CONH2
 
 
50 mg of resin IV.24 (0.008 mmol, 0.163 mmol/g) in 1.5 ml of 1,4-dioxane and 15 ml of 
dimethylsulfoxide was exposed to UV light (365 nm) for 2 h and 6 times 3 h. After each 
cleavage, the resin was filtered and washed with 1,4-dioxane. After evaporation of 1,4-dioxane 
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and removal of the dimethylsulfoxide with the Kugelrhor, 7.8 mg of compound IV.25 was 
obtained without further purification (86%).  
 
Bruto formula: C66H83O12NSi 
M.W.: 1110.5 g/mol 
Rf (ethyl acetate) = 0.55  
IR (film) 3424 (s), 2919 (s), 2860 (s), 1725 (s), 1672 (m), 1513 (w), 1455 (w), 1425 (w), 1260 (s), 
1172 (m), 1102 (s), 1025 (s), 803 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.58 (4H, dd, J = 8.0, 1.5 Hz), 7.37 (6H, m), 7.18 (10H, m), 7.09 (2H, 
d, J = 8.0 Hz), 6.82 (3H, m), 4.59 (1H, t, J = 3.1 Hz), 4.45 (2H, s), 4.42 (2H, s), 4.41 
(4H, s), 4.21 (2H, s), 3.93 (1H, dt, J = 9.6, 7.2 Hz), 3.87 (3H, s), 3.84 (3H, s), 3.81 (2H, 
t, J = 7.1 Hz), 3.78 (1H, m), 3.65 (2H, t, J = 7.1 Hz), 3.60 (1H, dt, J = 9.6, 7.2 Hz), 
3.49 (4H, s), 3.48 (2H, s), 3.43 (1H, m), 2.90 (2H, t, J = 6.8 Hz), 2.89 (2H, t, J = 7.0 
Hz), 2.83 (2H, t, J = 7.0 Hz), 2.52 (2H, t, J = 6.9 Hz), 2.33 (2H, t, J = 6.9 Hz), 1.80 
(1H, m), 1.70 (1H, m), 1.55 (4H, m), 1.02 (9H, s) ppm. 
ES-MS: m/z 1212 [M + TEA]+ 
 
Synthesis of acetate IV.28 
 
Selective deprotection of the THP protective group:  
 
AcOH / CH2Cl2 / H2O
80     /    15       / 5
60 °C
OTHP OTBDPS
O spacer
IV.24
ODMPM
hv2
OH OTBDPS
O spacer
IV.26
ODMPM
hv2
 
 
First method: Deprotection of the THP protecting group with acetic acid 
Resin IV.24 (100 mg, 0.016 mmol, 0.163 mmol/g) was treated with 2 ml of a solution of AcOH / 
CH2Cl2 / H2O (80 / 15 / 5) for 4 h at 60 °C. After filtration, the same reaction was repeated 6 
times 2 h. The resin was washed with dichloromethane (3 x 5 ml), methanol (3 x 5 ml), 5% of 
diisopropylethylamine in dichloromethane,  dimethylformamide (3 x 5 ml), methanol (3 x 5 ml), 
dichloromethane (3 x 5 ml) and was dried for 4 h under vacuum.  
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13C NMR (50 MHz, CD2Cl2) d 174.2, 173.3, 172.1, 155.3, 141.7, 140.0, 139.9, 137.9, 136.9, 135.1, 
132.6, 131.0, 130.8, 130.5, 130.3, 130.2, 129.7, 129.5, 129.0, 128.9, 112.6, 112.5, 110.7, 
75.4, 71.5 (polyethylene glycol peak), 66.6, 65.1, 64.6, 47.6, 45.9, 40.6, 40.3, 37.4, 
33.7, 31.9, 30.5, 28.0, 26.4, 22.9, 20.4 ppm.  
 
Second method: Deprotection of the THP protecting group with PPTS 
Pyridinium p-toluenesulfonate (0.066 g, 0.265 mmol) was added to a suspension of resin IV.24 
(0.315 g, 0.051 mmol, 0.163 mmol/g) in dry ethanol (3.2 ml). The mixture was heated at 55 °C 
overnight. After filtration, the resin was washed with ethanol (3 x 5 ml), dimethylformamide (3 
x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 x 5 ml).  
 
A sample of resin IV.26 (2 mg, 0.33 mmol, 0.165 mmol/g) was suspended in 100 ml acetonitrile 
and was irradiated with UV light (365 nm) for 3 h. The solution was analysed by ES-MS. 
M.W.: 1025 g/mol  
ES-MS: m/z 1026 [M + H]+, 1048 [M + Na]+, 1064 [M + K]+ 
 
Capping of the hydroxyl function as the acetate: synthesis of IV.27 
 
Ac2O, DMAP, DIPEA
CH2Cl2OH OTBDPS
O spacer
IV.26
ODMPM
hv2
OAc OTBDPS
O spacer
IV.27
ODMPM
hv2
 
 
A solution of acetic anhydride (16 ml, 0.174 mmol), diisopropylethylamine  (31 ml, 0.174 mmol) and 
4-dimethylaminopyridine (21.2 mg, 0.174 mmol) in dichloromethane (2 ml) was added to the THP 
deprotected resin IV.26 (0.1 g, 0.017 mmol, 0.165 mmol/g). The suspension was shaken for 20 
min. The procedure was repeated once again. The resin was washed with dimethylformamide (3 x 
5 ml), methanol (3 x 5 ml) and dichloromethane (3 x 5 ml) and was dried for 4 h under vacuum. 
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Cleavage of IV.27 from the resin: Synthesis of acetate IV.28 
 
hv (365 nm)
1,4-dioxane / DMSOOAc OTBDPS
O spacer
IV.27
ODMPM
hv2
OAc OTBDPS
O spacer
IV.28
ODMPM
CONH2
 
 
A sample of acetate IV.27 (50 mg, 0.0082 mmol, 0.164 mmol/g) in suspension in 1 ml of 1,4-
dioxane with 10 ml of dimethylsulfoxide was exposed to UV light (365 nm) for 4 times 3 h. After 
each cleavage, the resin was filtered and washed with 1,4-dioxane. After evaporation of 1,4-
dioxane and removal of the dimethylsulfoxide with the Kugelrhor, the sample was purified by 
column chromatography (ethyl acetate / isooctane: 8 / 2) to provide 4.8 mg of acetate IV.28 
(55%).  
 
Bruto formula : C63H77O12NSi 
M.W.: 1067 g/mol 
Rf (ethyl acetate) = 0.55  
IR (film) 2925 (m), 2848 (m), 2860 (s), 1737 (s), 1678 (m), 1619 (w), 1507 (w), 1461 (w), 1437 (w), 
1413 (w), 1360 (w), 1255 (m), 1231 (w), 1096 (m), 1025 (m), 667 (s) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.79 (4H, dd, J = 7.9, 1.5 Hz), 7.32-7.41 (6H, m), 7.17 (10H, m), 7.09 
(2H, d, J = 8.0 Hz), 6.82 (3H, m), 5.47 (1H, m), 5.08 (1H, m), 4.45 (2H, s), 4.42 (2H, s), 
4.41 (4H, s), 4.25 (2H, t, J = 7.1 Hz), 4.21 (2H, s), 3.87 (3H, s), 3.83 (3H, s), 3.81 (2H, 
t, J = 7.1 Hz), 3.64 (2H, t, J = 7.1 Hz), 3.49 (6H, s), 2.90 (4H, t, J = 7.0 Hz), 2.83 (2H, 
t, J = 7.0 Hz), 2.53 (2H, t, J = 6.8 Hz), 2.35 (2H, t, J = 6.8 Hz), 2.03 (3H, s), 1.02 (9H, 
s) ppm. 
ES-MS m/z 1085 [M + NH4]+ 
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Synthesis of 4-(4-(1-(tert-butylcarbonyloxyamino)ethyl)-2-methoxy-5-nitrophenoxy) butanoic 
acid IV.32 
 
NHCOCF3
O
OMe
MeO
IV.22
NO2
1) 1N NaOH,
MeOH
2) BocCO)2O
1,4-dioxane / H2O
3
O
NHBoc
O
OH
MeO
IV.32
NO2
3
O
70%
 
 
An aqueous solution of 1 N sodium hydroxide (16 ml, 16.0 mmol) and trifluoroacetamide IV.22 
(2.0 g, 4.9 mmol) in methanol (40 ml) was heated under reflux for 2 h. The methanol was 
evaporated in vacuo. 1,4-Dioxane (24 ml) and water (16 ml) were added and the pH of the solution 
was adjusted to pH = 9 with a 6 N aqueous solution hydrochloric acid. A solution of di-tert-butyl 
dicarbonate (1.7 ml, 7.36 mmol) in 1,4-dioxane (6 ml) was added and the mixture was stirred at 
room temperature for 2 h. After cooling to 0 °C, the pH was adjusted to 2-3 over 30 min with a 
solution of 10% of sodium hydrogen sulfate. The mixture was extracted with ethyl acetate. The 
combined organic phase were dried over anhydrous magnesium sulfate, filtered and evaporated 
under reduced pressure. The residue was purified by recrystallization from methanol to afford 
1.35 g of acid IV.32 (70%). 
 
Bruto formula: C18H26N2O8 
M.W.: 398.4 g/mol 
m.p.: 187 °C 
Rf (ethyl acetate / AcOH: 98 / 2) = 0.73 
IR (KBr) 3373 (m), 3338 (m), 2999 (w), 1736 (s), 1678 (s), 1584 (m), 1517 (s), 1445 (m), 1371 (m), 
1337 (s), 1288 (m), 1269 (s), 1219 (s), 1169 (s), 1072 (m), 1016 (w), 880 (w), 820 (w), 
758 (w), 648 (w) cm-1. 
1H NMR (500 MHz, DMSO-d6) d 12.18 (1H, s), 7.65 (1H, d, J = 8.1 Hz), 7.49 (1H, s), 7.23 (1H, s), 
5.14 (1H, dq, J = 14.4, 6.6 Hz), 4.05 (2H, t, J = 6.4 Hz), 3.88 (3H, s), 2.38 (2H, t, J = 
7.1 Hz), 1.94 (2H, m), 1.36 (3H, d, J = 6.6 Hz), 1.33 (9H, s) ppm. 
13C NMR (50 MHz, DMSO-d6) + DEPT d 174.0 (C), 154.8 (C), 153.5 (C), 146.3 (C), 139.9 (C), 135.9 
(C), 109.4 (CH), 108.3 (CH), 78.2 (C), 67.9 (CH2), 56.3 (CH3), 45.6 (CH), 30.0 (CH2), 
28.2 (CH3), 24.1 (CH2), 22.2 (CH3) ppm. 
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ES-MS: m/z 421 [M + Na]+, 416 [M + NH4]+ 
 
Synthesis of amide IV.33 
 
n-butylamine, DMF
HBTU, HOBt, DIPEA
NHBoc
O
OH
MeO
IV.32
NO2
3
O
NHBoc
O
NHn-Bu
MeO
IV.33
NO2
3
O
46%
 
 
To a solution of carboxylic acid IV.32 (0.5 g, 1.26 mmol) in dimethylformamide (12 ml) were 
added 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafuorophosphate (HBTU) (0.96 
g, 2.52 mmol), hydroxybenzotriazole (340 mg, 2.52 mmol) and diisopropylethylamine (0.44 ml, 
2.52 mmol). After stirring for 1 min, the amine (0.13 ml, 1.26 mmol) was added. The reaction was 
allowed to react for 3 h at room temperature. After addition of brine, the mixture was 
extracted with dichloromethane. The organic phase was dried over anhydrous magnesium sulfate, 
filtered and evaporated in vacuo. The remaining dimethylformamide was removed with kogelruhr 
apparatus. The residue was purified by column chromatography (ethyl acetate / isooctane: 4 / 6). 
The light yellow solid obtained was recrystallized in ethyl acetate to provide 0.26 g of amide 
IV.33 (46%). 
 
Bruto formula: C22H35N3O7 
M.W.: 453.2 g/mol 
m.p.: 136 °C 
Rf (ethyl acetate) = 0.55 
IR (film) 3364 (w), 2956 (w), 1677 (s), 1637 (m), 1518 (s), 1449 (w), 1368 (w), 1336(m), 1270 (s), 
1218 (s), 1170 (m), 1073 (w), 1015 (w), 879 (w), 813 (w), 759 (w), 621 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.57 (1H, m), 6.96 (1H, s), 6.68 (1H, m), 5.33 (1H, m), 5.20 (1H, m), 
4.09 (2H, t, J = 5.4 Hz), 3.93 (3H, s), 3.24 (2H, dt, J = 6.9, 5.9 Hz), 2.38 (2H, t, J = 
7.2 Hz), 2.18 (2H, m), 1.48 (3H, d, J = 6.9 Hz), 1.45-1.2 (13H, m), 0.89 (3H, t, J = 7.3 
Hz) ppm. 
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13C NMR (50 MHz, CDCl3) + DEPT d 171.9 (C), 154.8 (C), 153.7 (C), 146.7 (C), 140.3 (C), 109.8 (CH), 
109.1 (CH), 79.8 (CH), 68.5 (CH2), 56.3 (CH3), 47.9 (CH3), 39.2 (CH2), 32.8 (CH2), 31.7 
(CH2), 28.2 (CH3), 24.9 (C), 22.0 (CH3), 20.0 (CH2), 13.7 (CH3) ppm. 
ES-MS: m/z 471 [M + NH4]+, 929 [2M + Na]+ 
 
Synthesis of amine IV.34 
 
IV.34
20% TFA in CH2Cl2
NHBoc
O
NHn-Bu
MeO
IV.33
NO2
3
O
NH2
O
NHn-Bu
MeO
NO2
3
O98%
 
 
Compound IV.33 (0.15 g, 0.33 mmol) was treated with of a solution of 20% trifluoroacetic acid in 
dichloromethane (5 ml). The mixture was stirred for 20 min. The organic phase was washed with 
water. The aqueous phase was basified until pH = 9-10 with a saturated aqueous solution of 
sodium bicarbonate, the aqueous phase was washed with dichloromethane. The organic phase was 
dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure 
affording 114 mg of crude amine IV.34, which was used without further purification (98%).  
 
Bruto formula: C17H27N3O5 
M.W.: 353.2 g/mol 
Rf (dichloromethane / methanol: 9 / 1) = 0.57 
IR (film) 2959 (w), 2921 (w), 1648 (m), 1518 (s), 1455 (w), 1332 (m), 1267 (s), 1209 (m), 1049(w), 
873 (w), 597 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.46 (1H, s), 7.31 (1H, s), 5.71 (1H, m), 4.79 (1H, m), 4.08 (2H, t, J = 
6.0 Hz), 3.96 (3H, s), 3.23 (2H, dt, J = 6.9, 6.3 Hz), 2.38 (2H, t, J = 7.2 Hz), 2.17 (2H, 
m), 1.91 (2H, s), 1.44 (2H, m), 1.42 (3H, d, J = 6.5 Hz), 1.31 (2H, m), 0.89 (3H, t, J = 7.3 
Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 171.9 (C), 153.7 (C), 146.6 (C), 140.8 (C), 137.3 (C), 109.3 (CH), 
109.0 (CH), 68.5 (CH2), 56.3 (CH3), 47.9 (CH3), 39.3 (CH2), 32.9 (CH2), 31.7 (CH2), 24.9 
(C), 24.6 (CH3), 20.0 (CH2), 13.7 (CH3) ppm. 
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Coupling of acid scaffold III.6 on amine IV.34 
 
III.6
EDC, DMAP
IV.34
H
N
O
NHn-Bu
NO2
OMe
3
O
IV.31
O spacer
OTHP OTBDPSODMPM
H2N
O
NHn-Bu
NO2
OMe
3
O
78%
 
 
To a cooled solution (0 °C) of acid scaffold III.6 (108 mg, 0.097 mmol) and amine IV.34 (35 mg, 
0.099 mmol) in dry dichloromethane (1 ml) were added 1-[3-(Dimethylamino)propyl] -3-
ethylcarbodiimide hydrochloride (19 mg, 0.099 mmol) and 4-dimethylaminopyridine (12 mg, 0.099 
mmol). The solution was stirred at 0 °C for 1 h and allowed to react at room temperature 
overnight. The mixture was extracted with a saturated aqueous solution of ammonium chloride. 
The organic phase was dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo. 
The residue was purified by column chromatography (ethyl acetate / isooctane: 6 / 4) to provide 
110 mg of amide IV.31 (78%). 
 
Bruto formula: C83H107N3O17Si 
M.W.: 1445.7 g/mol 
Rf (ethyl acetate / isooctane: 8 / 2) = 0.37 
IR (film) 2932 (s), 2856 (m), 1736 (m), 1647 (m), 1517 (s), 1547 (m), 1428 (m), 1363 (m), 1268 (s), 
1215 (w), 1090 (s), 1029 (m), 822 (w), 704 (m), 490 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.59 (4H, dd, J = 7.0, 1.3 Hz), 7.53 (1H, s), 7.37 (6H, m), 7.16 (10 H, 
m), 7.08 (2H, d, J = 8.0 Hz), 6.91 (1H, s), 6.83 (3H, m), 6.41 (1H, d, J = 7.0 Hz), 5.64 
(1H, m), 5.51 (1H, m), 4.59 (1H, m), 4.45 (2H, s), 4.42 (2H, s), 4.39 (4H, s), 4.22 (1H, 
ABd, JAB = 10.8 Hz), 4.12 (1H, ABd, JAB = 10.8 Hz), 4.05 (2H, m), 3.93 (1H, m), 3.92 
(3H, s), 3.87 (3H, s), 3.84 (3H, s), 3.80 (2H, t J = 7.0 Hz), 3.77 (1H, m), 3.65 (2H, t = 
J = 7.1 Hz), 3.60 (1H, m), 3.47 (7H, m); 3.23 (2H, dt, J = 7.0, 6.0 Hz), 2.90 (2H, t, J = 
7.0 Hz), 2.88 (2H, t, J = 7.2 Hz), 2.83 (2H, t, J = 7.0 Hz), 2.51 (2H, m), 2.36 (4H, m), 
2.16 (2H, m), 1.80 (1H, m), 1.69 (1H, m), 1.56 (4H, m), 1.50 (3H, d, J = 6.9 Hz), 1.44 
(2H, m), 1.33 (2H, m), 1.02 (9H, s), 0.90 (3H, t, J = 7.3 Hz) ppm. 
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13C NMR (50 MHz, CDCl3) + DEPT d 172.8 (C), 171.9 (C), 170.7 (C), 153.7 (C), 148.9 (C), 148.5 (C), 
146.8 (C), 140.3 (C), 138.3 (C), 138.2 (C), 136.4 (C), 136.3 (C), 135.5 (CH), 134.3 (C), 
133.7 (C), 130.9 (C), 129.5 (CH), 129.1 (CH), 128.6 (CH), 127.6 (CH), 127.4 (CH), 127.3 
(CH), 120.1 (CH), 111.0 (CH), 110.9 (CH), 110.0 (CH), 109.9 (CH), 98.7 (CH), 73.1 (CH2), 
72.8 (CH2), 70.9 (CH2), 69.0 (CH2), 68.4 (CH2), 68.2 (CH2), 65.1 (CH2), 64,1 (CH2), 62.2 
(CH2), 56.3 (CH3), 55.9 (CH3), 55.8 (CH3), 47.2 (CH), 44.6 (C), 39.3 (CH2), 38.9 (CH2), 
36.0 (CH2), 32.8 (CH2), 31.7 (CH2), 30.9 (CH2), 30.7 (CH2), 29.7 (CH2), 29.2 (CH2), 26.8 
(CH3), 25.4 (CH2), 24.9 (CH2), 21.4 (CH3), 20.0 (CH2), 19.5 (CH2), 19.1 (CH2), 13.7 (CH3) 
ppm. 
ES-MS: m/z 1462 [M + NH4]+ 
 
Deprotection of the DMPM protecting group in compound IV.31: synthesis of IV.35 
 
IV.31
DDQ, 0 °C
CH2Cl2 / H2O
19        /   1
H
N
O
NHn-Bu
NO2
OMe
3
O
IV.35
O spacer
OTHP OTBDPSOH
60%
 
 
To a cooled (0 °C) solution of compound IV.31 (44.8 mg, 0.031 mmol) in 0.65 ml of a mixture of 
dichloromethane / water (19 / 1) was added dichlorodicyanoquinone (14 mg, 0.062 mmol). The 
solution was stirred at 0 °C for 30 min and the mixture was filtered over celite (wash with 
dichloromethane). The organic phase was washed with a saturated aqueous solution of sodium 
bicarbonate, dried over anhydrous magnesium sulfate, filtered and evaporated under reduced 
pressure. The residue was purified by column chromatography (ethyl acetate / isooctane: 8 / 2) 
to give 24 mg of IV.35 as sole product (60%). 
 
Bruto formula: C74H97N3O15Si 
M.W.: 1296.7 g/mol  
Rf (ethyl acetate / isooctane: 8 / 2) = 0.25 
IR (film) 3313 (w), 2930 (s), 2862 (s), 1735 (m), 1647 (s), 1519 (s), 1426 (w), 1364 (w), 1271 (s), 
1215 (m), 1174 (m), 1091 (s), 1026 (s), 812 (m), 704 (m) cm-1. 
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1H NMR (500 MHz, CDCl3) d 7.59 (4H, dd, J = 7.0, 1.2 Hz), 7.53 (1H, s), 7.37 (6H, m), 7.13 (12 H, 
m), 6.92 (1H, s), 6.42 (1H, d, J = 7.0 Hz), 5.63 (1H, m), 5.52 (1H, dq, J = 7.0, 6.9 Hz), 
4.59 (1H, m), 4.41 (6H, m), 4.19 (1H, ABd, JAB = 10.8 Hz), 4.11 (1H, ABd, JAB = 10.8 Hz), 
4.05 (2H, m), 3.93 (1H, m), 3.91 (3H, s), 3.82 (4H, t J = 7.0 Hz), 3.76 (1H, m), 3.59 
(1H, m), 3.46 (7H, m), 3.23 (2H, dt, J = 7.0, 6.0 Hz), 2.89 (2H, t, J = 7.0 Hz), 2.83 
(2H, t, J = 6.3 Hz), 2.82 (2H, t, J = 6.3 Hz), 2.53 (1H, m), 2.43 (1H, m), 2.35 (4H, m), 
2.15 (2H, m), 1.80 (1H, m), 1.69 (1H, m), 1.60 (1H, s), 1.56 (4H, m), 1.51 (3H, d, J = 6.9 
Hz), 1.44 (2H, m), 1.31 (2H, m), 1.02 (9H, s), 0.90 (3H, t, J = 7.3 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 172.9 (C), 172.1 (C), 170.9 (C), 153.7 (C), 146.7 (C), 140.2 (C), 
138.3 (C), 138.2 (C), 136.5 (C), 136.3 (C), 135.5 (CH) 133.7 (C), 129.5 (CH), 129.1 (CH), 
128.6 (CH), 127.6 (CH), 127.4 (CH), 127.3 (CH), 109.8 (CH), 109.7 (CH), 98.7 (CH), 73.2 
(CH2), 72.9 (CH2), 68.9 (CH2), 68.4 (CH2), 68.2 (CH2), 65.1 (CH2), 63.4 (CH2), 62.2 
(CH2), 56.3 (CH3), 47.2 (CH), 44.6 (C), 39.3 (CH2), 38.9 (CH2), 36.0 (CH2), 32.8 (CH2), 
31.7 (CH2), 30.8 (CH2), 30.7 (CH2), 29.7 (CH2), 29.2 (CH2), 26.8 (CH3), 25.4 (CH2), 24.9 
(CH2), 21.4 (CH3), 20.0 (CH2), 19.5 (CH2), 19.1 (CH2), 13.7 (CH3) ppm. 
ES-MS: m/z 1318 [M + Na]+ 
 
Deprotection of the TBDPS protecting group in compound IV.31: synthesis of IV.36 
 
IV.31
TBAF, AcOH
THF
91%
H
N
O
NHn-Bu
NO2
OMe
3
O
IV.36
O spacer
OTHP OHODMPM
 
 
To a solution of IV.31 (25 mg, 0.017 mmol) in dry tetrahydrofuran (0.2 ml) were added acetic 
acid (1 drop) and tetrabutylammonium fluoride (1 M in tetrahydrofuran) (52 ml, 0.052 mmol). The 
mixture was stirred overnight at room temperature. After extraction with water, the combined 
organic phase was dried over anhydrous magnesium sulfate, filtered and evaporated under 
reduced pressure. The residue was purified by column chromatography (ethyl acetate / 
isooctane: 8 / 2) to afford 18.5 mg of alcohol IV.36 (90%). 
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Bruto formula: C67H89N3O17 
M.W.: 1208.4 g/mol  
Rf (ethyl acetate / isooctane: 8 / 2) = 0.15 
IR (film) 3325 (w), 2926 (s), 2866 (s), 1733 (m), 1650 (s), 1517 (s), 1452 (w), 1364 (w), 1268 (s), 
1215 (w), 1158 (m), 1090 (s), 1029 (s), 802 (m), 604 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.53 (1H, s), 7.17 (12 H, m), 6.92 (1H, s), 6.83 (3H, m), 6.43 (1H, d, J 
= 7.0 Hz), 5.63 (1H, m), 5.52 (1H, dq, J = 7.0, 6.9 Hz), 4.59 (1H, m), 4.46 (2H, m), 4.43 
(2H, s), 4.40 (2H, s), 4.38 (4H, m), 4.19 (1H, ABd, JAB = 10.8 Hz), 4.11 (1H, ABd, JAB = 
10.8 Hz), 4.04 (2H, m), 3.93 (1H, m), 3.91 (3H, s), 3.87 (3H, s), 3.84 (3H, s), 3.83 (2H, 
t J = 7.0 Hz), 3.77 (1H, m), 3.66 (1H, dt, J = 7.0, 2.5 Hz), 3.60 (1H, m), 3.46 (6H, m); 
3.23 (2H, dt, J = 7.0, 6.0 Hz), 2.90 (4H, m), 2.83 (2H, m), 2.53 (1H, m), 2.44 (1H, m), 
2.35 (4H, m), 2.15 (2H, m), 1.80 (1H, m), 1.69 (1H, m), 1.60 (1H, s), 1.57 (4H, m), 1.51 
(3H, d, J = 6.9 Hz), 1.46 (2H, m), 1.32 (2H, m),  0.90 (3H, t, J = 7.3 Hz) ppm. 
13C NMR (50 MHz, CDCl3) d 172.9, 172.0, 170.8, 155.3, 148.8, 148.4, 146.7, 140.2, 138.2, 137.9, 
136.5, 136.3, 134.3, 130.8, 128.9, 127.6, 127.4, 120.1, 110.8, 110.7, 109.8, 98.7, 72.9, 
72.8, 70.9, 68.7, 68.3, 63.4, 62.3, 56.3, 55.8, 55.7, 44.4, 39.3, 38.7, 35.9, 32.8, 21.6, 
30.8, 29.7, 25.4, 24.9, 20.0, 19.5, 13.7 ppm. 
ES-MS: m/z 1230 [M + Na]+ 
 
Synthesis of acetate IV.37 
 
Selective deprotection of the DMPM protective group:  
 
DDQ, 0 °C, 1 h
CH2Cl2 / H2OOTHP OTBDPS
O spacer
IV.24
ODMPM
hv2
OTHP OTBDPS
O spacer
OH
hv2
 
 
To a cooled suspension (0 °C) of resin IV.24 (100 mg, 0.0163 mmol, 0.163 mmol/g) in a mixture of 
dichloromethane / water (1.4 ml / 0.1 ml) was added dichlorodicyanoquinone (7.2 mg, 0.0315 
mmol). The mixture was shaken for 1 h at 0 °C. After filtration, the resin was washed with an 
aqueous saturated solution of sodium bicarbonate (3 x 5 ml), phenol / methanol: 1 / 1 (3 x 5 ml), 
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toluene (3 x 5 ml), acetonitrile (3 x 5 ml), dimethylformamide (3 x 5 ml), methanol (3 x 5 ml), 
dichloromethane (3 x 5 ml). The resin was then dried for 4 h at the oil pump. 
 
13C NMR (50 MHz, CD2Cl2) d 174.2, 173.3, 172.2, 155.5, 148.5, 141.9, 140.1, 138.0, 137.1, 136.6, 
135.3, 131.2, 130.8, 130.7, 130.4, 129.2, 129.1, 110.9, 100.2, 75.2, 74.7, 73.2 
(polyethylene glycol peak), 66.8, 64.8, 63.5, 57.8, 46.1, 40.8, 40.5, 37.5, 33.9, 32.3, 
32.1, 28.2, 27.1, 26.2, 23.1, 21.1, 20.6 ppm. 
 
Capping of the hydroxyl function as the acetate:  
 
Ac2O, DMAP, DIPEA
CH2Cl2
OTHP OTBDPS
O spacer
OH
hv2
OTHP OTBDPS
O spacer
OAc
hv2
 
 
A solution of acetic anhydride (16 ml, 0.174 mmol), diisopropylethylamine (31 ml, 0.174 mmol) and 
4-dimethylaminopyridine (21.3 mg, 0.174 mmol) in dichloromethane (2 ml) was added to the 
DMPM deprotected resin. The suspension was shaken for (2 x 20 min). The solid phase was 
washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 x 5 ml) 
and dried for 4 h under vacuum. 
 
Cleavage from the resin: Synthesis of acetate IV.37 
 
hv (365 nm)
1,4-dioxane / DMSOOTHP OTBDPS
O spacer
OAc
hv2
OTHP OTBDPS
O spacer
OAc
CONH2
62% IV.37
 
 
A sample of the DMPM deprotected resin (48 mg, 0.008 mmol, 0.166 mmol/g) in suspension in 1 
ml of 1,4-dioxane and 10 ml of dimethylsulfoxide was exposed to UV light (365 nm) for 3 times 1 
h and 3 times 2 h. After each cleavage, the resin was filtered and washed with 1,4-dioxane. 
After evaporation of 1,4-dioxane and removal of the dimethylsulfoxide with the Kugelrhor, the 
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sample was purified by column chromatography (ethyl acetate / isooctane: 8 / 2) to provide 5.1 
mg of acetate IV.37 (62%). 
 
Bruto formula : C59H75O11NSi 
M.W.: 1002.2 g/mol 
Rf (ethyl acetate) = 0.55  
IR (film) 2939 (m), 2857 (m), 1737 (s), 1676 (m), 1514 (w), 1427 (w), 1362 (w), 1239 (w), 1089 (s), 
1031 (m), 703 (m) cm-1.  
1H NMR (500 MHz, CD3OD) d 7.52 (dd, 4H, J = 8.0, 1.4 Hz), 7.35 (6H, m), 7.17 (10H, m), 7.10 
(2H, d, J = 8.0 Hz), 4.55 (1H, m), 4.42 (2H, s), 4.39 (4H, s), 4.21 (2H, t, J = 6.9 Hz), 
4.14 (2H, s), 3.86 (1H, dt, J = 9.6, 7.0 Hz), 3.81 (2H, t, J = 6.5 Hz), 3.66 (1H, m), 3.57 
(1H, dt, J = 9.6, 7.0 Hz), 3.46 (2H, s), 3.45 (2H, s), 3.44 (2H, s), 3.39 (1H, m), 2.87 
(2H, t, J = 7.0 Hz), 2.83 (2H, t, J = 7.0 Hz), 2.81 (2H, t, J = 6.6 Hz), 2.47 (2H, m), 
2.41 (2H, m), 1.97 (3H, s), 1.76 (1H, m), 1.63 (1H, m), 1.54-1.47 (4H, m), 0.96 (9H, s) 
ppm. 
ES-MS m/z 1025 [M + Na]+ 
 
Synthesis of acetate IV.38 
 
Selective deprotection of the TBDPS protective group:  
 
TBAF, AcOH
THFOTHP OTBDPS
O spacer
IV.24
ODMPM
hv2
OTHP OH
O spacer
ODMPM
hv2
 
 
First method: TBAF in presence of acetic acid 
Acetic acid (5 ml, 0.087 mmol), tetrabutylammonium fluoride (87 ml, 0.087 mmol) and molecular 
sieves (400 pm) were added to a suspension of resin IV.24 (100 mg, 0.0163 mmol, 0.163 mmol/g) 
in dry tetrahydrofuran (2 ml). The mixture was shaken overnight at room temperature. The 
reaction was repeated overnight. After filtration, the resin was washed with ethanol (3 x 5 ml), 
dichloromethane (3 x 5 ml), dimethylformamide (3 x 5 ml), methanol (3 x 5 ml), dichloromethane 
(3 x 5 ml) and was dried for 4 h under vacuum. 
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13C NMR (50 MHz, CD2Cl2) d 174.5, 173.2, 172.1, 155.3, 148.3, 141.7, 140.0, 139.9, 137.9, 136.3, 
132.6, 130.2, 128.9, 121.4, 112.5, 110.7, 100.0, 73.2 (polyethylene glycol peak), 65.1, 
63.4, 57.7, 57.0, 47.6, 47.3, 45.9, 40.4, 37.4, 33.7, 32.1, 26.4, 22.9, 20.9 ppm. 
 
Second method: Ammonium fluoride 
To a suspension of resin IV.24 (0.100 g, 0.0163 mmol, 0.163 mmol/g) in dry methanol (1 ml) was 
added ammonium fluoride (14.5 mg, 0.392 mmol). The mixture was shaken overnight. The reaction 
was repeated again overnight and two times 4 h to get complete deprotection. After filtration, 
the resin was washed with methanol (3 x 5 ml), dimethylformamide (3 x 5 ml), methanol (3 x 5 
ml), dichloromethane (3 x 5 ml). A sample of the resin (2 mg, 0.34 mmol, 0.170 mmol/g) was 
suspended in 100 ml acetonitrile and was irradiated with UV light (365 nm) for 3 h. The solution 
was analysed by ES-MS. 
M.W.: 871 g/mol  
ES-MS: m/z 894 [M + Na]+ 
 
Third method: 70% hydrogen fluoride/pyridine 
To a suspension of resin IV.24 (12.0 mg, 1.93 mmol, 0.163 mmol/g) in dry tetrahydrofuran (100 
ml) was added a solution of 70% hydrogen fluoride/pyridine (5 ml, 33.6 mmol). The suspension was 
shaken overnight at room temperature. After filtration, the resin was washed with 
dimethylformamide (3 x 5 ml), methanol (3 x 5 ml), dichloromethane (3 x 5 ml). A sample of the 
resin (2 mg, 0.34 mmol, 0.170 mmol/g) was suspended in 100 ml acetonitrile and was irradiated 
with UV light (365 nm) for 3 h. The solution was analysed by ES-MS. 
ES-MS: m/z 894 [M + Na]+ 
 
Fourth method: TASF (tris-(dimethylamino)sulfur trimethylsilyldifluoride) 
To a suspension of resin (10.0 mg, 1.31 mmol, 0.131 mmol/g) in dry tetrahydrofuran (100 ml) was 
added 0.0975 M TASF in dimethylformamide (86.1 ml, 8.4 mmol). The suspension was shaken 
overnight at room temperature. After filtration, the resin was washed with dimethylformamide 
(3 x 5 ml), methanol (3 x 5 ml), dichloromethane (3 x 5 ml). A sample of the resin (2 mg, 0.4 mmol, 
0.170 mmol/g) was suspended in 100 ml acetonitrile and was irradiated with UV light (365 nm) for 
3 h. The solution was analyzed by ES-MS. 
ES-MS: m/z 894 [M + Na]+ 
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Capping of the hydroxyl function as the acetate:  
 
Ac2O, DMAP, DIPEA
CH2Cl2OTHP OH
O spacer
ODMPM
hv2
OTHP OAc
O spacer
ODMPM
hv2
 
 
A solution of acetic anhydride (16 ml, 0.174 mmol), diisopropylethylamine (31 ml, 0.174 mmol) and 
4-dimethylaminopyridine (21.3 mg, 0.174 mmol) in dichloromethane (2 ml) was added to the 
TBDPS deprotected resin (0.100 g, 0.0170 mmol, 0.170 mmol/g). The suspension was shaken for 
20 min (2 times). The solid phase was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 
ml) and dichloromethane (3 x 5 ml) and dried for 4 h under vacuum. 
 
Cleavage from the resin: synthesis of acetate IV.38 
 
hv (365 nm)
1,4-dioxane / DMSOOTHP OAc
O spacer
ODMPM
hv2
OTHP OAc
O spacer
ODMPM
CONH2
IV.38
 
 
A sample of TBDPS deprotected resin (75 mg, 0.013 mmol, 0.170 mmol/g) in suspension in 1.5 ml 
of 1,4-dioxane with 15 ml of dimethylsulfoxide was exposed to UV light (365 nm) for 3 times 2 h 
and 2 times 1 h. After each cleavage, the resin was filtered and washed with 1,4-dioxane. After 
evaporation of 1,4-dioxane and removal of the dimethylsulfoxide with the Kugelrhor, the sample 
was purified by column chromatography (ethyl acetate / isooctane: 8 / 2) to provide 6.5 mg of 
acetate IV.38 (56%).  
 
Bruto formula : C52H67O13N 
M.W.: 914.0 g/mol 
Rf  (ethyl acetate) = 0.55  
IR (film) 2924 (s), 2855 (s), 1737 (s), 1682 (m), 1515 (m), 1463 (w), 1419 (w), 1363 (w), 1264 (s), 
1239 (m), 1158 (w), 1092 (s), 1030 (s), 737 (s) cm-1. 
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1H NMR (500 MHz, CD3OD) d 7.17 (12H, m), 6.83 (3H, m), 4.55 (1H, m), 4.42 (2H, s), 4.40 (6H, s), 
4.21 (2H, t, J = 7.1 Hz), 4.13 (2H, s), 3.86 (1H, dt, J = 9.6, 7.0 Hz), 3.79 (3H, s), 3.72 
(3H, s), 3.66 (2H, t, J = 6.8 Hz), 3.66 (1H, m), 3.57 (1H, dt, J = 9.6, 7.0 Hz), 3.45 (6H, 
m), 3.39 (1H, m), 2.88 (2H, t, J = 7.0 Hz), 2.86 (2H, t, J = 4.6 Hz), 2.83 (2H, t, J = 6.8 
Hz), 2.49 (2H, m), 2.38 (2H, m), 1.97 (3H, s), 1.75 (1H, m), 1.64 (1H, m), 1.52-1.48 (4H, 
m) ppm. 
ES-MS: m/z 931 [M + NH4]+ 
 
7.5 Experimental part of part 5 
 
Deprotection of the side-chain of the amino acids Ser(OTrt) and His(NMtt) 
 
OGlySer(OTrt)NHAc
V.2
OGlyHis(NMtt)NHAc
V.3
ClCH2COOH / CH2Cl2 / H2O
3 x 2 h + overnight
OGlySer(OH)NHAc
V.4
OGlyHis(NH)NHAc
V.5
80        /     15     /    5
 
 
The resin V.2 and V.3 (100 mg, 0.11 mmol, 1.1 mmol/g) were treated with 2 ml of a solution of 
chloroacetic acid / dichloromethane / water (80 / 15 / 5) overnight. After filtration, the 
procedure was repeated three times 2 h to obtain the complete deprotection of the side-chain 
of serine and histidine. The deprotection was monitored by thin layer chromatography in 
chloroform / acetic acid (98 / 2). The presence of trityl and methyltrityl can be easily detected 
on thin layer chromatography due to their characteristic yellow colour. 
 
Cleavage of the dipeptide V.4 and V.5 from the resin 
 
OGlySer(OH)NHAc
V.4
OGlyHis(NH)NHAc
V.5
TFA / H2O / TIPS
15 min.
HOGlySer(OH)NHAc
V.6
HOGlyHis(NH)NHAc
V.7
95  /  2.5  /   2.5
 
 
Resins V.4 and V.5 (100 mg, 0.11 mmol, 1.1 mmol/g) were treated with 2 ml of a solution of 
trifluoroacetic acid / water / triisopropylsilane (95 / 2.5 / 2.5) for 15 min. The resin was washed 
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with dichloromethane.  The solution was evaporated under reduced pressure and dried under 
vacuum for 2 h. Analysis by 1H NMR (500 MHz) spectroscopy concluded to a complete 
deprotection of the side-chain of the amino acids serine and histidine. 
 
 Spectral data of V.6 
 
Rf (methanol / dichloromethane: 1 / 9) = 0.12 
1H NMR (500 MHz, CD3OD) d 4.49 (1H, t, J = 5.2 Hz), 3.95 (2H, s), 3.81 (2H, d, 5.2 Hz), 2.05 
(3H, s) ppm. 
Remark: No ES-MS has been recorded due to difficult protonation of V.6. The complete 
deprotection was only proved by 1H NMR (500 MHz). 
 
 Spectral data of V.7 
 
Rf (methanol / dichloromethane: 1 / 9) = 0.10 
1H NMR (500 MHz, CD3OD) d 8.80 (1H, s), 7.39 (1H, s), 4.79 (1H, t, J = 6.6 Hz), 4.00 (1H, ABd, 
JAB = 17.7 Hz), 3.90 (1H, ABd, JAB = 17.8 Hz), 3.29 (1H, m), 3.12 (1H, m), 1.99 (3H, s) 
ppm. 
ES-MS: m/z 277 [M + Na]+  
 
Synthesis of N-(9-fluorenylmethoxycarbonyl)-L-aspartic benzyl ester V.9 
 
H2N
O
OBn
COOH
L-aspartic acid
a-benzyl ester
FmocOSu, NaHCO3
1,4-dioxane / H2O
FmocHN
O
OBn
COOH
V.9
100%
 
 
A mixture of the commercially available L-aspartic acid a-benzyl ester (0.2 g, 0.89 mmol), N-(9-
fluorenylmethoxycarbonyloxy)succinimide (0.31 g, 0.91 mmol) and sodium bicarbonate (0.226 g, 
2.69 mmol) in a mixture of 1,4-dioxane (6.5 ml) / water (6.5 ml) was stirred overnight at room 
temperature. The mixture was cooled to 0 °C, acidified to pH = 3 with a solution of 1 N 
hydrochloric acid and was diluted to 25 ml with water. The mixture was extracted with ethyl 
acetate. The organic phase was dried over anhydrous magnesium sulfate, filtered and evaporated 
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under reduced pressure. The residue was purified by recrystallization from a mixture 
pentane/dichloromethane (9/1) to provide 0.4 g of Fmoc-protected amino acid V.9 (100%). 
 
Bruto formula: C26H23NO6 
M.W.: 445.4 g/mol 
m.p.: 87 °C 
Rf (dichloromethane / methanol / acetic acid: 9 / 0.8 / 0.2) = 0.64 
IR (film) 3415 (s), 2953 (m), 1715 (s), 1652 (m), 1511 (m), 1409 (m), 1339 (m), 1205 (m), 1041 (w), 
751.1 (m), 689 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.76 (2H, d, J = 7.6 Hz), 7.58 (2H, d, J = 7.1 Hz), 7.40 (2H, dd, J = 
7.4 Hz), 7.32 (5H, m), 7.31 (2H, m), 5.81 (1H, d, J = 8.3 Hz), 5.20 (1H, ABd, JAB = 12.6 
Hz), 5.19 (1H, ABd, JAB = 12.6 Hz), 4.71 (1H, dt, J = 8.3, 4.4 Hz), 4.42 (1H, ABdd, JAB = 
10.1, 7.2 Hz), 4.36 (1H, ABdd, JAB = 10.1, 7.2 Hz), 4.22 (1H, t, J = 7.1 Hz), 3.13 (1H, 
ABdd, JAB = 17.6, 4.6 Hz), 2.95 (1H, ABdd, JAB = 17.6, 4.6 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 175.9 (C), 170.4 (C), 156.1 (C), 143.7 (C), 143.5 (C), 141.2 (C), 
134.9 (C), 128.5 (CH), 128.1 (CH), 127.7 (CH), 127.0 (CH), 125.0 (CH), 119.9 (CH), 67.7 
(CH2), 67.35 (CH2), 50.2 (CH), 46.9 (CH), 36.3 (CH2) ppm. 
ES-MS: m/z 468 [M + Na]+ 
 
Synthesis of diester V.10 
 
FmocHN
O
OBn
COOH
V.9
FmocHN
O
OBn
V.10
O
O
HO(CH2)2SiMe3
DCC, DMAP
SiMe3
70%
 
 
To a cooled (0 °C) solution of carboxylic acid V.9 (2 g, 4.50 mmol), 2-trimethylsilylethanol (0.645 
ml, 4.50 mmol) and 4-dimethylaminopyridine (275 mg, 2.25 mmol) was added 1,3-
dicyclohexylcarbodiimide (0.93 g, 4.50 mmol). The mixture was stirred at 0 °C for 2 h and the 
solution was fitrated over celite. The organic phase was washed with an aqueous solution of 1 N 
hydrochloric acid and with water and was dried over anhydrous magnesium sulfate. After 
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filtration and evaporation under reduced pressure, the residue was purified by column 
chromatography (ethyl acetate / isooctane: 1 / 9) to provide 1.7 g of diester V.10 (70%). 
 
Bruto formula: C31H35NO6Si 
M.W.: 545.7 g/mol 
m.p.: 82 °C 
Rf (ethyl acetate / isooctane: 1 / 1) = 0.61 
IR (film) 2954 (w), 1728 (s), 1517 (m), 1450 (m), 1414 (w), 1354 (w), 1250 (m), 1177 (w), 1057 (m), 
936 (w), 859 (s), 838 (s), 759 (s), 740 (s) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.77 (2H, d, J = 7.5 Hz), 7.60 (2H, d, J = 7.5 Hz), 7.40 (2H, dd, J = 
7.5 Hz), 7.32 (5H, m), 7.31 (2H, m), 5.87 (1H, d, J = 8.6 Hz), 5.28 (1H, ABd, JAB = 12.2 
Hz), 5.16 (1H, ABd, JAB = 12.2 Hz), 4.70 (1H, dt, J = 8.6, 4.4 Hz), 4.43 (1H, ABdd, JAB = 
10.5, 7.3 Hz), 4.36 (1H, ABdd, JAB = 10.5, 7.3 Hz), 4.22 (1H, dd, J = 7.2 Hz), 4.15 (2H, 
m), 3.06 (1H, ABdd, JAB = 17.2, 4.4 Hz), 2.86 (1H, ABdd, JAB = 17.2, 4.4 Hz), 0.95 (2H, 
m), 0.04 (9H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 170.9 (C), 170.6 (C), 155.9 (C), 143.6 (C), 143.5 (C), 141.2 (C), 
135.1 (C), 128.5 (CH), 128.1 (CH), 127.6 (CH), 127.0 (CH), 125.0 (CH), 119.9 (CH), 67.7 
(CH2), 67.2 (CH2), 63.3 (CH2), 50.4 (CH), 46.9 (CH), 36.6 (CH2), 17.1 (CH2), -1.6 (CH3) 
ppm. 
ES-MS: m/z 563 [M + Na]+ 
 
Synthesis of N-(9-fluorenylmethoxycarbonyl)-trimethylsilylester L-aspartic V.8 
 
FmocHN
O
OBn
V.10
O
O
H2, Pd/C
EtOAc
FmocHN
O
OH
V.8
O
O
SiMe3 SiMe3
98%
 
 
To ester V.10 (2.05 g, 3.760 mmol) in distilled ethyl acetate (30 ml) was added 10% palladium on 
activated carbon (0.4 g, 0.376 mmol). The mixture was stirred overnight at room temperature 
and was filtered over celite. The organic phase was evaporated under reduced pressure. The 
residue was purified by recrystallization from dichloromethane / pentane (1 / 9) affording 1.65 g 
of protected amino acid V.8 (98%). 
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Bruto formula: C24H29NO6Si 
M.W.: 455.6 g/mol 
m.p.: 82 °C 
Rf (dichloromethane / methanol / acetic acid: 9 / 0.8 / 0.2) = 0.64 
IR (film) 3352 (m), 2951 (m), 1729 (s), 1501 (w), 1447 (m), 1381 (w), 1337 (w), 1243 (m), 1210 (w), 
1040 (m), 853 (m), 737 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.76 (2H, d, J = 7.5 Hz), 7.60 (2H, dd, J = 7.3, 3.3 Hz), 7.40 (2H, 
dd, J = 7.4 Hz), 7.31 (2H, dd, J = 7.4 Hz), 5.87 (1H, d, J = 8.5 Hz), 4.69 (1H, ddd, J = 
4.5 Hz), 4.45 (1H, ABdd, JAB = 10.5, 7.3 Hz), 4.37 (1H, ABdd, JAB = 10.5, 7.3 Hz), 4.22 
(3H, m), 3.08 (1H, ABdd, JAB = 17.5, 4.4 Hz), 2.87 (1H, ABdd, JAB = 17.5, 4.4 Hz), 1.01 
(2H, m), 0.04 (9H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 175.9 (C), 171.3 (C), 156.1, (C), 143.7 (C), 143.5 (C), 141.2 (C), 
127.7 (CH), 127.0 (CH), 125.1 (CH), 119.9 (CH), 67.4 (CH2), 63.7 (CH2), 50.2 (CH), 47.0 
(CH), 36.5 (CH2), 17.2 (CH2), -1.6 (CH3) ppm. 
ES-MS: m/z 478 [M + Na]+ 
 
Synthesis of a 81-members dipodal library with the IRORI radio-frequency tags 
encoding system 
 
O
O
O
O
O OTBDPS
spacer hn2
AA1,2,3
AA1,2,3
AA1,2,3
NH
Ac
AA4,5,6
AA4,5,6
AA4,5,6
NH
Ac
O
V.11
Amino acids:
First strand: AA1,2,3 = FmocSer(OTrt)OH
Second strand: AA4,5,6 = FmocHis(NMtt)OH
FmocPheOH
FmocValOH
FmocAlaOH
FmocLeuOH
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? Definition of building blocks: The building blocks (all different amino acids) were defined in 
the software ‘ACCUTAG SYNTHESIS MANAGER’.  
? Plan step: The number of steps was introduced (5 in our case) with explanation of each coupling 
step and a possible comment.  
Step 1: coupling Val, Phe, Ser(OTrt) 
Step 2: coupling Val, Phe, Ser(OTrt) 
Step 3: coupling Glycine 
Step 4: coupling His(NMtt), Leu, Ala 
Step 5: coupling His(NMtt), Leu, Ala 
 
? Perform synthesis: 
Solid-phase bound scaffold IV.26 (0.45 g, 0.086 mmol, 0.19 mmol/g) was prepared according to 
the previously described procedures and was divided into 81-microkans (number of microkans = 
number of compounds in the library). In each microkan was introduced 5.5 mg of resin and a 
radio frequency tag, which encodes for one compound of the library. In the sorting step, each 
kan was placed on the reading station, the tag was read and the compound was sorted into the 
proper reactor location. 
At this stage all microkans were divided in three vessels in which three different amino acids 
(step 1) were coupled: Val (vessel 1), Phe (vessel 2) and Ser (vessel 3). Each vessel after sorting 
contained 27 microkans. 
 
Gly
NH2
O OTBDPS
O spacer
ODMPM
hv2
 
 
1-Synthesis of the first strand 
 
General procedure for the coupling reactions 
To each vessel containing 27 microkans (148.5 mg, 0.030 mmol, 0.20 mmol/g) in 
dimethylformamide (25 ml) were added 3% N-methylmorpholine (0.75 ml), 1H-benzotriazol-1-
yloxy-tris(pyrrolidino)phosphoniumhexafluorophosphate (PyBOP) (58 mg, 0.111 mmol) and 
FmocValOH (38 mg, 0.111 mmol) or FmocPheOH (43.2 mg, 0.111 mmol) or FmocSer(OTrt)OH (64 
mg, 0.111 mmol). The suspension was stirred for 4-5 h. After filtration, the resin was washed for 
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15 min with dimethylformamide (4 x 20 ml).  To control the completeness of the coupling, one 
microkan of each vessel was opened and few beads were submitted to NF31 and TNBS tests. 
White beads were observed proving a complete coupling. 
 
General procedure for Fmoc deprotection 
The resin in each vessel was treated with a solution of 20% piperidine in dimethylformamide (2 x 
20 min). After filtration, the resin was washed for 15 min with dimethylformamide (4 x 20 ml). 
One microkan of each vessel was opened and few beads were submitted to NF31 and TNBS 
tests and red and orange beads were observed respectively.  
 
Sorting 
Each kan was placed on the reading station and was sorted for the next coupling. Each radio-
frequency tag was read and each kan was placed in the desired vessel.  
 
Coupling of Val, Phe, Ser 
The coupling was performed as described previously. 
 
Deprotection 
The Fmoc protecting group was removed as previously. One microkan of each vessel was opened 
and a few beads were submitted to NF31 and TNBS tests. Red and orange beads were observed 
respectively.  
 
Capping of the free terminal amino function 
To each vessel containing 27 microkans (148.5 mg, 0.030 mmol, 0.20 mmol/g) in dichloromethane 
(30 ml) was added acetylimidazole (328 mg, 2.98 mmol). The mixture was stirred overnight. 
After filtration, the resin was washed with dichloromethane (1 x 25 ml) and dimethylformamide 
(2 x 30 ml) for 15 min. The first strand was synthesised (figure 7.1). One microkan of each 
vessel was opened and a few beads were submitted to NF31 and TNBS tests. White beads were 
observed. 
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Gly
AA1,2,3
AA1,2,3
NH
Ac
O OTBDPS
O spacer
ODMPM
hv2
 
 
2-Synthesis of the second strand 
 
The three following steps are identical for all members of the library and were performed in one 
vessel. 
 
Deprotection of DMPM-protecting group 
To a vessel containing 81 microkans (445.5 mg, 0.089 mmol, 0.19 mmol/g) in a 19/1 ratio of 
dichloromethane (95 ml) / water (5 ml) was added at 0 °C dichlorodicyanoquinone (318 mg, 1.400 
mmol). The mixture was stirred for 2 h at 0 °C. After filtration, the resin was washed for 15 min 
with a solution of phenol/methanol (1/1), a saturated aqueous solution of sodium bicarbonate, 
acetonitrile, toluene, dimethylformamide, methanol and dichloromethane. 
 
Coupling of FmocGlyCl 
To a vessel containing 81 microkans (445.5 mg, 0.085 mmol, 0.19 mmol/g) in dichloromethane (90 
ml) were added FmocGlyCl (1.5 g, 4.73 mmol) and diisopropylethylamine (824 µl, 4.73 mmol). The 
mixture was stirred at room temperature overnight. The procedure was repeated three times 6 
h. After filtration, the resin was washed for 15 min with dichloromethane (1 x 25 ml) and 
dimethylformamide (2 x 30 ml). 
 
Deprotection 
The Fmoc protecting group was removed as previously. One microkan of each vessel was opened 
and a few beads were submitted to NF31 and TNBS tests. Red and orange beads were observed 
respectively.  
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Gly
AA1,2,3
AA1,2,3
NH
Ac
O OTBDPS
O spacer
O
hv2
Gly
NH2
 
 
Sorting 
At this stage, each kan was placed on the reading station and was sorted for the next coupling. 
Each radio-frequency tag was read and each kan was placed in the desired vessel.  
 
Coupling of His, Leu, Ala 
To a vessel containing 27 microkans (148.5 mg, 0.028 mmol, 0.19 mmol/g) in dimethylformamide 
(25 ml) were coupled FmocHis(NMtt)OH (70.4 mg, 0.111 mmol), FmocLeuOH (39.2 mg, 0.111 mmol) 
and FmocAlaOH (34.6 mg, 0.111 mmol) in vessel 1, vessel 2 and vessel 3 respectively. One 
microkan of each vessel was opened and a few beads were submitted to NF31 and TNBS tests. 
White beads were observed. 
 
Deprotection 
The Fmoc protecting group was removed. One microkan of each vessel was opened and a few 
beads were submitted to NF31 and TNBS tests. Red and orange beads were observed 
respectively.  
 
Sorting 
Each kan was placed on the reading station and was sorted for the next coupling. Each radio-
frequency tag was read and each kan was located in the desired vessel.  
 
Coupling of His, Leu, Ala 
The next amino acid was coupled as previously. One microkan of each vessel was opened and a 
few beads were submitted to NF31 and TNBS tests. White beads were observed proving a 
complete coupling.  
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Deprotection 
The Fmoc protecting group was removed. One microkan of each vessel was opened and a few 
beads were submitted to NF31 and TNBS tests. Red and orange beads were observed 
respectively. 
 
Capping of the free terminal amino function 
The free amino function was capped as described previously with acetylimidazole to obtain resin 
V.1. One microkan of each vessel was opened and a few beads were submitted to NF31 and 
TNBS tests. White beads were observed.  
 
O
O
O
O
O OTBDPS
spacer hn2
AA1,2,3
AA1,2,3
AA1,2,3
NH
Ac
AA4,5,6
AA4,5,6
AA4,5,6
NH
Ac
O
V.11
81 members
 
 
Deprotection of trityl and methyltrityl protecting groups on serine and histidine 
A vessel containing 81 microkans (445.5 mg, 71.3 mmol, 0.16 mmol/g) was treated with 100 ml of 
a solution of chloroacetic acid (132 g, 1.4 mol) in a mixture of water (25 ml) / dichloromethane 
(75 ml) overnight at room temperature. The procedure was repeated for 4 h. After filtration, 
the resin was washed with dimethylformamide (2 x 100 ml) and with dichloromethane (2 x 100 
ml). 
 
Protection of the amino function as Fmoc in V.15a 
 
FmocHN
OH
FmocOSu
1,4-dioxane, NaHCO3
H2N
OH V.15a98%
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To a solution of 2-aminoethanol (2 g, 32.8 mmol) in 520 ml of a mixture of 1,4-dioxane / water (1 
/ 1) were added N-(9-fluorenylmethoxycarbonyloxy) succinimide (11.1 g, 33.0 mmol) and sodium 
bicarbonate (8.25 g, 98.1 mmol). The mixture was stirred overnight at room temperature. After 
cooling to 0 °C, the solution was acidified to pH = 3 with an aqueous solution of 1 N hydrochloric 
acid. After dilution to 100 ml with water, the aqueous phase was extracted with 
dichloromethane. The combined organic phases were dried over anhydrous magnesium sulfate, 
filtered and evaporated under reduced pressure. The residue was recrystallized in a mixture 
dichloromethane/pentane (1/10), filtered and dried under vacuum providing 9.1 g of V.15a as a 
white powder (98%). 
 
Bruto formula: C17H17NO3 
M.W.: 283.3 g/mol  
m.p.: 138 °C 
Rf (ethyl acetate / isooctane: 1 / 1) = 0.15 
IR (film) 3476 (w), 3352 (m), 2940 (w), 1676 (s), 1542 (s), 1450 (m), 1272 (m), 1147 (w), 1069 
(m), 761 (m), 740 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.77 (2H, d, J = 7.5 Hz), 7.60 (2H, d, J = 7.5 Hz), 7.40 (2H, dd, J = 
7.5 Hz), 7.32 (2H, dd, J = 7.5 Hz), 5.25 (1H, s), 4.43 (2H, d, J = 6.5 Hz), 4.21 (1H, t, J 
= 6.5 Hz), 3.70 (2H, m), 3.34 (2H, m), 2.39 (1H, s) ppm. 
13C NMR (50 MHz, CDCl3 + few drops DMSO-d6) + DEPT d 156.7 (C), 143.8 (C), 141.0 (C), 127.4 
(CH), 126.8 (CH), 124.8 (CH), 119.7 (CH), 66.1 (CH2), 61.4 (CH2), 47.0 (CH2), 43.5 (CH) 
ppm. 
ES-MS: m/z 306 [M + Na]+, 588 [2M + Na]+ 
 
Formation of mesylate V.16a 
 
FmocHN
OSO2CH3
FmocHN
OH
CH3SO2Cl
NEt3, CH2Cl2
V.15a V.16a
 
 
Mesylchloride (0.82 ml, 10.6 mmol) and triethylamine (2.95 ml, 21.2 mmol) were added to a cooled 
(0 °C) solution of alcohol V.15a (2 g, 7.07 mmol) in dichloromethane (60 ml). The mixture was 
allowed to warm to room temperature and to react for one hour. After dilution in ethyl acetate, 
the mixture was extracted with brine. The organic phase was dried over anhydrous magnesium 
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sulfate, filtered and evaporated under reduced pressure. The residue was purified by column 
chromatography (ethyl acetate / isooctane: 1 / 1) to give 2.3 g of mesylate V.16a (90%). 
 
Bruto formula: C18H19NO5S 
M.W.: 361.4 g/mol  
m.p.: 104 °C 
Rf (ethyl acetate / isooctane: 1 / 1) = 0.22 
IR (film) 3476 (w), 3352 (m), 2940 (w), 1676 (s), 1542 (s), 1450 (m), 1272 (m), 1147 (w), 1069 
(m), 761 (m), 740 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.77 (2H, d, J = 7.5 Hz), 7.60 (2H, d, J = 7.5 Hz), 7.40 (2H, dd, J = 
7.5 Hz), 7.32 (2H, dd, J = 7.5 Hz), 5.25 (1H, s), 4.43 (2H, d, J = 6.5 Hz), 4.30 (2H, t, J 
= 4.8 Hz), 4.21 (1H, t, J = 6.5 Hz), 3.70 (2H, m), 3.34 (2H, m), 2.39 (1H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 156.3 (C), 143.7 (C), 141.3 (C), 127.7 (CH), 127.1 (CH), 124.9 
(CH), 119.9 (CH), 68.6 (CH2), 66.9 (CH2), 47.1 (CH), 40.4 (CH2), 37.4 (CH3) ppm. 
ES-MS: m/z 384 [M + Na]+ 
 
Synthesis of Alloc-protected amine V.15b 
 
AllocHN
OH
AllocCl
DIPEA, CH2Cl2
H2N
OH
76% V.15b
 
 
To a solution of 2-aminoethanol (2 g, 33.0 mmol) in dry dichloromethane (65 ml), were added 11.4 
ml of a saturated aqueous solution of sodium bicarbonate and diisopropylethylamine (11.6 ml, 66.4 
mmol). After addition of allylchloroformate (3.50 ml, 33.2 mmol), the solution was stirred 
overnight at room temperature. After addition of 100 ml of a saturated aqueous solution of 
sodium bicarbonate, the mixture was extracted with dichloromethane. The organic phase was 
dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The 
crude compound was purified by column chromatography (ethyl acetate / isooctane: 1 / 1) to 
afford 3.6 g of the desired alcohol V.15b (76%). 
 
Bruto formula: C6H11O3N 
M.W.: 145.1 g/mol  
Rf (ethyl acetate / isooctane: 1 / 1) = 0.14 
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IR (film) 3349 (s), 2942 (w), 2882 (w), 1702 (s), 1542 (s), 1459 (w), 1263 (s); 1149 (m), 1069 (m), 
995 (m), 995 (m), 935 (m), 778 (w) cm-1. 
1H NMR (500 MHz, CDCl3) d 5.90 (1H, m), 5.39 (1H, s), 5.29 (1H, m), 5.20 (1H, m), 4.55 (2H, d , J 
= 5.0 Hz), 3.69 (2H, m), 3.32 (2H, m), 2.89 (1H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 157.0 (C), 132.7 (CH), 117.7 (CH2), 65.7 (CH2), 61.8 (CH2), 43.3 
(CH2) ppm. 
ES-MS: m/z 146 [M + H]+, 168 [M + Na]+ 
 
Synthesis of tosylate V.16b 
 
AllocHN
OH
TsCl AllocHN
OTs
NEt3, CH2Cl2
V.15b V.16b92%
 
 
To a cooled (0 °C) solution of alcohol V.15b (500 mg, 3.45 mmol) in dichloromethane were added 
triethylamine (1.06 ml, 7.60 mmol) and tosylchloride (725 mg, 3.80 mmol). The mixture was 
stirred for 2 h and was then diluted with ethyl acetate. The organic phase was washed with 
brine. The combined organic phases were dried over anhydrous magnesium sulfate, filtered and 
evaporated under vacuum. The crude oil was purified by column chromatography (ethyl acetate / 
isooctane: 4 / 5) to provide 944 mg of tosylate V.16b (92%). 
 
Bruto formula: C13H17NO5S 
M.W.: 299.2 g/mol  
Rf (ethyl acetate / isooctane: 1 / 1) = 0.38 
IR (film) 2955 (w), 1714 (s), 1650 (w), 1598 (w), 1531 (m), 1455 (w), 1357 (s), 1258 (m); 1177 (s), 
1096 (m), 1012 (m), 917 (m), 775 (m), 664 (m), 580 (w), 554 (m) cm-1. 
1H NMR (500 MHz, CDCl3) d 7.78 (2H, d, J = 8.2 Hz), 7.35 (2H, d, J = 8.2 Hz), 5.87 (1H, m), 5.28 
(1H, d, J = 17.2 Hz), 5.21 (1H, d, J = 10.4 Hz), 5.08 (1H, s), 4.52 (2H, d , J = 5.5 Hz), 
4.09 (2H, t, J = 5.5 Hz), 3.45 (2H, dt, J = 5.3 Hz), 2.45 (3H, s) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 156.0 (C), 145.0 (C), 132.5 (CH), 129.9 (CH), 127.9 (CH), 117.7 
(CH2), 69.1 (CH2), 65.7 (CH2), 40.10 (CH2), 21.6 (CH3) ppm. 
ES-MS: m/z 300 [M + H]+, 322 [M + Na]+ 
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Synthesis of intermediate V.19 
 
DPPA
DBUOH OTBDPS
O spacer
IV.26
ODMPM
hv2
O OTBDPS
O spacer
V.19
ODMPM
hv2
PO(OPh)2
 
 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (4.0 ml, 0.0272 mmol) and diphenylphosphorazidate (60 
ml, 0.272 mmol) were added to a cooled (0 °C) suspension of resin IV.26 (48.7 mg, 0.008 mmol, 
0.16 mmol/g) in toluene (0.5 ml). After stirring for 2 h at 0 °C, the mixture was stirred overnight 
at room temperature. After filtration, the resin was washed with toluene (3 x 3 ml), 
dimethylformamide (3 x 3 ml), methanol (3 x 3 ml), and dichloromethane (3 x 3 ml) and was dried 
under vacuum for 4 h.  
 
IR (KBr) 3413 (m), 2878 (s), 1736 (w), 1638 (m), 1618 (s), 1509 (w), 1451 (m), 1355 (m), 1250 (m), 
1102 (s), 950 (s), 844 (m), 699 (s), 622 (w) cm-1. 
 
Photolytic cleavage of resin V.19 
 
CH3CN
hn
O OTBDPS
O spacer
V.19
ODMPM
hv2
PO(OPh)2
O OTBDPS
O spacer
ODMPM
CONH2
PO(OPh)2
 
 
Resin V.19 (1 mg, 0.14 10-3 mmol, 0.14 mmol/g) suspended in acetonitrile (100 ml) was submitted 
to photolytic cleavage (365 nm) for 4 h. The solution was analysed by ES-MS. 
 
M.W.: 1257 g/mol  
ES-MS: m/z 1280 [M + Na]+ 
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Synthesis of tosylate V.20 
 
TsCl, NEt3
CH2Cl2OH OTBDPS
O spacer
IV.26
ODMPM
hv2
OTs OTBDPS
O spacer
V.20
ODMPM
hv2
 
 
Tosylchloride (16.2 mg, 0.084 mmol) and triethylamine (12 µl, 0.084 mmol) were added to a 
cooled (0 °C) suspension of resin IV.26 (50 mg, 0.011 mmol, 0.21 mmol/g) in dichloromethane (1 
ml). The mixture was stirred overnight at room temperature. After filtration, the resin was 
washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and dichloromethane (3 x 5 ml) 
and dried under vacuum for 4 h. 
 
IR (KBr) 3025 (m), 3861 (s), 1737 (w), 1671 (m), 1509 (m), 1453 (s), 1347 (s), 1280 (s), 1086 (s), 
949 (m), 842 (m), 699 (s) cm-1. 
 
Photolytic cleavage of resin V.20  
 
CH3CN
hn
OTs OTBDPS
O spacer
V.20
ODMPM
hv2
OTs OTBDPS
O spacer
ODMPM
CONH2
 
 
Resin V.20 (1 mg, 0.16 10-3 mmol, 0.16 mmol/g) in suspension in acetonitrile (100 ml) was 
submitted to photolytic cleavage (365 nm) for 4 h. The solution was analysed by ES-MS. 
 
M.W.: 1179 g/mol  
ES-MS: m/z 1202 [M + Na]+ 
 
 
 
 
 
Part 7: Experimental part      
   
167
 
Synthesis of azide V.18 
 
NaN3
DMPUOTs OTBDPS
O spacer
V.20
ODMPM
hv2
N3 OTBDPS
O spacer
V.18
ODMPM
hv2
 
 
Sodium azide (15.5 mg, 0.24 mmol) triturated into a powder was added to a suspension of 
tosylate V.20 (37.0 mg, 0.006 mmol, 0.16 mmol/g) in 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-
pyrimidone (DMPU)  (0.5 ml). The suspension was heated at 40 °C overnight. The resin V.18 was 
filtered, washed with DMPU (3 x 3 ml), dimethylformamide (3 x 3 ml), methanol (3 x 3 ml) and 
dichloromethane (3 x 3 ml) and was dried under vacuum for 4 h. 
 
IR (KBr) 2866 (m), 2096 (w), 2023 (w), 1731 (w), 1637 (s), 1613 (s), 1514 (m), 1449 (w), 1355 (w), 
1273 (w), 1102 (m), 944 (w), 621 (w) cm-1. 
 
Photolytic cleavage of azide V.18 
 
CH3CN
hn
N3 OTBDPS
O spacer
V.18
ODMPM
hv2
N3 OTBDPS
O spacer
ODMPM
CONH2
 
 
Resin V.18 (1 mg, 0.16 10-3 mmol, 0.16 mmol/g) in suspension in acetonitrile (100 ml) was 
submitted to photolytic cleavage (365 nm) for 4 h. The solution was analysed by ES-MS. 
 
M.W.: 1050 g/mol  
ES-MS: m/z 1073 [M + Na]+ 
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Synthesis of acylazide V.24 
 
FmocHN NaN3+
EtOCOCl
NMM
FmocHN
O
OH
O
N3
b-alanine V.24
 
 
To a cooled solution (-20 °C) of Fmoc-protected b-alanine (200 mg, 0.640 mmol) in dry 
tetrahydrofuran (1 ml) were added ethylchloroformate (68 ml, 0.704 mmol) and N-
methylmorpholine (78 ml, 0.704 mmol). The mixture was stirred at -20 °C for 20 min before 
being allowed to warm to –5 °C. After 10 min at –5 °C, a solution of sodium azide (104 mg, 1.60 
mmol) in 160 ml water was added dropwise. After 10 min, a saturated aqueous solution of sodium 
chloride was added and the mixture was extracted with ethyl acetate. The organic phase was 
dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure to 
afford 208 mg of acylazide V.24,  which was used without further purification (97%). 
 
Bruto formula: C18H16N4O3 
M.W.: 336.35 g/mol  
Rf (ethyl acetate / isooctane: 3 / 7) = 0.29 
IR (film) 2949 (w), 2271 (s), 2139 (m), 1708 (s), 1522 (m), 1449 (m), 1255 (m), 1156 (m), 741 (m) 
cm-1. 
1H NMR (500 MHz, CDCl3) d 7.76 (2H, d, J = 7.5 Hz), 7.71 (2H, d, J = 7.5 Hz), 7.40 (2H, ABdd, J 
= 7.5 Hz), 7.32 (2H, ABdd, J = 7.5 Hz), 6.20 (1H, s), 4.50 (2H, d J = 7.2 Hz), 4.31 (1H, 
t, J = 7.2 Hz), 3.88 (2H, dd, J = 8.4, 7.7 Hz), 3.48 (2H, dd, J = 8.4, 7.7 Hz) ppm. 
13C NMR (50 MHz, CDCl3) + DEPT d 156.1 (C), 151.9 (C), 143.5 (C), 141.2 (C), 127.7 (CH), 127.1 
(CH), 125.2 (CH), 119.9 (CH), 68.2 (CH2), 46.7 (CH), 43.2 (CH2), 36.7 (CH2) ppm. 
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Synthesis of carbamate V.23 
 
FmocHN
NCO
V.22
OH OTBDPS
O spacer
IV.26
ODMPM
hv2
O OTBDPS
O spacer
V.23
ODMPM
hv2
NH
O
NHFmoc
2
 
 
A solution of acylazide V.24 (50 mg, 0.149 mmol) in dry toluene (1 ml) in presence of pyridine (12 
ml, 0.149 mmol) was heated to 70 °C for 1 h to form the intermediate V.22. The resin (30 mg, 
0.005 mmol, 0.16 mmol/g) was added to the solution and the mixture was heated at 70 °C 
overnight. After filtration, the resin V.23 was washed with toluene (3 x 3 ml), 
dimethylformamide (3 x 3 ml), methanol (3 x 3 ml) and dichloromethane (3 x 3 ml) and dried 
under vacuum for 4 h.  
 
The efficiency of the reaction was monitored by UV/VIS spectroscopy at 305 nm:  
Sample: m = 5 mg 
Absorbance: A = 0.239 
Theoretical loading: Loading = 0.16 mmol/g 
Measured loading:  Loading = 0.14 mmol/g 
Yield = 88% 
 
Synthesis of one member of the library 
 
O O
O spacer
O
CONH2
Gly
Ser(OH)
Phe
NH
Ac
Gly
His(NH)
Ala
NH
Ac
Gly
Asp(COOH)
Val
NH
Ac
V.29
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1-Synthesis of the first strand 
 
Coupling of FmocGlyOH on resin IV.26 
 
 a) Using acid chloride 
A solution of FmocGlyCl (0.265 g, 0.840 mmol), diisopropylethylamine (49.0 ml, 0.28 mmol) in 
dicholoromethane (3 ml) was added to the resin IV.26 (0.300 g, 0.05 mmol, 0.162 mmol/g). The 
suspension was skaken overnight. The coupling was repeated once again for 6 h. After filtration, 
the resin was washed with dimethylformamide (3 x 5 ml) and with methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml).  
 
The yield of the coupling was determined by UV/VIS monitoring at 300 nm:  
Sample: m = 6.0 mg 
Absorbance: A = 0.96 
According to the calibration curve, the experimental loading can be measured:  
A = 0.96; c (mol/l) = 0.124; V (ml) = 8; loading (mmol/g) = c (mol/l) x V (l) / m (g) = 0.165 mmol/g 
Calculated loading: 0.161 mmol/g 
Yield = 103 % 
 
A sample of the resin (2 mg, 0.400 mmol, 0.200 mmol/g) was suspended in 100 ml acetonitrile and 
was irradiated with UV light (365 nm) for 3 h. The solution was analyzed by ES-MS. 
M.W.: 1304 g/mol  
ES-MS: m/z 1327 [M + Na]+ 
 
 
 b) Using DIC, HOBt, DIPEA and DMAP 
To a suspension of resin IV.26 (0.30 g, 0.050 mmol, 0.162 mmol/g) in dry dimethylformamide (3 
ml) were added FmocGlyOH (125 mg, 0.42 mmol), 1-hydroxybenzotriazole (56.7 mg, 0.42 mmol), 
diisopropylcarbodiimide (67 ml, 0.42 mmol), diisopropylethylamine (71 ml, 0.42 mmol) and 4-
dimethylaminopyridine (0.021 mmol, 2.6 mg). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml).  
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The yield of the coupling was determined by UV/VIS monitoring at 300 nm.  
Sample: m = 5.7 mg 
Absorbance: A = 0.895 
According to the calibration curve, the experimental loading can be measured:  
A = 0.96; c (mol/l) = 0.116; V (ml) = 8 ; loading (mmol/g) = c (mol/l) x V (l) / m (g) = 0.162 mmol/g 
Calculated loading: 0.161 mmol/g 
Yield = 101 % 
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Coupling of FmocSer(OTrt)OH 
The carboxylic acid FmocSer(OTrt)OH (0.144 g, 0.252 mmmol) was first activated separatly 
with diisopropylcarbodiimide (40.0 ml, 0.252 mmol) and 1-hydroxybenzotriazole (34.0 mg, 0.252 
mmol). This solution was stirred for 30 min. at room temperature and was then added to the 
resin  (0.300 g, 0.047 mmol, 0.16 mmol/g). The mixture was skaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml). A sample of the resin was submitted to both 
colorimetric tests (TNBS and NF31) and colourless beads were observed. 
 
A sample of the resin (2 mg, 0.300 mmol, 0.150 mmol/g) was suspended in 100 ml acetonitrile and 
was irradiated with UV light (365 nm) for 3 h. The solution was analyzed by ES-MS. 
M.W.: 1633 g/mol  
ES-MS: m/z 1656 [M + Na]+, 1673 [M + K]+ 
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
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Coupling of FmocPheOH 
The carboxylic acid FmocPheOH (81.4 mg, 0.210 mmol) was first activated separately with 
diisopropylcarbodiimide (33.0 ml, 0.210 mmol) and 1-hydroxybenzotriazole (29.0 mg, 0.210 mmol). 
This solution was stirred for 30 min. at room temperature and was then added to the resin (0.30 
g, 0.045 mmol, 0.150 mmol/g). The mixture was skaken overnight at room temperature. After 
filtration, the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and colourless beads were observed. 
 
A sample of 2 mg of the resin (2 mg, 0.300 mmol, 0.147 mmol/g) was suspended in 100 ml 
acetonitrile and was irradiated with UV light (365 nm) for 3 h. The solution was analyzed by ES-
MS. 
M.W.: 1781 g/mol  
ES-MS: m/z 1804 [M + Na]+, 1820 [M + K]+ 
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Capping of the free amino functions 
Acetylimidazole (77 mg, 0.700 mmol) was added to a suspension of resin (0.250 g, 0.037 mmol, 
0.147 mmol/g) in dry dichloromethane (3 ml). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml). A sample of the resin was submitted to both 
colorimetric tests (TNBS and NF31) and intense coloured beads were observed. 
 
IR (KBr) 3572 (w), 3278 (w), 2860 (s), 1734 (m), 1669 (s), 1511 (s), 1453 (s), 1370 (s), 1264 (m), 
1073 (s), 947 (m), 841 (w), 698 (s) cm-1. 
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13C NMR (50 MHz, CD2Cl2) d 174.2, 173.3, 172.3, 171.4, 155.5, 150.0, 147,9, 145.1, 141.9, 140.2, 
138.1, 137.1, 135.4, 131.2, 130.8, 130.4, 130.2, 129.9, 129.3, 129.0, 121.6, 112.8, 112.7, 
111.0, 110.9, 88.3, 74.7, 74.2, 73.7, 72.1 (polyethyleneglycol peak), 71.2, 71.1, 70.2, 
67.1, 66.8, 65.0, 57.9, 57.4, 47.7, 46.2, 40.9, 40.5, 37.6, 36.2, 34.0, 32.0, 28.3, 26.6, 
24.4, 23.1, 20.6 ppm. 
 
A sample of resin V.25 (34.2 mg, 0.005 mmol, 0.147 mmol/g) in suspension in 1 ml of 1,4-dioxane 
containing 1% of dimethylsulfoxide was irradiated with UV light for 4 times 2 h. The solution was 
analyzed by ES-MS. After each cleavage, the resin was filtered and washed with 1,4-dioxane. 
After evaporation of 1,4-dioxane and removal of the dimethylsulfoxide with the Kugelrhor, the 
sample was purified by column chromatography (ethyl acetate) to provide 3.7 mg of the cleaved 
product (45%).  
 
Bruto formula: C96H108N4O16Si 
M.W.: 1600 g/mol  
Rf (ethyl acetate) = 0.53 
1H NMR (500 MHz, CD3OD) d 7.51 (4H, dd, J = 8.0, 1.4 Hz), 7.24 (38H, m), 6.81 (3H, m), 4.66 
(1H, dd, J = 7.5 Hz), 4.61 (1H, dd, J = 7.5 Hz), 4.42 (2H, s), 4.40 (2H, s), 4.37 (2H, s), 
4.36 (2H, s), 4.25 (2H, t, J = 6.4 Hz), 4.13 (2H, s), 3.95 (1H, ABd, JAB = 17.6 Hz), 3.86 
(1H, ABd, JAB = 17.5 Hz),  3.79 (2H, t, J = 6.4 Hz), 3.76 (3H, s), 3.69 (3H, s), 3.63 (2H, 
t, J = 6.4 Hz), 3.44 (6H, m), 3.38 (1H, m), 3.34 (1H, m), 3.12 (2H, m), 2.82 (6H, m), 
2.46 (2H, t, J = 6.4 Hz), 2.39 (2H, t, J = 6.4 Hz), 1.83 (3H, s), 0.95 (9H, s) ppm. 
ES-MS: m/z 1623 [M + Na]+, 1639 [M + K]+ 
 
2-Synthesis of the second strand 
 
Deprotection of the DMPM protecting group 
To a cooled (0 °C) suspension of resin V.25 (0.15 g, 0.023 mmol, 0.15 mmol/g) in a mixture of 
dichloromethane / water (1.4 ml / 0.1 ml) was added dichlorodicyanoquinone (14.3 mg, 0.063 
mmol). The mixture was shaken overnight at room temperature. After filtration, the resin was 
washed with an aqueous saturated solution of sodium bicarbonate (3 x 5 ml), phenol / methanol: 1 
/ 1 (3 x 5 ml), toluene (3 x 5 ml), acetonitrile (3 x 5 ml), dimethylformamide (3 x 5 ml), methanol 
(3 x 5 ml), dichloromethane (3 x 5 ml).  
 
Part 7: Experimental part      
   
174
 
A sample of 2 mg of the resin (2 mg, 0.300 mmol, 0.15 mmol/g) was suspended in 100 ml 
acetonitrile and was irradiated with UV light (365 nm) for 3 h. The solution was analyzed by ES-
MS. 
M.W.: 1450 g/mol  
ES-MS: m/z 1473 [M + Na]+ 
 
Coupling of FmocGlyOH 
To a suspension of resin (0.15 g, 0.023 mmol, 0.150 mmol/g) in dry dimethylformamide (3 ml) 
were added FmocGlyOH (63 mg, 0.21 mmol), 1-hydroxybenzotriazole (28.4 mg, 0.21 mmol), 
diisopropylcarbodiimide (33 ml, 0.21 mmol), diisopropylethylamine (36 ml, 0.21 mmol) and 4-
dimethylaminopyridine (2.6 mg, 0.021 mmol). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml).  
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Coupling of FmocHis(NMtt)OH 
The carboxylic acid FmocHis(NMtt)OH (78 mg, 0.126 mmmol) was first activated separatly with 
diisopropylcarbodiimide (20 ml, 0.126 mmol) and hydroxybenzotriazole (17 mg, 0.126 mmol). This 
solution was stirred for 30 min. at room temperature and was then added to the resin  (0.15 g, 
0.021 mmol, 0.14 mmol/g). The mixture was skaken overnight at room temperature. After 
filtration, the resin x was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and colourless beads were observed. 
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
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Coupling of FmocAlaOH 
The carboxylic acid FmocAlaOH (39 mg, 0.126 mmmol) was first activated separatly with 
diisopropylcarbodiimide (20 ml, 0.126 mmol) and hydroxybenzotriazole (17 mg, 0.126 mmol). This 
solution was stirred for 30 min. at room temperature and was then added to the resin  (0.15 g, 
0.021 mmol, 0.14 mmol/g). The mixture was skaken overnight at room temperature. After 
filtration, the resin x was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and colourless beads were observed. 
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Capping of the free amino functions 
Acetylimidazole (46 mg, 0.42 mmol) was added to a suspension of the resin (0.15 g, 0.021 mmol, 
0.14 mmol/g) in dry dichloromethane (3 ml). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml). A sample of the resin was submitted to both 
colorimetric tests (TNBS and NF31) and colourless beads were observed. 
 
Deprotection of the side-chain protecting groups trityl and methyltrityl group 
A sample of the resin (10 mg, 1.4 mmol, 0.14 mmol/g) was treated with a solution of 80% 
chloroacetic acid in a mixture dichloromethane/H2O (3/1) overnight at room temperature. The 
procedure was repeated 3 times two hours.  
 
A sample of 2 mg of the resin (2 mg, 0.280 mmol, 0.140 mmol/g) was suspended in 100 ml 
acetonitrile and was irradiated with UV light (365 nm) for 3 h. The solution was analyzed by ES-
MS. 
 
M.W.: 1515 g/mol  
ES-MS: m/z 1538 [M + Na]+ , 1300 [M – TBDPS + H + Na]+ 
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3-Synthesis of the third strand 
 
Deprotection of the TBDPS protecting group  
To a suspension of resin V.26 (150 mg, 0.021 mmol, 0.142 mmol/g) in 0.36 ml dimethylformamide 
was added TASF (0.0975 M) (tris-(dimethylamino)sulfur (trimethylsilyl)difluoride) in 
dimethylformamide (0.82 ml, 0.084 mmol). The suspension was shaken for 3 h at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml), dichloromethane (3 x 5 ml).  
 
Coupling of FmocGlyOH 
To a suspension of the resin (0.15 g, 0.023 mmol/g, 0.150 mmol/g) in dry dimethylformamide (3 
ml) were added FmocGlyOH (63 mg, 0.21 mmol), 1-hydroxybenzotriazole (28.4 mg, 0.21 mmol), 
diisopropylcarbodiimide (33 ml, 0.21 mmol), diisopropylethylamine (36 ml, 0.21 mmol) and 4-
dimethylaminopyridine (2.6 mg, 0.021 mmol). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml).  
 
Deprotection of the Fmoc protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Coupling of FmocAsp(COOTMSE)OH 
The carboxylic acid FmocAsp(COOTMSE)OH (57 mg, 0.126 mmmol) was first activated separatly 
with diisopropylcarbodiimide (20 ml, 0.126 mmol) and 1-hydroxybenzotriazole (17 mg, 0.126 
mmol). This solution was stirred for 30 min. at room temperature and was then added to the 
resin  (0.15 g, 0.021 mmol, 0.14 mmol/g). The mixture was skaken overnight at room temperature. 
After filtration, the resin x was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) 
and dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and colourless beads were observed. 
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Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Coupling of FmocValOH 
The carboxylic acid FmocValOH (43 mg, 0.126 mmmol) was first activated separatly with 
diisopropylcarbodiimide (20 ml, 0.126 mmol) and 1-hydroxybenzotriazole (17 mg, 0.126 mmol). 
This solution was stirred for 30 min. at room temperature and was then added to the resin  (0.15 
g, 0.021 mmol, 0.14 mmol/g). The mixture was skaken overnight at room temperature. After 
filtration, the resin x was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and colourless beads were observed. 
 
Deprotection of the Fmoc-protecting group 
The resin was treated with a solution of 20% piperidine in dimethylformamide (2 x 20 min). Then 
the resin was washed with dimethylformamide (3 x 5 ml), methanol (3 x 5 ml) and 
dichloromethane (3 x 5 ml). A sample of the resin was submitted to both colorimetric tests 
(TNBS and NF31) and intense coloured beads were observed. 
 
Capping of the free amino functions 
Acetylimidazole (46 mg, 0.42 mmol) was added to a suspension of the resin (0.15 g, 0.022 mmol, 
0.14 mmol/g) in dry dichloromethane (3 ml). The mixture was shaken overnight at room 
temperature. After filtration, the resin was washed with dimethylformamide (3 x 5 ml), 
methanol (3 x 5 ml) and dichloromethane (3 x 5 ml). A sample of the resin was submitted to both 
colorimetric tests (TNBS and NF31) and colourless beads were observed. 
 
Cleavage of tripodal member V.27 
A sample of resin V.27 (36.7 mg, 0.005 mmol, 0.14 mmol/g) in suspension in 1 ml of 1,4-dioxane 
containing 1% of dimethylsulfoxide was irradiated with UV light for 3 times 2 h. After each 
cleavage, the resin was filtered and washed with 1,4-dioxane. After evaporation of 1,4-dioxane 
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and removal of the dimethylsulfoxide with the Kugelrhor, the sample was purified by column 
chromatography (ethyl acetate) to provide 5.6 mg of compound V.28 (51%).  
 
M.W.: 2188 g/mol  
Rf (methanol / dichloromethane: 1 / 9) = 0.52 
 
Deprotection of the side-chain protecting groups trityl and methyltrityl group 
A sample of the resin (10 mg, 1.4 mmol, 0.14 mmol/g) was treated with a solution of 80% 
chloroacetic acid in a mixture dichloromethane / H2O (3 / 1) overnight at room temperature. The 
procedure was repeated 3 times two hours.  
A sample of 2 mg of the resin (2 mg, 0.280 mmol, 0.140 mmol/g) was suspended in 100 ml 
acetonitrile and was irradiated with UV light (365 nm) for 3 h. The solution was analyzed by ES-
MS. 
 
M.W.: 1690 g/mol  
ES-MS: m/z 868 [M + 2Na]2+, 1691 [M + H]+, 1713 [M + Na]+ 
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In addition, the limited mass-ion detection of our ES-MS equipment of 2000 g/mol did not allow 
the detection of the high molecular weight of the cleaved resin V.25 (2013 g/mol). 
104 The amount of DMAP needs to be carefully controlled to avoid deprotection of the Fmoc 
group and to avoid possible bicoupling. 
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9 Appendix 
 
 
Since 2001, NF31 is commercially available from ‘BACHEM’, catalog 2002, p 1282, 50 mg cost 
200 Swiss Franc (150 Euro) 
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NF31 
 
The name NF31 comes from Nadia Farcy who prepared this compound for the first time. The 
number corresponds to the page of the labbook. 
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10 Samenvatting 
 
In dit doctoraatswerk werd gewerkt aan de ontwikkeling van een nieuw niet-enzymatisch model 
voor het serineprotease a-chymotrypsine, gebaseerd op de katalytische triade 'serine- 
histidine-aspartaat'. Met behulp van een tripodale scaffold kan een combinatorische 
peptidebibliotheek gegenereerd worden waarin de drie aminozuren serine, histidine and 
aspartaat worden geïntegreerd elk in een peptideketen. De rol van de scaffold bestaat erin de 
nodige proximiteit te induceren tussen de verschillende katalytisch belangrijke aminozuur 
residues.  
 
Asp O
O
NNH H O
Ser
R-NH
R'
O
RNH2 R'COOH+
Katalytische triade
AZ1
AZ2
AZ3
AZ4
AZ5
AZ6
AZ7
AZ8
AZ9
scaffold
AspSer His
a-chymotrypsine
His
 
Schema 10.1 
 
De door ons ontworpen tripodale scaffold werd bereid uitgaande van het commercieel 
beschikbaar en goedkoop pentaerythritol. Scaffold III.6 bezit drie beschermde alcohol 
functies als aanhechtingspunten voor de peptideketens en een carbonzuur voor immobilisatie op 
de vaste drager.  
 
O
O
O
O
THPO
ODMPM
OTBDPS
spacer COOH
III.6
OH
HO OH
OH
pentaerythritol
 
 
Schema 10.2 
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In een eerste stadium werd de selectieve ontscherming van de drie beschermende groepen THP, 
DMPM en TBDPS bestudeerd. Een fotolabiele linker werd geïncorporeerd tussen de vaste fase 
en de pentaerytritol eenheid. Dit liet analyse en identificatie toe van de vrijgestelde producten 
na fotochemische afsplitsing. Het veratryl derivaat IV.23 ontwikkeld door Holmes wordt in de 
literatuur beschreven als de meest efficiente fotolabiele linker. Eerst werd dit carbonzuur 
gekoppeld aan de vaste drager waarna de Fmoc groep ontschermd werd. Vervolgens werd de 
tripodale scaffold met succes aan de fotolabiele linker gehecht. Na optimalisatie van de 
condities bleek dat UV-bestraling (365 nm) van een suspensie van product IV.24 in 1,4-dioxaan in 
aanwezigheid van 1% DMSO gedurende 9 u de beste resultaten gaf. Amide IV.25 werd aldus 
bekomen met een rendement van 86%.  
 
NHFmoc
O
MeO
OH
NO2
IV.23
3
O
O
O
O
O
OTHP
ODMPM
OTBDPS
spacer hn2
hn2
1. Selectieve ontscherming: 
a, b or  c
2. Ac2O, DIPEA, DMAP
3. hn (365 nm), 1,4-dioxaan
e / 1% DMSO
O
O
O
O
OR1
OR2
OR3
spacer CONH2
R1 R2 R3
THP
Ac
THP
THP
DMPM
DMPM
Ac
DMPM
TBDPS
TBDPS
TBDPS
Ac
IV.24
a) AcOH / CH2Cl2 / H2O: 80 / 15 / 5, 60 °C, 16 h; b) DDQ, CH2Cl2 / H2O: 19 / 1, 1 h, 0 
°C; c) TBAF, AcOH, moleculaire zeven (400 pm), THF of NH4F, MeOH of HF/pyr., THF 
of TASF, DMF.
3 stappen
IV.25
IV.37
IV.38
IV.28
 
 
Schema 10.3 
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De selectieve ontscherming van de verschillende OH-beschermende groepen kon nu op een 
efficiënte wijze gevolgd en geoptimaliseerd worden. De afsplitsing van de THP groep werd 
uitgevoerd met een oplossing van azijnzuur bij 60 °C of met behulp van PPTS bij 55 °C overnacht. 
De DMPM ether werd op selectieve wijze onstchermd met DDQ bij 0 °C gedurende 1 u. Langere 
reactietijd of hogere temperatuur leidde tot nevenreacties met de benzylethers aanwezig op de 
scaffold. Tot slot werd TBAF met azijnzuur gebruikt voor de ontscherming van de TBDPS ether. 
Elke ontscherming werd gevolgd met behulp van 13C NMR. De reproduceerbaarheid en efficiëntie 
van de beschreven procedures werd gecontroleerd na acylering van de alcoholfunctie en 
afsplitsing van de bekomen producten met UV-licht. De vrijgestelde acetaten IV.28, IV.37 en 
IV.38 werden geïsoleerd met een rendement van 55%, 62% and 56% respectievelijk. 
 
Voor de synthese van een tripodale bibliotheek dienden vervolgens geschikte beschermende 
groepen voor serine, histidine and aspartaat gekozen te woorden (schema 10.4). Het commercieel 
beschikbare FmocSer(OTrt)OH en FmocHis(NMtt)OH werden geselecteerd. De zuurgevoelige 
trityl en methytrityl groepen werden afgesplitst met behulp van chloorazijnzuur. In het geval 
van aspartinezuur werd gekozen voor de TMSE (trimethylsilylethyl) groep. Dit beschermde 
aspartinezuur werd bereid uitgaande van het commercieel beschikbare a-benzyl ester 
aspartinezuur. Volgens de literatuur kan de TMSE groep verwijderd worden met TBAF in DMF of 
TASF(tris-(dimethylamin)zwavel trimethylsilyldifluoride). 
 
C
Me
TBAF, DMF, 1 u
Trt =
Mtt =
 ClCH2COOH / CH2Cl2 / H2O
        
        80        /    15     /   5
 ClCH2COOH / CH2Cl2 / H2O
        
        80        /    15     /   5
 r.t.
 r.t.
FmocSer(OTrt)OH
FmocHis(NMtt)OH
Ontscherming
TASF, DMF, 3 u
FmocAsp(COO(CH2)2SiMe3)OH
V.8
 
 
Schema 10.4 
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In een laatste stadium werd een representatief lid van de tripodale bibliotheek gesynthetiseerd 
(zie V.27, schema 10.5). De afsplitsing van de THP groep werd gevolgd door de constructie van 
de eerste peptide keten. Glycine werd gekoppeld, gebruik makende van de DIC/HOBt methode in 
aanwezigheid van DMAP and DIPEA. De efficiëntie van deze koppelingsreactie werd gevolgd met 
behulp van UV-spectroscopie. Vervolgens werden serine en fenylalanine aangehecht. 
Ontscherming van de Fmoc groep en acylering van de vrije amine functies gaf het monopodale lid. 
Daarna werd de DMPM ether verwijderd met DDQ en de tweede peptideketen werd gegenereerd 
via een analoge procedure. Tot slot werd de TBDPS onstchermd met het TASF reagens en de 
laatste peptideketen werd opgebouwd met aspartinezuur en valine als aminozuren. De efficiëntie 
van alle koppelingsreacties werd nagegaan door de colorimetrische TNBS en NF31 testen. Een 
staal van het tripodale lid V.27 werd op dit stadium afgesplitst van de vaste drager en de 
structuur van het product werd bewezen door NMR analyse. Vervolgens werden de zijketen 
beschermende groepen op serine en histidine afgesplitst met chloorazijnzuur. Na fotolytische 
afsplitsing werd het tripodal lid V.30 geanalyseerd met behulp van massaspectroscopie. 
 
O
O
O
O
O O
spacer hn2
Gly
Ser
Phe
NH
Ac
Gly
His
Ala
NH
Ac
O
V.27
(TrtO)
Gly
Asp(COO(CH2)2SiMe3)
Val
NH
Ac(MttN)
O
O
O
O
O O
spacer CONH2
Gly
Ser
Phe
NH
Ac
Gly
His
Ala
NH
Ac
O
V.30
Gly
Asp
Val
NH
Ac
HO
HN
(COO(CH2)2SiMe3)
a) Zijketen ontscherming
b) hn (365 nm), 
1,4-dioxaan / 1% DMSO
 
Schema 10.5 
 
In de toekomst zal een tripodale bibliotheek opgebouwd worden op vaste fase gebruik makende 
van de split en mixmethode. Voor de screening van de bibliotheek werden een aantal 
testsubstraten I.16 ontwikkeld. Elk van die substraten vertoont een verschillende reactiviteit in 
een hydrolysereactie. Naast de zeer reactieve p-nitrofenylester I.16a werden het p-nitroanilide 
I.16b en het amide I.16c gesynthetiseerd. Bij behandeling van de bibliotheek met een van de 
kleurstoffen I.16 zal een potentiële katalysator met het substraat reageren waardoor een 
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transfer van de kleur op de vaste drager zal geobserveerd worden. Deze techniek laat een 
visuele detectie van eventuele katalysatoren toe. 
 
AZ1
AZ2
AZ3
AZ4
AZ5
AZ6
AZ7
AZ8
AZ9
scaffold
AspSer His
Bibliotheek
Screening
Visuele detectie
 
Schema 10.6 
 
De reactieve p-nitrofenylester I.16a werd gecommercialiseerd door Bachem (zie appendix). 
NF31 wordt momenteel gebruikt als testsubstraat voor de screening van de bibliotheek ten 
opzichte van hydrolytische activiteit en verder als nieuwe colorimetrische test voor de detectie 
van vrije aminefuncties op vaste drager. Deze nieuwe test is onder andere bijzonder nuttig voor 
het volgen van koppelingen op prolinederivaten daar dit niet mogelijk is met de tot nu toe 
gekende testprocedures. 
 
O2N N
N N
O
X
O
DR1
OPhNO2(p)
NHPhNO2(p)
NHCH2CH2OPhNO2(p)
I.16
a   X =
b   X =
c   X =
= NF31
 
 
Schema 10.7 
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(09) 245 59 68  
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Dr. A.P. Davis (Bristol, Groot-Brittannië) 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
dqf-COSY TOCSY ROESY 
 g V 
 b V 
 Na V Na V  
ND-aV 
Na D Na D 
 
 
bV-ND 
gV-ND  
 
 
 
 
Me-NV  
Na G3 
Na G1 Na G
2 
Na H 
Na S 
Na F 
Na A 
Na A 
bA 
b S  
b F 
b F 
b D 
b H 
Na G1 Na G3 
 
 
 
 
 
 
 
  
Me-NA Me-NF 
bF-NS 
bF-NS 
bS-NG  
bH-NG  
bA-NH 
 
Na S Na F 
Na D 
Na H 
Figure 5.4  
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